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Over the last decade, the 
number of children admitted 
to specialized intensive 
care units has increased 
significantly worldwide. 
The majority of critically ill 
infants nowadays survive. 
This development requires 
our focus to broaden from 
minimizing mortality rates 
to maximizing long-term 
quality of life following 
neonatal critical illness. 
The findings presented in 
this thesis demonstrate 
the importance of long-
term neurodevelopmental 
follow-up in survivors of 
neonatal critical illness and 
stress the need for early risk 
stratification and targeted 
intervention strategies for 
these children.
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General introduction
A young girl comes to our outpatient clinic for her follow-up visit at 8 years of age. As a 
neonate, she was treated with extracorporeal membrane oxygenation for severe meconium 
aspiration syndrome. Upon discharge, her cranial ultrasound was normal and routine visits 
in the first years of life showed favourable outcomes. In her records we see that on her routine 
IQ assessment at 5 years of age, she scored well-above average. She is a bright young girl, 
plays sports and is healthy. However, when asked how she is doing, she starts to cry. She says 
she keeps forgetting the plans she has made with friends or the homework she has to turn in 
the next day. She is in tears because she fears people will think she is not smart. Her parents 
are worried, they also question what will happen when she has to make the transition from 
primary school to high school. They do not understand what is wrong with her…
The number of critically ill neonates surviving after neonatal intensive care admission 
is increasing worldwide.1,2 The girl described here is, unfortunately, not unique. It is 
therefore of utmost importance that our focus broadens from prevention of mortality to 
long-term outcome in critically ill neonates.
A clearly delimited group of survivors of neonatal critical illness are children treated 
with neonatal extracorporeal membrane oxygenation (ECMO) or congenital diaphrag-
matic hernia (CDH) treated without ECMO. Since the first neonatal ECMO treatment 
applied in 1975, nearly 40,000 neonates have been treated with ECMO worldwide.3 The 
annual number of neonatal ECMO runs has decreased over the years and there has been 
a shift from respiratory to cardiac runs. Nonetheless, the most frequent underlying diag-
noses for neonatal ECMO remain meconium aspiration syndrome (MAS) and congenital 
diaphragmatic hernia (CDH). The survival rate following MAS is over 90%. CDH is a rare 
congenital anatomical malformation associated with significant mortality and morbid-
ity due to pulmonary hypoplasia and pulmonary hypertension. In the most severe cases 
of CDH, patients require treatment with ECMO and mortality rates are 49%.3 Over the 
past decade, standardized treatment protocols for CDH patients have led to less need 
for ECMO and to lower mortality rates.4 
The assessment of long-term outcome in these children is therefore increasingly 
important. Of particular concern is the neuropsychological outcome following neonatal 
critical illness. The brain is rapidly developing during the first months of life and therefore 
particularly vulnerable in these children.5 Given the importance of neuropsychological 
functioning both for academic performance and daily life activities, it is imperative to 
correctly identify and treat survivors of neonatal ECMO and/or CDH at risk of such long-
term impairments.
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idenTificaTion of PaTienTS aT riSk 
neuropsychological assessment
Within the last decade, a number of studies have evaluated long-term neuropsychologi-
cal outcome following neonatal ECMO and/or CDH. Fortunately, a significant number 
of children survive without overt neurological abnormalities, such as haemorrhage or 
periventricular leukomalacia.6,7 Moreover, general cognitive outcome seems generally 
comparable to that of healthy children at various stages of development.8-12 Strikingly, 
however, the incidence of school problems is significantly higher in these children com-
pared to the general population.11,13 This is highly suggestive of an alternative expla-
nation related to specific neuropsychological deficits rather than general intellectual 
functioning.
A limited number of follow-up studies have assessed specific neuropsychological 
functions in neonatal ECMO and/or CDH survivors. Sustained attention has been evalu-
ated in 8-year-old survivors of CDH, both in patients treated with and without ECMO. 
Attention deficits were found in 68% of children compared to the general population, 
with no influence of treatment type.13 In 8-year-old neonatal ECMO survivors following 
CDH as well as other diagnoses, sustained attention deficits were found as well, while 
visual-motor integration was normal.11 In the UK ECMO Trial, verbal and visual memory 
were assessed in 7-year-old survivors of severe respiratory failure randomized to receive 
either neonatal ECMO or conventional management.10 Both groups had significantly 
worse verbal and visual memory compared to the norm.10 Taken together, these studies 
suggest both memory and attention deficits following neonatal critical illness, while 
intelligence and visual-motor integration are normal.10,11,13 However, neuropsychologi-
cal assessment including all major cognitive domains in the same cohort is lacking. As 
such, the domains most affected following neonatal ECMO and/or CDH remain largely 
speculative. To improve identification of patients at risk, clear delineation of the neuro-
psychological profile following neonatal ECMO and/or CDH is needed.
neuroimaging
It is crucial to identify patients at risk of school problems as early as possible. Illness and 
treatment characteristics, such as underlying diagnosis or the duration of mechanical 
ventilation, may be useful to predict neuropsychological impairments as early as in 
infancy. However, as of yet, results have not been conclusive. Severity of illness rather 
than independent clinical characteristics may increase a child’s risk of long-term impair-
ments11,14, but quantifying severity of illness is difficult and clinically useful risk factors 
remain unknown. Therefore, it is important to investigate alternative ways to improve 
early identification. The use of advanced neuroimaging techniques to parcellate specific 
neurobiological correlates of impaired outcome may be useful in this respect. Studies 
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utilizing sophisticated neuroimaging methods to study survivors of neonatal ECMO 
and/or CDH are scarce.14,15 Van den Bosch et al. showed cortical thickness and global 
brain volumes in 8-to-15 year-old neonatal ECMO survivors to be similar to healthy 
controls, despite verbal memory problems in survivors.15 These results suggest that 
the underlying brain injury in ECMO survivors may be more specific and/or subtle. In 
school-age children who experienced neonatal hypoxia, specific alterations in bilateral 
hippocampal volume were found compared to healthy controls, which were associated 
with memory deficits in patients.9 In preterm infants, hippocampal volume measured 
at term-equivalent age correlated with memory outcomes both at two years and 
seven years of age.16,17 These findings indicate a potential predictive value of MRI. The 
neurobiological alterations associated with long-term neuropsychological deficits are 
therefore of interest, but remain unknown in survivors of neonatal ECMO and/or CDH.
TreaTmenT of PaTienTS aT riSk
Given the increased risk of neuropsychological impairments and school failure following 
neonatal ECMO and/or CDH, it is essential to find ways to prevent or diminish impaired 
outcome. However, few such intervention strategies are available. Cognitive training 
programs are based on the idea that repetitive mental exercise of one cognitive task re-
sults in improved functioning that may generalize to other tasks with similar underlying 
skills. A widely evaluated cognitive training for children with working-memory problems 
is Cogmed Working-Memory Training (CWMT).18 In children born preterm or with ADHD, 
studies have demonstrated near- and, although to a lesser extent, far-transfer effects 
after CWMT, i.e. improvements on trained and untrained cognitive functions.19,20 As 
working-memory is one of the fundamental building blocks for higher cognitive func-
tioning and highly associated with academic performance, CWMT may be beneficial for 
survivors of neonatal ECMO and/or CDH.21 However, its effectiveness remains unstudied 
in these children.
aimS and ouTline of ThiS TheSiS 
Growing up after neonatal ECMO and/or CDH has long-term neurodevelopmental con-
sequences.10,11,13-15 Therefore, long-term follow-up is of great importance in these chil-
dren. Neuropsychological follow-up after neonatal critical illness should have two main 
objectives: 1) (early) identification of patients at risk; 2) improving neuropsychological 
outcome in patients at risk. This thesis addresses these objectives (Figure 1).
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Identification. The specific neuropsychological profile and its underlying neurobiol-
ogy remain largely unknown – knowledge that is essential in order to improve (early) 
identification of patients at risk. First, the specific neuropsychological profile following 
neonatal ECMO and/or CDH is delineated, from infancy to school-age (chapters 2 & 3) 
and into adolescence (chapter 4). Secondly, the neurobiology following neonatal ECMO 
is compared to healthy controls using advanced neuroimaging techniques (chapter 
5), and the associations between brain alterations and long-term neuropsychological 
deficits are investigated in survivors of neonatal ECMO and/or CDH (chapter 6). Lastly, 
the pathophysiology underlying the brain alterations and associated long-term neuro-
psychological deficits across survivors of common causes of neonatal critical illness is 
explored by reviewing the literature (chapters 9 & 10).
Treatment. In addition to reliable and early identification of patients at risk, there is a 
need for treatment modalities or intervention strategies to improve neuropsychological 
outcome in these children. Therefore, the effects of a cognitive training program on neu-
ropsychological outcome (chapter 7) and brain connectivity (chapter 8) in school-age 
survivors of neonatal ECMO and/or CDH are studied.
Finally, the results of the studies are placed in a broader perspective and aims for 
future research are described (chapter 11).
Long-term follow-up after neonatal ECMO and/or CDH 
Identification Treatment 
Neuropsychological profile  
1. Infancy  
2. School-age 
3. Adolescence 
Pathophysiology 
1. Clinical 
2. Neurobiological 
Cogmed Working-Memory Training 
1. Neuropsychological outcome 
2. Brain connectivity 
figure 1. A schematic overview of the contents of this thesis
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abSTracT
objective To assess the longitudinal development of intelligence and its relation to 
school performance in a nationwide cohort of neonatal ECMO survivors as well as evalu-
ate predictors of outcome at eight years.
methods Repeated measurements of intelligence in neonatal ECMO survivors were 
collected at two, five and eight years (n = 178) with validated, standardized instruments. 
Selective attention (n = 148) and type of education were evaluated in the eight-year-
olds.
results Intelligence was found to remain stable and average across development (mean 
IQ(SD) at 2 years = 102(18); at 5 years = 100(17); at 8 years = 99(17)), p = .15. Children 
attending regular education without the need for help (n = 101, mean z-score(SD) = 
-1.50(1.93)) performed significantly better on the selective attention task compared to 
those children in need of extra help (n = 65, mean z-score(SD) = -2.54(3.18)) or those 
attending special education (n = 13, mean z-score(SD) = -4.14(3.63)), p = .03. However, 
only children attending special education had below average intelligence (mean IQ(SD) 
= 76(15)), compared to average intelligence for those attending regular education, both 
with (mean IQ(SD) = 95(15)) and without help (mean IQ(SD) = 105(16)). Children with 
congenital diaphragmatic hernia scored significantly lower on both IQ (CDH mean IQ(SD) 
= 93(20); MAS mean IQ(SD) = 100(15); other diagnoses mean IQ(SD) = 100(19), p = .04) 
and selective attention (CDH, mean z-score(SD) = -3.48(3.46)); MAS mean z-score(SD) = 
-1.60(2.13); other diagnoses mean z-score(SD) = -1.65(2.39), p = .002) compared to other 
diagnoses.
conclusion Intelligence testing alone does not identify those at risk for academic prob-
lems for the majority of neonatal ECMO survivors. We propose internationally standard-
ized follow-up protocols that focus on long-term problem-oriented neuropsychological 
assessment.
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inTroducTion 
Extracorporeal membrane oxygenation (ECMO) has been used in over 28,000 neonates 
with severe respiratory failure who are unresponsive to conventional medical manage-
ment.1 Survival rates have remained stable over the years with 5-10% surviving with 
severe neurological complications.1 The remaining 90% of survivors are at risk for subtler 
long-term neurodevelopmental problems.2-4 Despite increasing awareness of these 
problems, the current standardized (international) follow-up protocols are inadequate 
for the detection of neuropsychological deficits in neonatal ECMO survivors.1,5 As the 
ELSO recommendations have not been reviewed since 1997, an evidence-based update 
is mandatory.6
In many follow-up programs, intelligence remains the primary outcome measure.5,6 
Previous studies have shown intelligence to be comparable to that of healthy children at 
various stages of development.2,3,7-9 IQ testing can give valuable insight into the overall 
cognitive functioning of an individual, but is not suited to detect subtle neuropsycho-
logical impairments.10 Extensive neuropsychological testing in neonatal ECMO survivors 
has demonstrated deficits especially in the attention and (working) memory domains 
in 8- and 17-year-olds2,4 with an increased need for extra help in school.2,4,8 Since IQ is 
generally within the average range, the school problems are likely due to specific neu-
ropsychological impairments. However, this remains largely speculative and IQ has not 
been studied longitudinally.
In this study, we aimed to investigate the relationship between school problems and 
cognitive outcome in neonatal ECMO survivors. To do so, we first assessed the longitu-
dinal development of intelligence at two, five and eight years of age in a nationwide 
cohort of neonatal ECMO survivors. We then evaluated type of education attendance 
in relation to intelligence and to selective attention at eight years of age. Finally, we 
studied whether school performance and cognitive outcome at eight years of age were 
influenced by clinical characteristics. We hypothesized that intelligence is normal across 
the three ages and unrelated to the school problems observed in neonatal ECMO sur-
vivors. Based on this, we propose standardized, problem-oriented follow-up aimed at 
specific neuropsychological domains that can be internationally implemented.
meThodS
Population 
Patients born between January 1996 and December 2006 treated with ECMO within the 
first 28 days of life and participating in the structured prospective post-ECMO follow-up 
program were eligible for the current study (n = 278). Children were either part of the 
Chapter 2
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follow-up program that was initiated in 2001 at the Erasmus MC-Sophia Children’s Hos-
pital in Rotterdam (n = 143) or at the Radboud University Medical Centre in Nijmegen 
initiated in 1998 (n = 135). ECMO support was given according to the criteria described 
by Stolar et al11 which did not change over time. Entry and exclusion criteria for follow-up 
were previously described.2,7 The post-ECMO follow-up program is the standard of care 
in the Netherlands2,7,12, therefore Institutional Review Board approval was waived. Only 
those children of whom at least the mental developmental index at two and IQ at eight 
years of age were evaluated were included (Rotterdam, n = 96, Nijmegen, n = 82) (Figure 
1). Demographic and medical characteristics of the patients are reported in Table 1.
Neonatal ECMO patients in the Netherlands  
born between Jan. 1996 and Dec. 2006, 
n = 384 
• Rotterdam, n = 195 
• Nijmegen, n = 189 
Eligible, n = 278 
Died, n = 106 (27%) 
No FU at 2, n = 74 
• Untraceable, n = 22 
• Refusal, n = 22 
• Untestable, n =17 
• Tested elsewhere, n = 3 
• Organizational, n = 10* 
Remaining, n = 204 
FU at 2, but not at 8, n = 26  
• Untraceable, n = 5 
• Refusal, n = 10 
• Untestable, n = 7 
• Tested elsewhere, n = 4 
Follow-up at 2, 5 and 8 years of age, n = 178 
• Rotterdam, n = 96 
• Nijmegen, n = 82 
figure 1. Inclusion flowchart of the neonatal ECMO survivors
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Table 1. Patient characteristics
All (n = 178) MAS (n = 97) CDH (n = 36) Other (n = 45)
a) Demographic 
Gender
Male 96 (54) 46 (47) 24 (67) 26 (58)
Female 82 (46) 51 (53) 12 (33) 19 (42)
Ethnicity 
Dutch 143 (81) 75 (78) 31 (86) 37 (82)
Non-Dutch 34 (19) 21 (22) 5 (14) 8 (18)
Unknown 1 1 0 0
MEL
Low 45 (27) 21 (23) 11 (34) 13 (30)
Moderate 65 (39) 38 (42) 10 (30) 17 (40)
High 56 (34) 31 (35) 12 (36) 13 (30)
Unknown 12 7 3 2
Type of education at 8
Regular 100 (56) 58 (60) 18 (51) 24 (53)
Regular with help 65 (37) 36 (37) 15 (43) 14 (31)
Special education 12 (7) 3 (3) 2 (6) 7 (16)
Unknown 1 0 1 0
b) Clinical 
Birthweight (grms) 3461 (552) 3512 (551) 3316 (436) 3465 (624)
Gestational age (wks) 40 (2) 41 (2) 39 (1) 39 (2)
Type of ECMO
VA 155 (87) 77 (79) 36 (100) 42 (93)
VV 21 (12) 18 (19) 0 (0) 3 (7)
VV conversion to VA 2 (1) 2 (2) 0 (0) 0 (0)
Unknown 1 0 0 0
Age start ECMO (dys) 1 (0-23) 1 (0-10) 1 (0-11) 2 (0-23)
Hours on ECMO 140 (24-369) 135 (24-288) 177 (63-369) 138 (53-288)
Mechanical vent. (dys) 14 (3-68) 13 (6-32) 28 (7-68) 13 (3-40)
O2 post-ECMO
1 day – 1 week 87 (53) 51 (56) 9 (30) 27 (63)
>1 week - <1 month 64 (39) 35 (39) 14 (47) 15 (35)
>1 month 13 (8) 5 (5) 7 (23) 1 (2)
Unknown 14 6 6 2
CLD presence
yes 39 (23) 18 (20) 16 (50) 5 (11)
No 129 (77) 74 (80) 16 (50) 39 (89)
Unknown 10 5 4 1
Chapter 2
28
neuropsychological assessment 
Intelligence 
Intelligence was measured at two, five and eight years of age. For two-year-olds, the 
Bailey Developmental Scales (BOS 2-30) (n = 100) or, from December 2003, the Bailey 
Scales of Infant Development – Second Edition – Dutch version (BSID-II-NL) (n = 78) were 
used to assess mental outcome. These standardized instruments both assess verbal and 
non-verbal development of 2-to-30 month-old children and are substantially related to 
each other.13 
The Revised Amsterdam Intelligence Test (RAKIT) short-form was used at five years.14 
For the eight-year-olds, the RAKIT (n = 102) or the Wechsler Intelligence Scale for 
children (WISC-III-NL; n = 76) was used.15 Both tests assess verbal and non-verbal intel-
ligence, have been shown to have good reliability and validity14,15, and have been used 
interchangeably by our group before.16 
For all four tests, a normalized population mean of 100 with a standard deviation of 15 
is used.13-15 The outcome on all four tests is referred to as intelligence or IQ.
Selective attention
Selective attention was measured in the eight-year-old children (n = 148) with the Dot 
Cancellation paper-and-pencil test. The main outcome measure was working-speed, 
which was converted into z-scores (individual score minus the population score divided 
by the population standard deviation). Good validity, sensitivity, reliability and Dutch 
normative data have been reported.17 
Table 1. Patient characteristics (continued)
All (n = 178) MAS (n = 97) CDH (n = 36) Other (n = 45)
Abnormal CUS
yes 17 (10) 6 (6) 2 (6) 9 (20)
No 159 (90) 91 (94) 33 (94) 35 (80)
Unknown 2 0 1 1
N (%) is reported for all demographic variables. Non-Dutch refers to children with at least one non-native 
Dutch parent. The mean (SD) is reported for birthweight and gestational age. The median (range) is report-
ed for age start ECMO in days, total amount of hours on ECMO and time on mechanical ventilation in days. 
N (%) was reported for extra oxygen need post-ECMO, type of ECMO and CLD presence. Other diagnoses 
were sepsis (n = 10), persistent pulmonary hypertension of the newborn (PPHN; n = 30), pneumonia (n = 
2), congenital cystic adenomatoid malformation of the lung (n = 1), pneumothorax (n = 1) and infant re-
spiratory distress syndrome (n = 1). Abbreviations: MAS, meconium aspiration syndrome; CDH, congenital 
diaphragmatic hernia; MEL; maternal educational level; grms, grams; wks, weeks; dys, days; ECMO, extracor-
poreal membrane oxygenation; O2 post-ECMO, extra oxygen supply post-extubation; VA, venoarterial; VV, 
venovenous; CLD, chronic lung disease; CUS, cranial ultrasound.
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Procedures and study design
Children underwent neuropsychological evaluation by a psychologist at two, five and 
eight years of age. Parents filled in questionnaires on ethnicity (Dutch/≥1 non-native 
Dutch parent) and maternal educational level (MEL; high/moderate/low). MEL refers to 
the highest type of education completed by the mother.18 Various medical character-
istics were recorded prospectively: birth weight, gestational age, diagnosis, age at the 
start of ECMO, ECMO duration/type (venoarterial (VA)/venovenous (VV)/VV conversion 
to VA), duration of mechanical ventilation, extra oxygen supply post extubation, chronic 
lung disease (CLD; yes/no)19 and abnormal cranial ultrasound (CUS; yes (i.e. parenchymal 
or intracranial bleedings)/no).
data analysis 
Clinical characteristics of participants and non-participants of the follow-up program 
were compared using independent-samples T-tests for the normally distributed data 
and Mann-Whitney U tests for the non-normally distributed data.
The developmental trajectory of intelligence was evaluated using repeated-measures 
ANOVA. Normality tests were performed. Mauchly’s test was used to assess and correct 
for sphericity.
Type of education attendance at eight years of age and its relations to intelligence at 
two, five and eight and selective attention at eight were analyzed using Kruskal-Wallis H 
tests. For post-hoc analyses, the three education categories were transformed into two 
dummy variables: 1) regular education with help versus regular education and special 
education and 2) special education versus regular education with and without help. 
Independent samples T-tests were then conducted to evaluate which groups differed.
Next, the effect of diagnosis (meconium aspiration syndrome (MAS), congenital dia-
phragmatic hernia (CDH), other diagnoses) on intelligence at all ages, and selective at-
tention at eight years were evaluated using Kruskall-Wallis H tests, as previous research 
has shown CDH patients to perform worse compared to children with other diagnoses.2 
Finally, associations between IQ at two years, IQ at five years and outcome at eight 
years of age were evaluated using multivariate linear regression analyses, adjusted for 
MEL and parents’ ethnicity.20-22 Parents’ ethnicity was used because a child’s verbal skills, 
and thus neurodevelopmental outcome, may be affected by a parent who was born out-
side of the Netherlands and does not speak Dutch as their first language.21 The influence 
of medical characteristics on IQ and selective attention at eight years of age was tested 
in two separate models. Diagnosis, type of ECMO, duration of mechanical ventilation 
and CLD were added into the multivariate linear regression analyses. The assumptions 
for multivariate linear regression analysis were checked with normal probability plots 
of the residuals and the Durbin-Watson test. Multicollinearity was evaluated using the 
criterion that variance inflation factors could not exceed 2.5.23 
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Analyses were performed with SPSS 22.0 (IBM, Chicago, IL, USA). For all analyses, a 
p-value of < .05 was considered statistically significant.
reSulTS
Participants had a significantly higher birthweight than non-participants (mean birth-
weight (SD) = 3461 (552) and 3294 (556) grams respectively; p = .02). No other clinical 
differences were found between participants and non-participants.
developmental trajectory of intelligence
Intelligence fell within the normal range at two, five and eight years of age (Figure 2).13-15 
Mauchly’s test indicated that the assumption of sphericity had been violated (p < .001), 
therefore Greenhouse-Geisser corrected tests are reported (ɛ = .01). Intelligence was 
found to remain stable from two, to five, to eight years of age (p = .15, n = 152). At eight 
years old, six children (3%) had low IQ scores (<70), 39 children (22%) had below average 
IQ scores (≤85), 103 children (58%) had average IQ scores (85-115) and 30 children (17%) 
had an above average IQ (≥115).
outcome and type of education 
Intelligence 
Sixty-five (37%) of the ECMO survivors needed extra help at school at eight years versus 
20% of children in the general population.24 Twelve children (7%) in our cohort attended 
special education at eight years of age (Table 1a), compared to 4.4% in the general 
population.24 To get a better understanding of the relatively high proportions of children 
receiving extra help and attending special education, we analyzed its relationship with 
intelligence. Children attending special education had significantly lower intelligence 
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figure 2. Longitudinal assessment of in-
telligence following neonatal ECMO 
Mean (SD) of MDI/IQ was reported at 
two, five and eight years of age. The 
population mean IQ (SD) = 100 (15). Ab-
breviations: MDI, mental developmental 
index; IQ, intelligence quotient.
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from two years onwards, whereas those attending regular education, irrespective of their 
need for extra help, had comparable intelligence to the general population (Table 2).
Selective attention
The ECMO survivors who attended regular education without help performed significantly 
better on the selective attention task compared to those needing extra help or attending 
special education (p = .02). Selective attention did not significantly differ between the ECMO 
survivors attending special education and those needing extra help (p = .75) (Table 2).
diagnosis 
Intelligence did not differ at two and five years of age between MAS, CDH or other diag-
noses. At eight years of age, CDH patients had a significantly lower IQ than those with 
other diagnoses, (p = .04). Furthermore, significant differences were found on selective 
attention between the three diagnostic groups (p = .007), with the CDH group scoring 
lowest on the selective attention task (Table 3).
Table 2. Outcome based on type of education attendance at eight years of age
MDI 2 yrs 
(n = 178)
IQ 5 yrs 
(n = 152)
IQ 8 yrs
(n = 178)
Selective attention 8 yrs 
(n = 148)
Regular education 105 (16) 106 (14) 104 (16) -1.50 (1.93)
Regular education with help 100 (19) 95 (17) 95 (15) -2.54 (3.18)
Special education 83 (19)* 81 (15)* 77 (15)* -2.91 (2.21)
Mean (SD) of MDI/IQ and mean z-score (SD) of selective attention as measured by working speed are re-
ported based type of education. Mean z-score (SD) = 0 (1). IQ population mean (SD) = 100 (15).
*Significantly different IQ score than the general population at p < .001.
Abbreviations: MDI, mental developmental index; yrs, years.
Table 3. Neuropsychological outcome based on diagnosis
MDI 2 yrs IQ 5 yrs IQ 8 yrs Selective attention 8 yrs
MAS 104 (18) 101 (14) 100 (15) -1.60 (2.13)
n 97 81 97 86
CDH 98 (18) 98 (21) 93 (20)* -3.48 (3.46)*
n 36 32 36 30
Other 99 (18) 99 (18) 100 (19) -1.39 (1.88)
n 45 39 45 32
Mean (SD) of MDI/IQ and mean z-score (SD) of selective attention as measured by working speed are re-
ported based on diagnosis. The IQ population mean = 100 (15). Mean z-score (SD) = 0 (1). *Significantly 
different compared to other diagnostic groups at p < .05.
Other diagnoses include persistent pulmonary hypertension of the newborn, sepsis, cardinal respiratory 
insufficiency, persistent fetal circulation and respiratory syncytial infection.
Abbreviations: MDI, mental developmental index; MAS, meconium aspiration syndrome; CDH, congenital 
diaphragmatic hernia; yrs, years.
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Predictors of outcome at eight years 
Low MEL increased the likelihood of having a lower IQ at eight years of age. Also, chil-
dren with higher IQ scores at five years of age were more likely to have higher IQ at eight. 
Having a lower IQ score at five years of age increased the likelihood of a poorer score on 
the selective attention task at eight years of age (Table 4).
None of the medical characteristics were significantly related to outcome at eight 
years of age (Table 4).
diScuSSion
This is the first longitudinal assessment of IQ in a large group of children treated with 
neonatal ECMO. We showed that intelligence falls within the average range at two, five 
and eight years of age and remains stable. This is in line with previous cross-sectional 
Table 4. Predictors of outcome at eight years
IQ 8 yrs Selective attention 8 yrs
Demographic predictors 
Low MEL B = -4.72, p = .03
(ci -8.90 – -0.53)
B = 0.04, p = .94
(CI -1.00 – 1.08)
Dutch ethnicity B = -1.80, p = .45
(CI -6.51 – 2.92)
B = -1.10, p = .09
(CI -2.27 – 0.15)
MDI at two B = 0.07, p = .22
(CI -0.04 – 0.18)
B = -0.01, p = .54
(CI -0.04 – 0.02)
IQ at five B = 0.75, p < .001
(ci 0.63 – 0.88)
B = -0.07, p < .001
(ci -0.10 – -0.04)
Medical predictors
CDH B = -5.02, p = .25
(CI -13.65 – 3.62)
B = 1.31, p = .07
(CI -0.08 – 2.70)
MAS B = -0.43, p = .89
(CI -6.70 – 5.83)
B = -0.01, p = .98
(CI -1.04 – 1.02)
VA B = 2.82, p = .49
(CI -5.21 – 10.84)
B = -0.10, p = .87
(CI -1.27 – 1.08)
Mech. vent. (days) B = -.19, p = .19
(CI -0.46 – 0.09)
B = 0.04, p = .06
(CI -0.00 – 0.09)
Multivariate regression analyses to assess the influence of demographic and medical characteristics on 
outcome at eight years of age. Selective attention is measured by working-speed given in seconds; a higher 
score represents slower working-speed and vice versa. MEL (high MEL versus low and moderate MEL; low 
MEL versus high and moderate MEL) and diagnosis (CDH versus rest; MAS versus rest) are dummy variables 
(yes = 1, no = 0). Ethnicity is Dutch (1) or non-Dutch (0).
A P-value of > .05 was considered statistically significant.
Abbreviations: yrs, years; MEL, maternal educational level; MDI, mental developmental index; CDH, con-
genital hernia diaphragmatic; MAS, meconium aspiration syndrome; VA ECMO, venoarterial extracorporeal 
membrane oxygenation; CLD, chronic lung disease.
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studies.2,3,7,8,21 Strikingly, a large group of children attending regular education needed 
extra help in school, despite average intelligence. We found that these school difficul-
ties were related to selective attention problems. As current follow-up protocols focus 
mainly on IQ, language and visuomotor integration – domains that have been shown to 
remain intact following neonatal ECMO6,7,25-27 – those ECMO survivors at risk for school 
problems will not be identified. Our results underline the importance of standardized, 
evidence-based and problem-oriented neuropsychological follow-up following neona-
tal ECMO.
Despite the fact that the ECMO survivors included in this study did not have severe 
neurological morbidity, twice as many children in our cohort needed extra help at 
regular education compared to the general population24, as previously found by our 
group.2 However, all had average intelligence, which did not differ from those who did 
not need help in school. Also, a relatively high number of ECMO survivors attended 
special education compared to the general population.24 These children had below 
average intelligence. Interestingly, both the ECMO survivors needing extra help and 
the ones attending special education performed significantly worse on the selective 
attention task compared to the ECMO survivors not needing help in school. Our find-
ings therefore allow us to identify two groups of neonatal ECMO survivors who (without 
overt neurological deficits) are at risk of long-term school problems: those with lower 
IQ and related neuropsychological impairments and those with average IQ but with 
isolated neuropsychological deficits. For children attending special education, poor 
selective attention is more in accordance with – and may be partly explained by – their 
below average intelligence. The combination of which may lead to the need for special 
education. However, for those children needing extra help, isolated neuropsychological 
deficits may cause the need for educational support.
For identification of those at risk of school problems, especially of the ECMO survivors 
with average intelligence, problem-oriented neuropsychological assessment that goes 
beyond testing global cognitive functioning with the use of an IQ test10 is essential. 
Attention and (working) memory have been shown to be overlapping constructs that 
share much of the same pathways in the brain.29 The attention problems observed in our 
cohort could therefore be accompanied by (working)memory deficits. Indeed, earlier 
studies have shown neuropsychological problems to lie mainly in the attention and 
memory domains in these children.2-4,28 It is therefore highly recommended that, besides 
intelligence, both attention and memory are focused on following neonatal ECMO. Us-
ing the current guidelines, neonatal ECMO survivors at risk for school problems will not 
be identified.6,7,25,27,30 We therefore propose a problem-oriented revision of follow-up 
protocols.
Since neuropsychological impairments in neonatal ECMO survivors have shown 
to emerge in childhood and to persist even into adolescence2-4, neuropsychological 
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follow-up that extends beyond the age of five is crucial.6 Neonatal follow-up of prema-
ture infants has shown early developmental assessments of high-risk infants to often 
be imprecise – especially for those with milder impairments that at a later age do affect 
their school performance.31 It is likely that this is similar to neonatal ECMO follow-up. 
Moreover, neuropsychological testing beyond early childhood is important as these 
types of deficits at a later age may not only continue to hamper academic performance, 
but also affect the ability to participate in society and thus lead a fulfilling life.4 However, 
as we have shown intelligence at five years of age to be highly predictive of IQ at eight, 
elaborate IQ assessment both at five and at eight may be redundant. To make most ef-
ficient use of time and resources, assessment of a full IQ can be considered at five years 
of age so that specified neuropsychological assessment can be conducted at eight years 
of age. At eight years, IQ can be screened with the use of a few subtests and, only if 
needed, a full IQ test can be administered. Such a problem-oriented approach will make 
risk stratification and early identification of those neonatal ECMO survivors at risk for 
school problems more feasible.
Finally, within follow-up of neonatal ECMO survivors, certain risk factors of impaired 
neurodevelopment should be taken into account. IQ at eight years old and selective 
attention were lower in CDH patients compared to children with other underlying 
diagnoses. These findings confirm earlier work demonstrating CDH patients to have 
generally worse outcomes.2 Our proposal of problem-oriented and evidence-based 
neuropsychological follow-up therefore seems even more critical for this particular 
patient group. None of the other clinical characteristics studied were found to predict 
outcome at eight years of age, this is in line with previous findings.2,4 Low MEL signifi-
cantly increased the likelihood of lower IQ at eight years of age. Although this result is 
not specific to neonatal ECMO survivors31,32, it is important to take into account during 
neonatal ECMO follow-up.
In this nationwide study we are the first to longitudinally assess intelligence in a large 
group of neonatal ECMO survivors. We have identified two specific groups of neonatal 
ECMO survivors who may be at risk for school problems: those with neuropsychological 
impairments despite having average intelligence and those with below average intel-
ligence and neuropsychological impairments. As sources for educational support are 
available for all schools in the Netherlands, the number of children needing educational 
support or special education reported in this study are likely to be accurate. Furthermore, 
due to the high level of compliance, selection bias is highly unlikely. Nonetheless, our 
study has some limitations. First, a Dutch test measuring selective attention was used 
which limits cross-sectional comparisons. On the other hand, we were able to compare 
our data to Dutch normative data. Second, 11% of children (n = 31) did not complete 
the neuropsychological assessment at two and/or eight years of age due to cognitive or 
behavioral impairments (n = 14, seen elsewhere with severe cognitive impairment (i.e. 
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IQ < 70); n = 11, too tired or uncooperative at time of assessment; n = 6, tested elsewhere 
but had average IQ scores), which may have resulted in a bias. However, the percent-
age of dropouts due to severe cognitive impairment was relatively low in comparison 
to the total number of participants, making significant bias unlikely. Third, treatment 
technologies, especially the use of centrifugal pumps, a smaller priming volume and 
new membranes with subsequently other adherence of commonly used drugs, are con-
stantly changing and this may affect long-term outcomes. The current findings may thus 
not be generalizable to patients treated in recent years. Future studies should compare 
outcome between patients treated in different time periods to see what the effects of 
technology changes are in the long-term. Finally, at the time of data collection, our neu-
ropsychological follow-up consisted only of intelligence and attention tests. Therefore, 
other cognitive functions that might be susceptible to impairment following neonatal 
ECMO, such as memory and executive functioning4, were not evaluated. Future studies 
should include these cognitive functions when assessing long-term neurodevelopment 
in neonatal ECMO survivors.
concluSion
Neonatal ECMO survivors have an overall average and stable IQ from two, to five, to eight 
years of age. Despite this, a large group is at risk for school problems. In the majority of 
ECMO survivors at risk, these school problems were related to isolated selective atten-
tion deficits. IQ alone is therefore not a reliable predictor of school performance or even 
eventual participation in society. As current neonatal ECMO follow-up protocols mainly 
focus on IQ and language and visuomotor integration, those children at risk will not 
be identified. Our findings emphasize the need for evidence-based, problem-oriented 
neuropsychological follow-up with a focus on attention and memory functioning fol-
lowing neonatal ECMO. Taken into account should be risk factors such as low MEL and/
or a CDH diagnosis. As neuropsychological impairments have been shown to emerge in 
childhood and persist into adolescence, follow-up should extend beyond five years of 
age.
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abSTracT
objective Until now, long-term outcome studies have focused on general cognitive 
functioning and its risk factors following neonatal extracorporeal membrane oxygen-
ation (ECMO) and/or congenital diaphragmatic hernia (CDH). However, it is currently 
unknown which neuropsychological domains are most affected in these patients, and 
which clinical variables can be used to predict specific neuropsychological problems. 
This study aimed to identify affected neuropsychological domains and its clinical deter-
minants in survivors of neonatal ECMO and/or CDH.
design Prospective follow-up study.
Setting Tertiary university hospital.
Patients Sixty-five eight-year-old survivors of neonatal ECMO and/or CDH.
interventions None.
measurements and main results Intelligence, attention, memory, executive function-
ing and visuospatial processing were evaluated using validated tests and compared with 
Dutch reference data. Assessed risk factors of outcome were illness severity indicators, 
number of anesthetic procedures in the first year of life and growth at one year. Patients 
had average intelligence (mean IQ±SD: 95±16), but significantly poorer sustained 
attention (mean z-score±SD: ─2.73±2.57), verbal (immediate: ─1.09±1.27; delayed: 
─1.14±1.86) and visuospatial memory (immediate: ─1.48±1.02; delayed: ─1.57±1.01; 
recognition: ─1.07±3.10) than the norm. ECMO-treated CDH patients had significantly 
lower mean IQ (84±12) than other neonatal ECMO patients (94±10) and CDH patients 
not treated with ECMO (100±20). Maximum vasoactive-inotropic score was negatively 
associated with delayed verbal (B = ─0.02, 95%CI: ─0.03 to ─0.002, p =.026) and visuo-
spatial memory (B = ─0.01, 95%CI: ─0.02 to ─0.001, p = .024).
conclusions We found memory and attention deficits in eight-year-old survivors of 
neonatal ECMO and CDH. The maximum dose of vasoactive medication was negatively 
associated with verbal and visuospatial memory, which may suggest an effect of early 
cerebral hypoperfusion in determining these abnormalities.
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Risk factors of neuropsychological deficits
inTroducTion
The majority of children growing up following neonatal extracorporeal membrane 
oxygenation (ECMO) and/or congenital diaphragmatic hernia (CDH) have a generally 
average IQ, yet show impaired neurodevelopmental outcome and school problems.(1-3) 
Until now, most long-term studies of school-age survivors have focused on IQ and atten-
tion, hampering our understanding of the specific neuropsychological problems after 
neonatal critical illness.(1-3) Furthermore, it remains largely unclear which patients are 
at risk of impaired outcome and why. For early identification and intervention of patients 
at risk, it is crucial to increase our understanding of neuropsychological domains most 
frequently impaired and the risk factors determining impaired outcome.
Earlier studies have found that markers of illness severity, such as ECMO requirement 
and the presence of chronic lung disease, were predictive of neuropsychological deficits 
in CDH patients.(2) Still, clinically useful risk factors of such deficits following neonatal 
critical illness remain unknown. Our group has recently shown specific hippocampal 
volume alterations that were related to verbal memory impairments in school-aged 
neonatal ECMO survivors.(4,5) The hippocampus appears specifically vulnerable to 
hypoxic-ischemic injuries.(6,7) Using measures of hypoperfusion could possibly aid in 
predicting neuropsychological outcomes following neonatal critical illness, as hypoper-
fusion may result in hypoxic-ischemic and eventually reperfusion injury in the hippo-
campus. Additionally, poor growth in the first year of life has been reported in CDH and 
ECMO-treated patients(8,9) and has been associated with worse neurodevelopmental 
outcome.(10,11) However, the effects of poor growth on specific neuropsychological 
functions in school-aged survivors of neonatal critical illness remain unknown.
In this study, neuropsychological outcome was evaluated in school-aged CDH survi-
vors treated with or without neonatal ECMO and in neonatal ECMO-treated survivors 
following other diagnoses. We hypothesized that children would mainly have attention 
and memory deficits, despite a generally average IQ. We expected markers of increased 
severity of illness and hypoperfusion as well as poor growth in the first year of life to 
have negatively affected neuropsychological outcome at school-age.
maTerial and meThodS
Population 
We included CDH and neonatal ECMO patients born between January 2006 and March 2009. 
Participants were routinely seen at eight years of age as part of a structured prospective 
longitudinal follow-up program that includes regular physical and neurodevelopmental 
assessments until 18 years.(12) ECMO treatment was applied in case of severe respiratory 
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failure using the criteria described by Stolar et al.(13). Since November 2007, CDH patients 
were treated according to the standardized CDH-EURO Consortium treatment protocol.
(14) In case of persistent poor tissue perfusion and/or hypotension (arterial blood pressure 
below normal levels for gestational age and not improving after fluid boluses), treatment 
with dobutamine and/or dopamine was initiated, followed by norepinephrine, epinephrine 
or milrinone in case of persistent hypotension. Exclusion criteria were: genetic syndromes 
known to affect neurodevelopment, severe neurologic or developmental impairments pre-
venting standardized assessments, late CDH diagnosis (>7 days of life), or a paraesophageal 
hernia. We used a protocol with extended neuropsychological assessments, implemented in 
January 2014 (Supplemental File 1).(1,2) Included children were divided into three groups: 
ECMO patients following other diagnoses than CDH (“ECMO-other”), CDH patients treated 
with ECMO (“CDH-ECMO”) and CDH patients not treated with ECMO (“CDH-non-ECMO”). 
This post-ECMO/CDH follow-up program is standard of care, therefore Institutional Review 
Board approval was waived (MEC-2017-185).(2,15)
data collection 
Relevant clinical data were collected at the time of hospitalization (Supplemental Meth-
ods). The Pediatric Logistic Organ Dysfunction-2 (PELOD-2) score(16) was collected in 
the first 24 hours of pediatric intensive care unit (PICU) stay (or up to ECMO cannulation 
in ECMO-treated patients if ECMO was initiated within the first 24 hours of PICU stay), the 
maximum vasoactive-inotropic score (VIS)(17) was recorded up until ECMO cannulation 
for the ECMO-treated patients or up until hernia repair for the CDH-non-ECMO patients.
Follow-up data included growth measurements (height, weight, head circumference) 
at 6 months and 1 year, which were converted into z-scores (individual score minus the 
norm score divided by the norm SD).(19) Height-corrected-for-target height z-score was 
calculated as follows: height-for-age z-score – target height z-score.(20) 
Neuropsychological evaluation was performed by an experienced pediatric psycholo-
gist. Socioeconomic status was assessed from maternal education level.(21) 
neurodevelopmental outcome tests
Validated neuropsychological tests were administered in their Dutch versions to assess 
skills in six domains (Supplemental File 1): 
1 IQ: 
 a.  Two-subtest short-form (Block Design and Vocabulary) of the Wechsler Intel-
ligence Scale for Children (WISC-III-NL)(22).
2 Attention: 
 a.  Processing speed: Trail Making Test section A (TMTA)(23,24).
 b.  Selective attention and cognitive flexibility: Stroop color-word test (STROOP)
(23,24) and Trail Making Test section B (TMTB)(23,24).
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 c.  Sustained attention: Dot Cancellation Test (DCT)(25).
3 Verbal memory: 
 a.  Working-memory: subtest Digit Span of the WISC-III-NL(22).
 b.  Immediate and delayed recall: Rey Auditory Verbal Learning Test (RAVLT)(26).
4 Visuospatial memory: 
 a.  Working-memory: subtest Spatial Span of the Wechsler Nonverbal Scale of Abil-
ity (WNV)(27).
 b.  Immediate and delayed recall: Rey Complex Figure Test (RCFT)(28).
5 Executive functioning: 
 a.  Key Search and Modified Six Elements of the Behavioral Assessment of the Dys-
executive Syndrome (BADS-C-NL)(29).
6 Visuospatial processing: 
 a.  Copy of the Rey Complex Figure Test (RCFT Copy)(28).
Neuropsychological test scores were converted into z-scores. Scores were inverted where 
appropriate so that a higher score always equated with better performance. Z-scores ≤ 
-1 were regarded as likely to represent impaired functioning (general population: mean 
z-score = 0; SD = 1)(23).
Statistical analysis 
Differences in patient characteristics between the three groups (ECMO-other, CDH-ECMO 
and CDH-non-ECMO) were evaluated with chi-square or Fisher’s exact tests for categori-
cal variables, and with independent samples t-tests and one-way analysis of variance 
(ANOVA) for normally distributed variables. Mann-Whitney U tests and Kruskal-Wallis tests 
were used for continuous variables that were not normally distributed. Differences in neu-
ropsychological outcome between the three groups were assessed with one-way ANOVA.
Univariable analyses were performed to assess the influence of clinical characteristics 
on the following neuropsychological outcomes of interest: intelligence, sustained at-
tention, verbal memory immediate recall, verbal memory delayed recall, visuospatial 
memory immediate recall and visuospatial memory delayed recall. The independent 
variables included: maximum VIS, ECMO, type of ECMO (venoarterial or venovenous), 
sepsis, ventilator-free days in the first 28 days of life, duration of initial hospital stay, 
growth z-scores at 1 year (paired t-test showed largest growth deflection from 6 months 
to 1 year) and number of anesthetic procedures during the first year of life. Next, mul-
tivariable linear regression analyses were used to identify which independent variables 
remained significant predictors in a multivariable model. The assumptions for linear 
regression analysis were checked with normal probability plots of the residuals. Multi-
collinearity was evaluated in the multivariable models using the criterion that variance 
inflation factors should not exceed 2.5(30).
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Analyses were performed with SPSS 21.0 (IBM, Armonk, Ny, USA), a two-sided p-value 
< .05 was considered statistically significant.
reSulTS 
Patient characteristics 
Sixty-five patients aged 8.0±0.6 years were included: 25 ECMO-other patients, 10 CDH-
ECMO patients, and 30 CDH-non-ECMO patients (Supplemental Figure 1). Illness severity 
during hospital admission differed between the three groups (Table 1). The CDH-ECMO 
patients had the highest PELOD-2 score, the highest maximum VIS, the highest rate 
of sepsis, and the longest duration of mechanical ventilation and hospital stay. Sepsis 
occurred in three ECMO-other patients (during ECMO: n = 2; after ECMO: n = 1), four 
CDH-ECMO patients (after ECMO: n = 4), and one CDH-non-ECMO patient after hernia 
repair. Four (50%) patients required vasoactive medication during sepsis. The median 
maximum VIS during sepsis was lower than the median maximum VIS before the ECMO 
run and none of the patients had a higher maximum VIS during sepsis (Table 1). Char-
acteristics of eligible patients who were lost to follow-up or refused follow-up (n = 14) 
did not differ from included patients (data not shown). None of the patients treated with 
ECMO (both ECMO-other and CDH-ECMO) had signs of cerebral hemorrhage or vessel 
occlusion on cranial ultrasounds performed before and after the ECMO run.
Table 1. Patient characteristics
Characteristics
ECMO-other1
(n = 25)
CDH-ECMO
(n = 10)
CDH-non-ECMO
(n = 30) p-value
Gestational age (weeks) 40.9 (40.0-41.1) 39.2 (36.7-40.7) 38.5 (38.0-39.3) <0.001
Birth weight (kilograms) 3.5 (0.5) 3.1 (0.8) 2.9 (0.4) 0.001
Male 14 (56%) 5 (50%) 18 (60%) 0.842
Ethnicity 0.602
Dutch 19 (76%) 9 (90%) 26 (87%) 
Other 6 (24%) 1 (10%) 4 (13%) 
Maternal Education Level 0.592
Low 6 (24%) 3 (33%) 8 (29%) 
Moderate 12 (48%) 3 (33%) 16 (57%) 
High 7 (28%) 3 (33%) 4 (14%) 
Unknown 0 1 2 
Inborn 4 (16%) 4 (40%) 18 (60%) 0.0032
ECMO-related 
Highest oxygenation index prior to ECMO 33 (28-40) 38 (26-54) 0.72
Age start ECMO (days) 2 (1-4) 1 (1-2) 0.30
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Table 1. Patient characteristics (continued)
Characteristics
ECMO-other1
(n = 25)
CDH-ECMO
(n = 10)
CDH-non-ECMO
(n = 30) p-value
Duration of ECMO (hours) 92 (54-100) 172 (131-212) <0.001
ECMO mode <0.0012
VA 7 (28%) 10 (100%) 
VV converted to VA 1 (4%) 
VV 17 (68%) 
CDH-related
Left sided hernia 8 (80%) 25 (83%) 1.002
Age at surgery (days) 4 (3-6) 3 (2-4) 0.32
Patch repair 9 (90%) 17 (57%) 0.072
Surgical technique
Laparotomy 10 (100%) 20 (67%) 0.042 
Thoracoscopy 10 (33%)
Hospital Admission-related
PELOD-2 score3 7 (7-9) 9 (8-9) 6 (5-7) <0.001
Maximum VIS4 40 (35-70) 107 (91-142) 40 (5-76) <0.001
Dobutamine treatment 24 (96%) 10 (100%) 19 (63%) 0.042 
Dopamine treatment 22 (88%) 7 (70%) 13 (43%) 0.012 
Norepinephrine treatment 13 (52%) 10 (100%) 15 (50%) 0.022 
Epinephrine treatment 2 (8%) - 2 (7%) 1.002 
Milrinone treatment - 2 (20%) - 0.032 
Vasopressin treatment - - - - 
CPR during initial hospital stay 2 (8%) 1 (10%) 0 (0%) 0.182
Sepsis during initial hospital stay5 3 (12%) 4 (40%) 1 (3%) 0.012
Days of mechanical ventilation 10 (7-11) 40 (16-51) 10 (5-18) 0.001
Ventilator-free days in the first 28 days of life 18 (17-21) 0 (0-12) 19 (10-23) 0.001
Days of initial PICU stay 13 (10-16) 70 (24-101) 21 (12-35) <0.001
Days of initial hospital stay 24 (21-29) 91 (48-156) 36 (20-53) 0.004
Pulmonary hypertension
yes 13 (57%) 8 (80%) 12 (48%) 0.252 
No 10 (43%) 2 (20%) 13 (52%) 
Missing 2 0 5 
Inhaled nitric oxide treatment 22 (88%) 10 (100%) 10 (33%) <0.0012
Sildenafil treatment 2 (8%) 6 (60%) 1 (3%) <0.0012
Chronic lung disease6
yes 2 (10%) 8 (80%) 8 (28%) <0.0012 
No 19 (90%) 2 (20%) 21 (72%) 
Missing 4 1 
Follow-up 
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neuropsychological outcome 
IQ fell within the normal range for the group as a whole. Sustained attention, verbal 
memory (immediate and delayed recall) and visuospatial memory (immediate and 
delayed recall as well as recognition) were below average compared to the general 
population (Table 2). The majority of patients had normal outcomes in working-memory, 
executive functioning and visuospatial processing. However, over 50% had impaired 
outcomes (z-score ≤ -1) on one or more of the memory and attention tests (Figure 1).
When analyzing the three groups separately, we found that CDH survivors treated 
with ECMO had a significantly lower IQ compared to both other groups. However, no 
significant differences were found between the three groups on any of the other neuro-
psychological outcomes (Table 2).
Table 1. Patient characteristics (continued)
Characteristics
ECMO-other1
(n = 25)
CDH-ECMO
(n = 10)
CDH-non-ECMO
(n = 30) p-value
Number of anesthetic procedures first year of life 2 (2-3) 4 (3-4) 1 (1-2) <0.001
Weight-for-height z-score at 1 year -0.38 (0.86) -1.80 (0.76) -0.88 (0.97) 0.001
Height-corrected-for-target height z-score at 1 year -0.27 (0.96) -0.36 (0.69) -0.43 (0.78) 0.02
Head circumference-for-age z-score at 1 year -0.47 (1.16) -0.50 (1.31) -0.39 (1.15) 0.96
Data are expressed as mean (standard deviation), median (interquartile range) or number (percentage), as 
appropriate.
P-value = significant difference between the groups.
1 ECMO treatment was given in case of meconium aspiration syndrome (n = 18), persistent pulmonary 
hypertension of the newborn (n = 2), congenital heart disease (monoventricular heart with transposition 
of the great vessels and total anomalous pulmonary venous return) (n = 1), sepsis (n = 1), respiratory insuf-
ficiency due to respiratory syncytial virus (n = 1), infant respiratory distress syndrome with bilateral pneu-
mothorax (n = 1), pulmonary hypoplasia due to bilateral hydrothorax (n = 1).
2 Fisher’s exact test was used.
3 PELOD-2 score in the first 24 hours of PICU stay or up to ECMO cannulation if ECMO was initiated in the 
first 24 hours of PICU stay was calculated.16
4 The maximum VIS recorded during PICU stay up until ECMO cannulation for the ECMO-treated patients or 
up until hernia repair for the CDH non-ECMO patients.17 VIS was maximal at the median age of 1 (1-1) day in 
the ECMO patients, at the median age of 1 (0-1) day in the CDH ECMO patients, and at the median age of 0 
(0-1) days in the CDH non-ECMO patients.
5 Sepsis during initial hospital stay (clinical suspicion of sepsis with positive blood culture). ECMO-other: 2 
patients had sepsis during ECMO; 1 patients after ECMO; maximum VIS during sepsis: 10 (5-15). CDH-ECMO: 
4 patients had sepsis after ECMO; maximum VIS during sepsis: 2.5 (0-32.5). CDH non-ECMO: 1 patient had 
sepsis after hernia repair; maximum VIS during sepsis: 0.
6 Chronic lung disease defined as oxygen dependency at 28 days of life.(18)
Abbreviations: CDH = congenital diaphragmatic hernia; CPR = cardiopulmonary resuscitation; ECMO = ex-
tracorporeal membrane oxygenation; PELOD-2 = Pediatric Logistic Organ Dysfunction-2; PICU=pediatric 
intensive care unit; VA = venoarterial; VIS = vasoactive-inotropic score; VV = venovenous.
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Predictors of neuropsychological outcome 
Table 3 shows the results of the regression analyses. In the univariable analyses, severity 
of illness indicated by the need for ECMO, treatment with venoarterial-ECMO, maximum 
VIS, ventilator-free days, and duration of initial hospital stay were associated with neu-
ropsychological outcome, in particular with IQ. The number of anesthetic procedures 
during the first year of life was associated with IQ and sustained attention, and weight-
for-height at 1 year was positively associated with IQ.
In the multivariable analyses, a higher maximum VIS remained associated with worse 
verbal and visuospatial memory delayed recall, such that an increase in maximum VIS 
of 20 points would result in a decrease of the verbal and visuospatial memory delayed 
recall z-scores of 0.4 and 0.2, respectively. Patients with impaired verbal memory had 
a significantly higher maximum VIS (72±44) than patients with normal verbal memory 
(40±32), p = .003. Patients with impaired visuospatial memory had a higher maximum 
VIS (64±45) than patients with normal visuospatial memory (44±33), although this was 
not significant (p = .118). The VIS remained a significant predictor of verbal and visuo-
spatial memory delayed recall when group (ECMO-other, CDH-ECMO, CDH-non-ECMO) 
was added to the model (data not shown).
Growth or other illness severity indicators were no longer associated with neuropsy-
chological outcome in the multivariable analyses (Supplemental Table 1).
0%
20%
40%
60%
80%
100%
Attention Verbal memory Visuospatial memory Executive functioning Visuospatial processingIntelligence
figure 1. Presence of neuropsychological impairments in the study population
Percentage of patients with a z-score ≤ -1 (impaired; as shown by the dark colored bars) and > -1 (normal; 
as shown by the grey colored bars) on each of the neuropsychological tests.
Abbreviations: WISC-III-NL = Wechsler Intelligence Scale for Children, Dutch version; TMT = Trail Making 
Test; Stroop = Stroop Color Word Test; DCT = Dot Cancellation Test; RAVLT = Rey Auditory Verbal Learning 
Test; RCFT = Rey Complex Figure Test.
Please refer to the Supplemental File for a description of the tests.
Chapter 3
48
Table 2. Overview of neuropsychological outcome
Neuropsychological test
All 
(n = 65)
ECMO-other 
(n = 25)1
CDH-ECMO 
(n = 10)
CDH-non-ECMO 
(n = 30) p-value 
Intelligence
WISC-III-NL 95 (16) 94 (10) 84 (12) 100 (20) .029
Attention
TMT A -0.33 (0.86) -0.25 (1.05) -0.45 (0.53) -0.36 (0.79) .963
TMT B -0.18 (0.98) 0.08 (1.03) -0.28 (1.08) -0.37 (0.88) .267
STROOP -0.61 (1.01) -1.00 (0.76) -0.29 (1.11) -0.39 (1.10) .081
DCT -2.73 (2.57) -2.88 (2.09) -3.88 (2.91) -2.25 (2.76) .173
Verbal memory
WISC-III-NL Digit span 0.06 (1.09) -0.08 (1.15) -0.34 (0.94) 0.31 (1.07) .706
RAVLT immediate -1.09 (1.27) -1.26 (1.24) -1.55 (1.03) -0.79 (1.33) .664
RAVLT delayed -1.14 (1.86) -1.38 (1.46) -1.87 (1.16) -0.70 (2.24) .117
Visuospatial memory
WNV Spatial Span -0.31 (0.99) -0.39 (0.79) -0.85 (0.76) -0.06 (1.14) .613
RCFT immediate -1.48 (1.02) -1.52 (1.02) -1.86 (0.69) -1.31 (1.09) .417
RCFT delayed -1.57 (1.01) -1.56 (1.01) -1.89 (0.77) -1.47 (1.09) .689
RCFT recognition -1.07 (3.10) -1.09 (1.51) -0.62 (0.95) -0.47 (1.22) .117
Executive functioning
Key Search -0.12 (0.94) -0.26 (0.98) -0.04 (1.09) -0.05 (0.89) .694
Modified Six Elements -0.60 (0.87) -0.95 (0.90) -0.46 (0.47) -0.46 (0.92) .194
Visual spatial processing
RCFT copy -0.26 (1.02) -0.36 (1.00) -0.69 (1.02) -0.02 (1.01) .107
Mean (standard deviation)=average IQ score or average z-score of the neuropsychological test.
One-way analysis of variance was used to identify differences between the groups on neuropsychological 
outcome.
P-value=significant difference between the groups.
1 ECMO treatment was given in case of meconium aspiration syndrome (n = 18), persistent pulmonary 
hypertension of the newborn (n = 2), congenital heart disease (monoventricular heart with transposition 
of the great vessels and total anomalous pulmonary venous return) (n = 1), sepsis (n = 1), respiratory insuf-
ficiency due to respiratory syncytial virus (n = 1), infant respiratory distress syndrome with bilateral pneu-
mothorax (n = 1), pulmonary hypoplasia due to bilateral hydrothorax (n = 1).
Abbreviations: CDH = congenital diaphragmatic hernia; DCT = dot cancellation test; ECMO = extracorpo-
real membrane oxygenation; RAVLT = Rey auditory verbal learning test; RCFT = Rey complex figure test; 
STROOP = Stroop color word test; TMT = trail making test; WISC-III-NL = Wechsler Intelligence Scale for 
Children, Dutch version.
Please refer to Supplementary File 1 for a description of the neuropsychological tests.
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diScuSSion
This is the first study evaluating all major neuropsychological domains in school-aged 
survivors of neonatal ECMO and/or CDH. We found sustained attention and verbal and 
visuospatial memory deficits in over half of the patients, while other neuropsychological 
domains fell within the average range. CDH survivors treated with ECMO had lower IQ 
than the other two groups, who had an average IQ. Nonetheless, the observed atten-
tion and memory problems were more severe than expected based on their IQ. This 
incongruity between attention and memory problems with IQ for all three groups in-
dicates specific impairments in these domains. A higher dose of vasoactive medication 
(indicated by the maximum VIS recorded up until ECMO cannulation or hernia repair) 
was associated with lower scores on verbal and visuospatial memory delayed recall. 
Interestingly, impaired memory and attention were found in all diagnostic groups, ex-
cept for better, although not significantly, verbal memory in the CDH-non-ECMO group 
(within one standard deviation of the norm). Attention deficits have been reported in 
these patients previously, also despite generally average IQ.(1-3,15) However, other 
neuropsychological domains were not assessed in these studies. In the present study, 
we evaluated all major neuropsychological domains, and thereby identified a specific 
neuropsychological profile following ECMO and/or CDH. Our findings may serve as a 
starting point for intervention-based studies designed to improve cognitive functioning 
in these children.
As we found memory and attention deficits in the majority of patients, it is imperative 
to identify potential risk factors. Over the years, several severity of illness scoring sys-
tems have been developed including the VIS.(17) In the univariable analyses, maximum 
VIS as well as ventilator-free days and duration of initial hospital stay were indepen-
dently associated with neuropsychological outcome, mainly with IQ. This indicates that 
severity of illness plays an important role in determining cognitive outcome in these 
survivors. Interestingly, in the multivariable analyses, only the maximum VIS recorded 
up until ECMO cannulation or hernia repair remained associated with delayed verbal 
and visuospatial memory. The hippocampus is highly involved in delayed memory and 
has previously been shown to be altered following ECMO and/or CDH.(4,5,31,32) The 
hippocampus has been found to be particularly susceptible to cerebral hypoperfusion 
resulting in hypoxia-ischemia.(6,7,33) Although this study does not show a causative 
effect of vasoactive medication regarding memory problems, we speculate that receiv-
ing high levels of vasoactive medication in the first period of life may be an indirect 
marker of temporarily (regional) inadequate brain perfusion. A high need for vasoactive 
medication could therefore be a useful component in estimating severity of illness and 
risk of memory impairments at school-age in these survivors. Although we cannot make 
any recommendations based on our findings, the VIS may be valuable in determining 
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the need for and timing of ECMO treatment in neonates with severe respiratory failure, 
which should be investigated in future studies. The VIS has been validated to predict 
clinical outcomes in infants who require cardiac surgery(17,34), representing another 
group of critically ill children requiring circulatory support by vasopressor drugs. Future 
studies are needed to further validate the usefulness of this score for long-term out-
come in neonatal critical illness survivors, and to study the direct association between 
maximum VIS and brain areas susceptible to ischemic-reperfusion injury such as the 
hippocampus.
Attention and memory problems at school-age have also been found in other groups 
of critically ill neonates such as premature infants and infants with congenital heart 
disease.(31, 35) Studies in premature infants have found that lower scores on executive 
functioning were associated with the severity of illness(36), although others have not 
confirmed this(37). Multicenter studies are needed to develop a multimodal prediction 
model which may be the key to earlier identification of critical illness survivors at risk of 
impaired neurodevelopmental outcome. Predictors of interest would be specific mark-
ers of illness severity, such as the maximum VIS, in combination with predetermined 
assessment of neurobiological correlates, such as imaging of the hippocampus.
We did not find any associations between growth at one year and long-term neu-
ropsychological outcome. Although many CDH patients show poor growth during the 
first year of life(9), only one study has found an association between weight and head 
circumference at 2-3 years and general cognitive functioning at this age, although not 
at five years.(11) In preterm born infants, several studies have demonstrated a positive 
association between weight gain and head growth and cognitive outcomes.(10) How-
ever, a recent study in children with extremely low birth weight showed no effect of 
catch-up-growth in the first two years of life on neurocognitive outcome at 11 years.(38) 
Most studies in preterm born infants did not take into account the severity of illness. It 
is therefore uncertain whether poor growth itself or severity of critical illness leading to 
poor growth, is more important in determining adverse neuropsychological outcome in 
premature infants. Although we cannot draw definitive conclusions, our study indicates 
that in ECMO and CDH patients, the severity of illness has a greater impact on neuropsy-
chological outcome than growth in the first year of life.
Our study has some limitations. First, the relatively small sample sizes of the three 
diagnostic groups is a frequent problem in follow-up studies including patients with 
rare diagnoses, limiting the interpretability of our regression analyses. Multicenter col-
laborations with standardized management and structured follow-up are important to 
increase sample sizes and get a better understanding of the pathophysiology underly-
ing long-term outcome. Second, Magenetic Resonance Imaging data were not available 
and we therefore could not examine whether maximum VIS was associated with brain 
structures susceptible to cerebral hypoperfusion. Standardized neuroimaging studies 
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both at neonatal and school-age will aid in understanding pathophysiologic concepts of 
early brain development and long-term outcome, and are therefore important in future 
studies. Third, there are likely multiple factors involved in the development of long-term 
neuropsychological impairments following ECMO and/or CDH, such as exposure to 
inflammation(7), anesthetics(39), and stress(40) in early life, and/or a complex interplay 
amongst these factors. As of now, techniques to reliably measure these mechanisms 
and their interactions are lacking. Future studies are needed to develop specific brain 
monitoring techniques that can be used during PICU stay for early identification of 
patients at risk of long-term impairments.
concluSion
We found sustained attention, verbal and visuospatial memory deficits in eight-year-old 
survivors of neonatal ECMO and/or CDH. These findings emphasize the need for stan-
dardized neuropsychological follow-up including attention and memory assessments 
until school-age and beyond in these survivors. Maximum VIS in the first day(s) of PICU 
admission was negatively associated with verbal and visuospatial memory at eight 
years. This suggests that this measure of severity of illness, possibly indicating (cerebral) 
hypoperfusion during early life, is related to specific neuropsychological functions in 
eight year-old neonatal ECMO and/or CDH survivors. Future studies using advanced 
neuroimaging techniques in combination with clinical characteristics and neuropsycho-
logical evaluation will aid in a better understanding of this finding and are needed for 
early identification and intervention of patients at risk. Our findings of specific attention 
and memory problems can serve as a starting point for developing and implementing 
early intervention strategies that focus on improving attention and memory in these 
patients.
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SuPPlemenTary maTerial
Supplemental methods. description of data collection.
Relevant clinical data were collected at the time of hospitalization (refer to supplemen-
tary methods for description of variables), including: gestational age, birth weight, gen-
der, ethnicity (Dutch/≥1 non-native Dutch parent), inborn, the need for ECMO, Pediatric 
Logistic Organ Dysfunction-2(PELOD-2) score(16) in the first 24 hours of pediatric inten-
sive care unit(PICU) stay (or up to ECMO cannulation in ECMO-treated patients if ECMO 
was initiated in the first 24 hours of PICU stay), the maximum vasoactive-inotropic score 
(VIS)(17) was recorded up until ECMO cannulation for the ECMO-treated patients or up 
until hernia repair for the CDH-non-ECMO patients, cardiopulmonary resuscitation(CPR) 
during initial hospital stay, sepsis during initial hospital stay (clinical suspicion of sepsis 
with positive blood culture), duration of initial mechanical ventilation, ventilator-free 
days in the first 28 days of life, duration of PICU stay, duration of initial hospitalization, 
pulmonary hypertension on echocardiography during PICU admission, inhaled nitric 
oxide requirement, sildenafil requirement, the presence of chronic lung disease(oxygen 
dependency at 28 days of life)(18), and number of anesthetic procedures in the first year 
of life (including CDH repair and/or ECMO (de)cannulation). Additional characteristics 
for ECMO patients included: highest oxygenation index before ECMO, age at start ECMO, 
ECMO type, ECMO duration, and cranial ultrasound result before and after ECMO. Ad-
ditional data for CDH patients were: diaphragmatic defect side, surgical repair technique 
(thoracoscopy or laparotomy), age at surgery, and patch repair requirement.
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Supplemental file 1. descriptions of the neurodevelopmental tests.
Intelligence 
Wechsler Intelligence Scale for Children (WISC-III-NL)
The RAKIT or the Wechsler Intelligence Scale for children was used. Both tests assess 
verbal and non-verbal intelligence, have been shown to have good reliability and valid-
ity(1, 2), and have been used interchangeably by our group before.(3) For both tests, a 
normalized population mean of 100 with a standard deviation of 15 is used.(1, 2)
Attention 
Dot Cancellation Test
This paper-and-pencil test measures sustained selective attention and concentration in 
terms of speed and accuracy. It consists of a paper on which figures made of three, four 
or five dots are displayed in 33 rows. The child is instructed to cross off all figures with 
four dots, as precise and as fast as they can.(4) 
Stroop Color Word Test (STROOP)
The Stroop consists of three trials: in the first trial (Stroop 1) the subject must read color 
names, in the second trial (Stroop 2) name printed colors, and in the third trial (Stroop 
3) name printed colors not denoted by the color name. The test can be administered to 
children and adults in the age range 8-65 years. Selective attention is measured with 
this test.(5, 6) 
Trail Making Test (TMT)
This paper and pencil test consists of two parts. In the first part (part A), the subject 
must draw lines to consecutively connect numbered circles on a sheet. In the second 
part (part B), the subject must consecutively but alternately connect numbered and let-
tered circles on another worksheet. The goal of the test is to finish each part as quickly 
as possible. The test can be administered to children and adults in the age range 6-89 
years. This test measures visual conceptual and visuomotor tracking as well as divided 
attention.(5, 6)
Verbal memory 
WISC-III-NL – subtest Digit Span 
The Digit Span consists of random number sequences that increase in length and that 
the examiner reads aloud at the rate of 1 number per second. The child has to reproduce 
these numbers in the same order. Next, the sequences must be recalled backwards (3-
5-7 becomes 7-5-3). The first part of the test measures short-term auditory memory and 
short-term retention capacity. The second part measures auditory working memory. A 
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difference of 4 or more points between forward and backward Digit Span in favor of 
forward is indicative of a working-memory problem.(7) 
Rey Auditory Verbal Learning Test (RAVLT)
The RAVLT consists of five presentations with recall of a 15-word list, a sixth recall 
trial after 30 minutes, and a seventh recognition trial. This test measures memory span, 
short- and long-term verbal memory, verbal recognition, learning curve, and retroactive 
or proactive interference. It can be administered to children and adults in the age range 
6-89 years.(8, 9)
Visuospatial memory 
Wechsler Nonverbal Scale of Ability (WNV) – subtest Spatial Span 
The Spatial Span requires the child to touch a group of blocks arranged on a board in a 
nonsystematic manner in the same and reverse order as demonstrated by the examiner. 
The first part of the test measures short-term visuospatial memory and short-term re-
tention capacity. The second part measures visuospatial working-memory.(10) 
Rey Complex Figure Test (RCFT)
The RCFT consists of three trials. First the child has to copy a complex figure. Then after 
3 and after 30 minutes the figure must be drawn from memory. Next, different figures 
are shown and the child has to indicate whether these figures were in the original figure. 
The last two trials measure short- and long-term visual-spatial memory, and visual-
spatial recognition. This test can be completed by children and adults in the age range 
6-89 years.(11, 12) 
Executive functioning 
Key Search 
A test of strategy formation. The child is asked to demonstrate how they would search 
a field for a set of lost keys and their strategy is scored according to its functionality.(13) 
Modified Six Elements
The child is asked to work on six different tasks for which they have five minutes. There 
are some rules the child has to obey during the task, while making sure that by the end 
of the five minutes, all six of the tasks have been done and the child has done as much 
as possible of each task. This is a test of planning, task scheduling and performance 
monitoring.(13) 
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Visual spatial processing 
Rey Complex Figure Test (RCFT)
The RCFT consists of three trials. First the child has to copy a complex figure. Then after 
3 and after 30 minutes the figure must be drawn from memory. Next, different figures 
are shown and the child has to indicate whether these figures were in the original figure. 
The first trial measures visual integration. This test can be completed by children and 
adults in the age range 6-89 years.(11, 12)
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Neonatal ECMO and/or CDH patients  
born between Jan. 2006-Mar. 2009 
n = 127 
Eligible, n = 83 
Died, n = 28 (21%) 
Eligible, n = 7 
• Initially treated in other center but 
follow-up in our center, n = 6 
• Earlier follow-up visit, n=1 
Eligible but not included, n = 18  
• Lost to follow-up/refused follow-up, n = 14 
• Tested with old protocol, n = 1 
• Tested elsewhere, n = 3 
Tested with neuropsychological protocol implemented in 2014 
 n = 65 
Not Eligible, n = 23  
• Not testable†, n = 9  
• Late diagnosis of CDH, n = 10 
• Paraesophageal hernia, n = 4  
Supplemental figure 1. Flowchart of the study population
† Severe neurologic or developmental impairments (n = 5; 3 patients had primary hemorrhage at cranial 
ultrasound performed after the ECMO run); Simpson-Golabi-Behmel Syndrome (n = 2); Down Syndrome (n 
= 1); Mitochondriopathy (n = 1).
Abbreviations: CDH = congenital diaphragmatic hernia; ECMO = extracorporeal membrane oxygenation.
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abSTracT
objectives To assess neuropsychological outcome in 17- and 18-year–old neonatal 
extracorporeal membrane oxygenation survivors.
design A prospective longitudinal follow-up study.
Setting Follow-up program at the Erasmus MC-Sophia Children’s Hospital in Rotterdam, 
The Netherlands.
Patients Thirty adolescents 17 or 18 years old, treated between 1991 and 1997, under-
went neuropsychological assessment.
interventions None.
measurements and main results Attention, memory, executive functioning, visual-
spatial functions, social-emotional functioning, and behavior were assessed with vali-
dated instruments, and data were compared with reference data. Included predictors 
for analysis of adverse outcome were diagnosis, age at start extracorporeal membrane 
oxygenation, convulsions, and use of anti-epileptics. Adolescents’ performance (ex-
pressed as mean [SD] z-score) was significantly lower than the norm on short-term and 
long-term verbal memory (z-score = -1.40 [1.58], p = .016; z-score = -1.54 [1.67], p = 
.010, respectively), visual-spatial memory (z-score = -1.65 [1.37], p = .008; z-score = -1.70 
[1.23], p = .008, respectively), and working memory (32% vs 9% in the norm population). 
Parents reported more problems for their children regarding organization of materials 
(z-score = −0.60 [0.90]; p = .03) and behavior evaluation (z-score = −0.53 [0.88]; p = .05) 
on a questionnaire. Patients reported more withdrawn/depressed behavior (z-score = 
−0.47 [0.54]; p = .02), somatic complaints (z-score = −0.43 [0.48]; p = .03), and social 
problems (z-score = −0.41 [0.46]; p = .04). Patients reported more positive feelings of 
self-esteem and an average health status.
conclusions Adolescents treated with neonatal extracorporeal membrane oxygenation 
are at risk of verbal, visual-spatial, and working-memory problems. Future research 
should focus on 1) the longitudinal assessment of specific neuropsychological skills in 
adolescence and adulthood; 2) identifying risk factors of neuropsychological dysfunc-
tion; 3) evaluating to what extent “severity of illness” is responsible for acquired brain 
injury; and 4) effects of timely cognitive rehabilitation.
67
Memory problems in adolescent survivors
inTroducTion
Neonatal extracorporeal membrane oxygenation (ECMO) stabilizes and supports criti-
cally ill newborns with acute and potentially reversible, respiratory failure.(1) Worldwide, 
approximately 28,000 neonates have been treated with ECMO for this reason, with 75% 
surviving to discharge or transfer.(2) The most common underlying conditions were 
meconium aspiration syndrome (MAS), congenital diaphragmatic hernia (CDH), and 
persistent pulmonary hypertension of the newborn.(2) The best results were obtained 
in MAS patients (94% survival) and the worst in CDH patients (51%).(2) 
Survivors are at risk of serious complications, such as intra-cranial hemorrhage and 
infarctions.(3) Internationally, routine neuroimaging during ECMO treatment showed 
abnormalities in 10–59% of infants, depending on case mix and case selection.(3) In the 
Netherlands, the prevalence of brain injury during ECMO treatment was 17.3% nation-
wide.(4) These findings alone are sufficient reasons for early identification of survivors 
at risk of adverse neurodevelopmental outcome and close monitoring in the long-term. 
Moreover, critical illness, ECMO-treatment itself, and post-ECMO treatment factors may 
have consequences for outcomes in general.
Various studies have reported neuropsychological outcome of neonatal ECMO survi-
vors until school age, showing that intellectual outcome did not differ from that of norm 
populations but that these children had deficits in attention, memory, and visual-spatial 
functions and more frequently had special educational needs.(5–9) Neonatal ECMO 
survivors might be at risk of neuropsychological problems at older age because of the 
poor development of executive functioning, such as working-memory and planning. 
Executive functioning is needed to develop academic, behavioral, and social function-
ing and prepare for effective participation in society (e.g., finding a job). As these neu-
ropsychological functions start to develop in early childhood but continue into young 
adulthood, these children may be at risk of “growing into deficits”.(10) The aim of this 
study was to evaluate the neuropsychological outcome at adolescent age.
maTerialS and meThodS
Population 
Data were obtained within the framework of a post-ECMO follow-up program – initiated 
in 2001 in our hospital – in which children’s lung function, growth, and development 
are regularly assessed until 18 years old.(11,12) This study concerned 17- to 18-year–old 
adolescents who between February 1991 and June 1997 had been treated with neonatal 
venoarterial ECMO at the ICU of the Erasmus MC-Sophia Children’s Hospital in Rotter-
dam. In all cases, the cannula had been placed by the same surgical team in the right 
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cervical region. ECMO support was given in case of severe respiratory failure and an 
estimated mortality risk of higher than 80% using the entry criteria reported by Stolar et 
al(13). These criteria were: an oxygenation index (OI) greater than 40 beyond 4 hours or 
an alveolar arterial oxygen gradient greater than 600 during 6–8 hours, with an Fio2 of 
100%, and signs of barotraumas or acute deterioration. During the study period, these 
entry criteria did not change in our institution.
The follow-up program is the standard of care for ECMO-treated neonates in the Neth-
erlands.(11,12) The Erasmus MC Medical Ethical Review Board stated that “the Medical 
Research in Human Subjects Act (in Dutch: “WMO”) does not apply to this study because 
subjects are not being submitted to any handling nor are there rules of human behavior 
being imposed”. All participants and their parents provided permission to use the data.
design 
During the routine follow-up visit, structured questionnaires were used: parents of the 
adolescents provided information on socioeconomic status (SES; based on maternal 
education)(14) and ethnicity (at least one parent of Dutch/non-Dutch origin). Adoles-
cents were asked about their academic achievement.
Overall intelligence was taken as the intelligence quotient (IQ) score at age 8 or 12 
years. If IQ had been assessed at both ages, we used the IQ score assessed at 12 years. 
The follow-up program provides for a formal neuropsychological assessment by a pedi-
atric psychologist. As part of the neuropsychological assessment, the parents filled out 
questionnaires in the waiting room of the hospital and the adolescents in the consulta-
tion room. In the first 10 years of the follow-up program, these assessments were limited 
and geared to individual needs, but from January 2012, a standard assessment battery 
was used for the neuropsychological tests (Supplemental Digital Content 1).
The following clinical data were retrieved: underlying disease (CDH, MAS, and other 
diagnoses); gestational age; birth weight; age at start ECMO; time on ECMO; highest OI 
and mean airway pressure prior to ECMO; duration of ventilation; oxygen dependency 
after extubation (< 1wk, 1wk to 1 mo, and > 1 mo); the presence of chronic lung disease 
(CLD) (15); abnormal cranial ultrasound (CUS: no and yes); use of morphine or other 
sedatives (< 1 wk, 1 wk to 1 mo, and > 1 mo); use of muscle relaxants (no, ICU: 1 d to 1wk, 
and ICU: > 1wk); the presence of convulsions (no, clinical but not tested, and confirmed 
on an electroencephalograph); use of antiepileptics (no, prophylactically, therapeuti-
cally < 1 mo, and therapeutically > 1 mo); and diagnosis of epilepsy at later age (no, yes, 
and dubious).
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instruments 
Validated neuropsychological tests and questionnaires were administered in their Dutch 
versions to assess skills in different domains (see brief descriptions of the tests in the 
Supplemental Digital Content 1).(16–25)
Neuropsychological tests: 
1. Intelligence: Wechsler Intelligence Scale for Children.
2. Attention: Trail Making Test and Stroop Color-Word test.
3. Memory: subtests Rebus Learning and Auditory Comprehension of the Kaufman 
Intelligence Test; subtest digit span of the Wechsler Adult Intelligence Scale; the Rey 
Auditory Verbal Learning Test (RAVLT); and the Rey Complex Figure Test (RCFT).
4. Executive functioning: Tower test.
5. Visual-spatial processing: RCFT copy.
Questionnaires: 
1. Executive functioning: Behavior Rating Inventory of Executive Functioning (BRIEF; 
filled out by parents).
2. Social-emotional functioning: self-esteem: Self Perception Profile for Children (SPPC); 
health status: Pediatric Quality of Life Inventory (PedsQL).
3. Behavior: youth Self-Report (ySR).
data analysis 
Differences in medical and background characteristics (Table 2) between participants 
and nonparticipants were assessed with either the Mann-Whitney U test (continuous 
variables) or the chi square test (categorical variables).
To enable comparison of the results of the different neuropsychological assessments, 
all outcomes were converted into z-scores (individual score minus the mean population 
score divided by the population SD). These z-scores were compared with the z-score 
of IQ using paired sample t-tests. In this way, we analyzed whether the outcomes of 
the neuropsychological tests were concordant with IQ. Outcomes in z-scores on the 
neuropsychological tests and questionnaires were then compared with the z-scores 
of the general population (mean z-score = 0; SD = 1) using paired samples t-tests. The 
assumption of normality was assessed. The difference between the digit-span forward 
and backward was assessed using the chi-square test.
The influence of each medical variable on the neuropsychological domains on which 
the adolescents showed impaired performance compared with the general population 
was assessed using univariate linear regression analyses. Those medical variables that 
were found to be significant predictors of impaired neuropsychological outcome were 
then added together – with SES as a covariate – in a multivariate linear regression model. 
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To check the assumptions for linear regression analysis and to examine the applicability 
of the model, normal probability plots of the residuals and multicollinearity was evalu-
ated.(26) 
All analyses were done using SPSS Statistics for Windows, Version 22.0 (IBM, Armonk, 
Ny). A p value of .05 was used.
reSulTS
Patients 
Between February 1991 and June 1997, 72 neonates had been treated with ECMO. 
Eighteen (25%) had died prior to original hospital discharge (nine CDH; three MAS; six 
other diagnoses). Twenty of the 54 survivors (37%) did not attend follow-up at 17 years 
old: 11 refused, four had follow-up elsewhere, two only underwent medical examina-
tion because they had recently been tested elsewhere (MAS with developmental delay 
and other diagnosis with intellectual disability), two had emigrated, and one was not 
seen because of organizational reasons. For 17 of these 20 patients, data on outcome 
or state of health were available. Seven had average intelligence (one with epilepsy 
and an infarct, one with attention deficit hyperactivity disorder, and one with attention 
deficit disorder), six had developmental delay, and four had intellectual disability (one 
with epilepsy and one with attention deficit hyperactivity disorder). Most medical and 
background characteristics did not statistically differ between participants and nonpar-
ticipants; the exceptions are abnormal CUS, use of muscle relaxants, and the presence 
of convulsions (Table 1).
neuropsychological assessment and questionnaires 
Of the 34 adolescents (63%) attending follow-up, three had abnormal CUS as neonates 
(occlusion of the middle and anterior cerebral artery, subependymal hemorrhage grade 
1, and watershed stroke).
Of all 34 participants, three could not complete the assessment battery because of 
intellectual disability and/or behavioral problems and only filled in questionnaires on 
self-esteem, health status, and behavior (CDH with intellectual disability, MAS with intel-
lectual disability and possible autism, and CDH with intellectual disability [including a 
chromosome X duplication] and autism). For organizational reasons, one other patient 
(CDH with average intelligence) was not tested and only filled in the questionnaires. 
The other 30 adolescents had been assessed at the age of 17 or 18 years, but not all had 
performed all tests because of the fact that the follow-up assessments were first geared 
to individual needs and standardized from January 2012 (Table 2). The assumption of 
normality was met for the neuropsychological data and questionnaires.
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Table 1. Medical and background variables
Participants (n=36) Non-participants (n=18) p value
Diagnosis, No. (%) 0.34
MAS 22 (61) 9 (50)
CDH 5 (14) 1 (6)
Other 9 (25) 8 (44)
Gestational age in weeks, median (range) 40 (34-43) 40 (35-42) 0.94
Birth weight in grams, median (range) 3295 (2160-4980) 3220 (2300-4360) 0.99
Age start ECMO in hours, median (range) 28 (8-600) 25 (8-120) 0.26
Time on ECMO in hours, median (range) 122 (47-309) 127 (72-510) 0.65
Highest oxygenation index prior to ECMO, median (range) 54 (27-130) 55 (32-95) 0.81
Highest mean airway pressure prior to ECMO
(cm H2O), median (range) 21 (14-28) 20 (16-26) 0.63
Duration of ventilation in days, median (range) 10 (4-37) 10 (5-34) 0.95
Oxygen dependency post extubation, No. (%) 0.04
1 day- 1 week 18 (50) 7 (39)
>1 week- 1 month 6 (17) 6 (33)
>1 month 9 (25) -
Missing 3 (8) 5 (28)
CLD, No. (%) 0.16
yes 10 (28) 1 (5)
Missing 3 (8) 4 (22)
Abnormal cranial ultrasound, No. (%) 0.04
yes 5 (14) 7 (39)
Missing - 1 (6)
Use of morphine or other sedatives, No. (%) 0.77
<1 week 11 (31) 6 (33)
1 week- 1 month 21 (58) 8 (44)
>1 month 4 (11) 3 (17)
Missing - 1 (6)
Use of muscle relaxants, No. (%) 0.09
No 3 (8) -
Intensive Care Unit 1 day- 1 week 20 (56) 14 (78)
Intensive Care Unit >1 week 13 (36) 2 (11)
Missing - 2 (11)
Presence of convulsions, No. (%) 0.007
No 25 (69) 10 (56)
Clinical, but not tested 10 (28) 2 (11)
Confirmed on electroencephalograph 1 (3) 6 (33)
Use of anti- epileptics, No. (%) 0.26
No 14 (39) 4 (22)
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academic achievement 
Of the 30 adolescents assessed at age 17 or 18 years, five were enrolled in special educa-
tion (15%), eight in secondary education (24%; two in preparatory vocational secondary 
education and training [in Dutch: VMBO], five in Senior General Secondary Education 
[in Dutch: HAVO], and one in University Preparatory Education [in Dutch: VWO]). Twenty 
adolescents were enrolled in senior secondary vocational education and training (60%; 
in Dutch: MBO), and one (3%) was enrolled in first cycle higher education (in Dutch: 
HBO).
In the Dutch population, 6% of adolescents who are 17 and 18 years old attend special 
education, 27% secondary education, 49% vocational education, and 18% first cycle 
higher education(27). The percentages differed significantly from the reference norm 
(chi-square test, 63.8; p < .001).
Table 1. Medical and background variables (continued)
Participants (n=36) Non-participants (n=18) p value
Prophylactically 11 (31) 6 (33)
Therapeutically <1 month 5 (14) 1 (6)
Therapeutically >1 month 6 (17) 7 (39)
Diagnosis of epilepsy at later age, No. (%) -
No 27 (75) -
yes 3 (8) -
Dubious 3 (8) -
Missing 3 (8) 18 (100)
Male gender, No. (%) 17 (47) 11 (61) 0.40
Medical and background variables (continued)
Ethnicity, No. (%) 0.25
Dutch 24 (67) 8 (44)
Missing - 9 (50)
SES, No. (%) 0.95
Low 19 (53) 5 (28)
Moderate 12 (33) 4 (22)
High 3 (8) 1 (6)
Missing 2 (6) 8 (44)
Results are presented as n (%) or median (range). MAS = meconium aspiration syndrome; CDH = congeni-
tal diaphragmatic hernia; other = persistent pulmonary hypertension in the newborn (n=7), sepsis (n=5), 
asphyxia (n=3), pulmonary hypoplasia due to kidney failure (n=1), respiratory syncytial virus (n=1); ECMO = 
extracorporeal membrane oxygenation; CLD = chronic lung disease as defined by Jobe and Bancalari(15). 
SES = socio-economic status based on maternal education(40).
P value: difference between participants and non-participants; the Mann-Whitney test was used for con-
tinuous variables; the chi-square test was used for categorical variables
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neuropsychological outcome 
Intelligence
Based on outcomes of intelligence tests at 8 years (n = 3) or 12 years (n = 27), the mean 
IQ(SD) for the entire group was calculated to be 90.3(19.4). The mean IQ z-score was 
-0.65(1.29), which is significantly below the norm of the Dutch population (p = .03). Six 
children had scored below 70 at age 8 or 12 years. When those six were removed from 
the analyses, the IQ of the remainder of the group was 97.5(13.8).
Attention 
Selective and divided attention did not differ from what was expected based on their 
IQ (Table 2).
Memory
The adolescents scored significantly lower (Table 2) on short-term and long-term verbal 
(RAVLT immediate and delayed recall) and visual-spatial memory (RCFT immediate and 
delayed recall) than what was expected based on their IQ (Table 2). One adolescent had 
visual problems that could primarily affect the RCFT results but was able to copy the 
figure (RCFT copy) without major problems, indicating specific visual-spatial memory 
problems to explain the low scores on the RCFT immediate and delayed recall.
The adolescents scored significantly higher (Table 2) than expected based on their IQ 
on auditory short-term memory (digit span). However, the proportion of adolescents 
scoring lower on the backward span than on the forward span (indicative of a working-
memory problem [28]) was significantly higher than the norm population (25) (32% vs 
9%; p < .01).
Executive Functioning
The adolescents scored significantly higher than expected based on their IQ on the 
Tower test (Table 2), which measures planning.
Visual-spatial processing
Results did not differ from what was expected based on their IQ (Table 2).
Questionnaires 
Executive Functioning
Figure 1 graphically shows that the parents of the entire group on average evaluated 
executive functioning of their children to be less positive than that of the normal popu-
lation (BRIEF organization of materials: mean [SD] = -0.60 [0.90], p = .03; BRIEF behavior 
evaluation: mean [SD] = -0.53 [0.88], p = .05).
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Self-Esteem 
The adolescents on average evaluated their behavior more positive than the reference 
population (SPPC behavior: mean [SD] = 0.67 [1.00], p < .01).
Health Status 
The adolescents’ health status on average did not significantly differ from that of the 
normal population. The adolescents rated their physical, emotional, social, school, and 
psychosocial functioning similarly to healthy peers (PedsQL physical functioning: mean 
Table 2. Overview of neuropsychological outcome
Neuropsychological test n IQ mean (SD) Mean (SD) p value
Attention
TMT A 22 -0.69 (1.36) -0.71 (1.75) 0.95
TMT B -0.90 (1.28) 0.39
TMT B/A -0.50 (0.93) 0.34
Stroop 1 22 -0.69 (1.36) -0.94 (1.59) 0.18
Stroop 2 -0.79 (1.56) 0.74
Stroop 3 -0.90 (1.33) 0.45
Stroop -0.41 (1.08) 0.34
Memory
KAIT rebus learning 29 -0.59 (1.28) -0.83 (1.11) 0.38
KAIT rebus learning delayed -0.74 (1.56) 0.82
KAIT auditory comprehension -0.34 (0.87) 0.22
KAIT auditory comprehension delayed -0.70 (1.24) 0.63
WAIS Digit span 22 -0.69 (1.36) -0.12 (1.12) 0.014
RAVLT immediate 28 -0.63 (1.33) -1.40 (1.58) 0.02
RAVLT delayed -1.54 (1.67) 0.010
RAVLT recognition 14 -0.66 (1.24) -0.69 (1.53) 0.76
RCFT immediate 9 -0.47 (1.21) -1.65 (1.37) 0.008
RCFT delayed -1.70 (1.23) 0.008
RCFT recognition -1.07 (0.69) 0.20
Executive functioning
Tower 29 -0.64 (1.32) -0.06 (0.96) 0.03
Visual spatial processing
RCFT copy 9 -0.47 (1.21) -0.97 (1.48) 0.29
n= number of adolescents assessed with that specific neuropsychological test. IQ mean (SD) = average 
z-score IQ of the adolescent group assessed with that specific test. Mean (SD) = average z-score of the 
neuropsychological test. P value = outcome of the paired samples t-test between IQ and neuropsychologi-
cal outcome. P value = significant outcome of the paired sample t-test. TMT = Trail Making Test; Stroop = 
Stroop Color Word Test; KAIT = Kaufman Adult Intelligence Test; WAIS = Wechsler Adolescent Intelligence 
Scale; RAVLT = Rey Auditory Verbal Learning Test; RCFT = Rey Complex Figure Test; Tower = Tower test.
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[SD] = 0.25 [1.06]; PedsQL emotional functioning: mean [SD] = 0.49 [0.92]; PedsQL social 
functioning: mean [SD] = 0.06 [1.08]; PedsQL school functioning: mean [SD] = -0.01 
(1.14); PedsQL psychosocial functioning: mean [SD] = 0.24 [0.95]).
Behavior Problems 
The adolescents on average reported more internalizing behavior problems than found 
in the normal population (ySR withdrawn/depressed: mean [SD] = -0.47 [0.54], p = .02; 
ySR somatic complaints: mean [SD] = -0.43 (0.48), p = .03; ySR social problems: mean 
[SD] = -0.41 [0.46], p = .04) (Figure 1).
factors influencing neuropsychological outcome 
Regression analyses were performed to assess whether any medical characteristics 
(Table 1) could predict the four neuropsychological outcome variables that were signifi-
cantly lower than in the normal population (RAVLT, both immediate and delayed recall; 
RCFT, both immediate and delayed recall).
First, univariate regression analyses with all medical variables identified four medi-
cal variables with an individual significant influence on one or more of the outcome 
variables: diagnosis, age at start ECMO, the presence of convulsions, and use of antiepi-
leptics (Table 3). Next, multiple regression analyses were done with these four medical 
variables while correcting for SES. In the analyses, multicollinearity was evaluated. The 
multivariate regression model showed none of the medical variables to be significant 
predictors once added all together.
figure 1. Proxy- and self-re-
ported outcome
ySR = youth Self Report.
BRIEF = Behavior Rating Inven-
tory of Executive Functioning.
Z-score = Individual norm score 
minus the population norm 
score divided by the standard 
deviation of the population.
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diScuSSion
In this first worldwide study of neuropsychological outcome of neonatal ECMO survivors 
at adolescent age, we found that short-term and long-term verbal deficits and visual-
spatial memory problems were present in a large proportion of these adolescents, even 
after adjustment for IQ. Impaired visual acuity could have caused the poor visual-spatial 
memory results (RCFT immediate and delayed recall) in our study. One adolescent 
indeed had visual problems but still was able to copy the figure (RCFT copy) without 
major problems. Therefore, we believe that our results indicate specific visual-spatial 
memory problems in this population. Poorer processing skills combined with poor spa-
tial abilities and lower scores on visual memory testing have been reported in 7-year-old 
neonatal ECMO survivors.(8) Our findings suggest that these problems may persist into 
later life and could possibly affect academic performance and participation in society.
In this study, the subjects performed significantly better than expected based on 
their IQ on auditory short-term memory (digit span). The digit span is comprised of a 
forward span and a backward span component. The forward component requires more 
from short-term auditory memory(29), whereas the backward component requires 
more from working-memory(28) and may evoke more visuospatial image processes.(30)
Almost one-third of adolescents in this study scored significantly lower on the backward 
component than on the forward component compared to 9% in the norm popula-
tion(25), suggesting deficits in working-memory. Deficits in working-memory have been 
identified in children with acquired brain injury as well.(31) 
Concerning the adolescents’ executive functioning skills, in this study, parents re-
ported more problems compared with the reference norm on the scales organization 
of materials and behavior evaluation in the adolescents. In practice, this could mean, 
for example, that they have difficulty in organizing homework assignments or do not 
evaluate their work after they have finished. We did not assess these specific executive 
Table 3. Predictors of neuropsychological outcome
Univariate Regression 
Analyses
RAVLT Immediate 
Recall
RAVLT Delayed Recall RCFT 
Immediate Recall
RCFT 
Delayed Recall
Diagnosis NS NS β = −0.79; p = 0.01
(CI, −3.66 to −0.69)
β = −0.69; p = 0.04
(CI, −3.30 to −0.11)
Age start ECMO NS β = 0.40; p = 0.04
(CI, 0.001 to 0.029)
NS NS
Presence of convulsions β = 0.43; p = 0.03
(CI, 0.20 to 2.66)
NS NS NS
Use of antiepileptics β = −0.46; p = 0.30
(CI, −3.54 to −0.21)
β = −0.45; p = 0.03
(CI, −3.67 to −0.20)
NS NS
RAVLT = Rey Auditory Verbal Learning Test, RCFT = Rey Complex Figure Test, NS = not significant, ECMO = 
extracorporeal membrane oxygenation. 
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functions, only planning. Further research should make clear whether the problems 
reported by the parents could be because of other poor executive functioning skills or 
(working)memory problems.
The key brain regions supporting working-memory are the dorsolateral and ventro-
lateral prefrontal and parietal cortex.(32) These regions are also involved in organization 
skills and behavior evaluation (functions that parents reported to be suboptimal in their 
children). It would, therefore, be worthwhile to specifically study these brain regions 
in neonatal ECMO survivors with the use of neuroimaging. Another brain region, the 
hippocampus, is highly and selectively susceptible to injury caused by hypoxia-ischemia 
(including ECMO treatment)(33–36) and has been shown to lead to memory dysfunc-
tions in later childhood.(33) This type of injury might be a partial explanation for the 
verbal and visual-spatial memory problems found in this study. Neuroimaging studies 
should, therefore, also focus on the more subcortical located hippocampus.
Regarding social-emotional functioning, the adolescents reported more withdrawn 
behavior and somatic and social problems compared with the norm population. On the 
other hand, they had a significantly more positive feeling of self-competence. This is not 
an unusual finding. In a study with adolescent, preterm born children, the vast majority 
were content with their activities and participation in society although most of them 
were neither in school nor employed at age 19.(37) In the same vein, we have previously 
found that self-reported emotional functioning of children with congenital anomalies 
treated with or without neonatal ECMO was not affected at the age of 8 years.(7) 
We were unable to identify significant predictors of the memory problems. Still, 
we believe that “severity of illness” is a predictor for neuropsychological outcome of 
neonatal ECMO survivors, rather than ECMO treatment itself. This notion is supported 
by findings in children with CDH who were not treated with ECMO.(7) Outcome after 
neonatal ECMO treatment is determined by many different factors: pretreatment related 
(e.g., congenital anomalies or loss of cerebral autoregulation), treatment related (such 
as intracranial hemorrhage), and posttreatment related (e.g., CLD and prolonged hos-
pitalization).(9) However, a specific severity of illness scoring system for ECMO treated 
patients is not available.(38) We believe that the lack of such a scoring system – together 
with the small sample size – may explain why we did not find significant predictors of 
outcome at older age.
This study has some limitations. First, only 63% of participants in the follow-up pro-
gram had been assessed at adolescent age. We started our follow-up program in 2001, 
and therefore, a large proportion of the survivors was invited a long time after their 
treatment. This resulted in a small sample. In other studies with participants born from 
1996 onward, we had participation rates above 85%.(11,12) Bias may have occurred 
because significantly more nonparticipants than participants had abnormal CUS during 
ECMO (Table 1). Second, the fact that the average IQ was significantly below the norm 
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is a potential source of bias. In previous studies in (pre)school-aged ECMO survivors, 
intelligence was found to be equal to the norm.(7,8,11) We assume that the generally 
low SES in this study contributes to the low IQ in this group, as low SES is associated 
with poorer cognitive development.(39) To avoid confounding the neuropsychological 
outcome, we corrected for both IQ and SES in the statistical analyses. Further to this 
issue, the use of IQ obtained at 8 and 12 years old, rather than at adolescent age, could 
be considered a limitation. However, previous evidence that intelligence is stable from 
infancy into adolescence (40) was confirmed for the 14 adolescents who were evaluated 
at both 8 and 12 years in this study. Third, we addressed selective and divided attention 
but not sustained attention. In a previous study, we found sustained attention problems 
in 8-year-old children treated with neonatal ECMO.(7) Because poor sustained attention 
can interfere with memory, it is not clear whether the observed memory problems are 
primary or secondary dysfunctions. Fourth, we did not correct for multiple testing (n = 
20) in the analyses of the neuropsychological tests. If we had done so, none of the results 
would have been significant. We decided to present the uncorrected results because this 
first study on neuropsychological outcome in neonatal ECMO survivors at adolescent 
age yields further directions for improvement of care and future follow-up studies. Fifth, 
we did not have a control group of adolescents who had similar severity of illness in the 
neonatal period but who did not undergo ECMO treatment. With two ECMO centers 
in the Netherlands, covering a relatively small geographical area, the large majority of 
neonates with similar severity of illness who are not born prematurely (i.e., born after 34 
weeks of gestation with birth weight > 2,000 gm) are treated with ECMO. Therefore, it 
will be difficult to obtain controls with similar severity of illness who survived without 
ECMO. As an alternative, patients from countries with less access to ECMO treatment 
could serve as controls. However, variety in treatment protocols and neuropsychological 
assessments may bias the results of such a study. For similar reasons, we consider the 
use of a historic control group of infants treated before the ECMO era not appropriate.
Despite the limitations, this study is of value as it is the first reporting on neuropsycho-
logical outcome following neonatal ECMO at 17–18 years and has important implica-
tions for patient care. Considering that we found neuropsychological deficits persisting 
into adolescence – thereby extending the evidence of “growing into deficit” in these 
patients – it is of utmost importance that we report outcome at this age in order to 
understand at which neuropsychological processes interventions should be aimed.
concluSion
This study showed verbal, visual-spatial, and working-memory problems in adolescents 
of 17–18 years old treated with neonatal ECMO. Furthermore, parents reported some 
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aspects of executive functioning as impaired in their children. Positively, health status 
and sense of self-competence did not seem affected. Considering the findings of this 
study in light of the outcome at school-age, future research should focus on 1) the longi-
tudinal neuropsychological outcome, specifically of (working) memory, 2) developing a 
standardized scoring system to quantify “severity of illness”, 3) evaluating to what extent 
“severity of illness” is responsible for acquired brain injury, and 4) evaluation of effects 
of cognitive rehabilitation (which is currently performed in our department). To achieve 
these goals, it would be necessary to set up multicenter follow-up programs with inter-
nationally standardized assessment instruments and neuroimaging.
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SuPPlemenTary maTerial 
Supplemental digital content 1. descriptions of the neuropsychological 
tests.
Intelligence 
Wechsler Intelligence Scale for Children (WISC-III-NL)
Intelligence test for children between the ages 6 and 16. The test generates a full scale IQ 
(FSIQ), Total Verbal IQ (TVIQ) and Total Performance IQ (TPIQ). The IQ scores are derived 
from five verbal and five performance subtests. There are also three supplemental tests 
(1, 2).
Attention 
Trail Making Test (TMT)
This paper and pencil test consists of two parts. In the first part (part A), the subject 
must draw lines to consecutively connect numbered circles on a sheet. In the second 
part (part B), the subject must consecutively but alternately connect numbered and let-
tered circles on another worksheet. The goal of the test is to finish each part as quickly 
as possible. The test can be administered to children and adults in the age range 6-89 
years. This test measures visual conceptual and visuomotor tracking as well as divided 
attention (3, 4).
Stroop Color Word Test (Stroop)
The Stroop consists of three trials: in the first trial (Stroop 1) the subject must read color 
names, in the second trial (Stroop 2) name printed colors, and in the third trial (Stroop 
3) name printed colors not denoted by the color name. The test can be administered to 
children and adults in the age range 8-65 years. Selective attention is measured with 
this test (3, 4).
Memory 
Kaufman Intelligence Test (KAIT) – subtest Rebus Learning
The subject learns a word or concept associated with a rebus (a picture that stands for 
a word) and then has to read aloud phrases and sentences that are composed of these 
rebuses. This is repeated after 30 minutes. This test measures short- and long-term 
visual/verbal associative memory. Adolescents and adults in the age range 14-85 years 
can take the test (5, 6).
Kaufman Intelligence Test (KAIT) – subtest Auditory Comprehension 
The subject has to listen to a recording of a news story, then answer literal and inferen-
tial questions about the story. This test measures short- and long-term (after 45 minutes) 
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verbal memory and verbal logic reasoning. Adolescents and adults in the age range 
14-85 years can take the test (5, 6).
Wechsler Adult Intelligence Scale – Third Edition (WAIS-III) – subtest Digit Span 
The Digit Span consists of random number sequences that increase in length and that 
the examiner reads aloud at the rate of 1 number per second. The subject has to repro-
duce these numbers in the same order. Next, the sequences must be recalled backwards 
(3-5-7 becomes 7-5-3). The first part of the test measures short-term auditory memory 
and short-term retention capacity. The second part measures auditory working memory. 
A difference of 4 or more points between forward and backward Digit Span in favor of 
forward is indicative of a working-memory problem. The test is applicable to adolescents 
and adults in the age range 16-85 years (7).
Rey Auditory Verbal Learning Test (RAVLT)
The RAVLT consists of five presentations with recall of a 15-word list, a sixth recall 
trial after 30 minutes, and a seventh recognition trial. This test measures memory span, 
short- and long term verbal memory, verbal recognition, learning curve, and retroactive 
or proactive interference. It can be administered to children and adults in the age range 
6-89 years (8, 9).
Memory and visual-spatial functioning 
Rey Complex Figure Test (RCFT)
The RCFT consists of three trials. First the subject has to copy a complex figure. Then 
after 3 and after 30 minutes the figure must be drawn from memory. Next, different 
figures are shown and the subject has to indicate whether these figures were in the 
original figure. This test measures visual integration, short- and long-term visual-spatial 
memory, and visual-spatial recognition. It can be completed by children and adults in 
the age range 6-89 years (4, 10).
Executive functioning 
Tower Test (Tower)
The subject must plan ahead to rearrange five colored rings in varying sizes from the 
initial position on three upright sticks to a new predetermined position in as few moves 
as possible. When two or more rings are at the same stick, the smaller ones must always 
be on top of the larger ones. Only one ring can be moved at the same time. This test 
measures planning ability and can be administered to children and adults in the age 
range 8-89 years (11, 12).
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Behavior Rating Inventory of Executive Functioning questionnaire (BRIEF)
This questionnaire is filled out by parents of children and adolescents between the ages 
of 6 and 18 years. Different areas of executive functioning are addressed in 75 questions 
that form 8 subscales: Inhibition, Cognitive Flexibility/Shifting, Emotional Control, Initi-
ate, Working-memory, Plan/organize, Organization of materials, Monitor. The 8 subscales 
make up two indices: Behavior Regulation Index (ability to adjust thinking and regulate 
emotions and behavior) and Metacognition Index (ability to independently carry out 
tasks and solve problems based on the judgment of own behavior). A total executive 
functioning score can be derived as well (13, 14).
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abSTracT
aim To examine the neurobiology of long-term neuropsychological deficits following 
neonatal extracorporeal membrane oxygenation (ECMO).
method This cross-sectional study assessed white matter integrity and hippocampal 
volume of ECMO survivors (8-15yrs) and healthy controls (8-17yrs) using Diffusion Tensor 
Imaging and structural MRI, respectively. Neuropsychological outcome was evaluated in 
patients. Included clinical predictors of white matter integrity: age start ECMO, ECMO 
duration, highest oxygenation index before ECMO, highest mean airway pressure and 
mechanical ventilation duration.
results ECMO survivors (n = 23) had lower global fractional anisotropy than healthy 
children (n = 54) (patients = .368; comparison group = .381; p = .018), but similar global 
mean diffusivity (p = .41). ECMO survivors had lower fractional anisotropy in the left 
cingulum bundle (patients = .345; controls = .399; p < .001) and higher mean diffusivity 
in a region of the left parahippocampal cingulum (patients = .916; comparison group = 
.871; p < .001). Higher global mean diffusivity predicted worse verbal memory in ECMO 
survivors (n = 17) (β = -.74, p = .008). ECMO survivors (n = 23) had smaller bilateral hip-
pocampal volume than healthy children (n = 43) (left: p < .001; right: p < .001) and this 
was related to worse verbal memory (left: β = .65, p = .018; right: β = .71, p = .006).
interpretation Neonatal ECMO survivors are at risk for long-term brain alterations, 
which may partly explain long-term neuropsychological impairments. Neuroimaging 
may contribute to better risk stratification of long-term impairments.
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inTroducTion
Extracorporeal membrane oxygenation (ECMO) has been used in over 28,000 neonates 
with severe respiratory failure, 74% of whom survived to discharge or transfer.1 Previous 
studies found 10-59% of ECMO patients to have abnormalities on routine neuroimag-
ing during treatment.2 Furthermore, neurological complications such as hypoxia and 
cerebrovascular injury have been reported.3,4
Neurodevelopmental follow-up of these children shows long-term (subtle) neuropsy-
chological impairments that emerge in childhood and persist into adolescence.5-7 Despite 
normal intelligence, these attention and memory deficits result in patients being at risk 
for school failure.5-7 These results suggest a ‘growing into deficit’ phenomenon where 
subtle brain injuries acquired at a young age become functionally evident over time 
when demands on cognitive functioning increases.8 This ‘growing into deficit’ is nested 
within different developmental processes that occur in the brain (i.e. myelination) during 
childhood and adolescence. Thus, it is important to study the underlying neurobiology of 
long-term neuropsychological impairments within a developmental framework.
Studies utilizing sophisticated neuroimaging methods to study neonatal ECMO 
survivors are scarce.9,10 Structural MRI in school-age children who experienced neo-
natal hypoxia have shown bilateral lower hippocampal volume compared to healthy 
controls.9 Furthermore, the lower hippocampal volume was associated with the extent 
of memory deficits. Our group previously found cortical thickness and global brain vol-
umes in neonatal ECMO survivors (8-15 years) to be similar to healthy controls, despite 
verbal memory problems in the patients.10 These results suggest that the underlying 
brain injury in ECMO survivors is specific and/or subtle and therefore may not always 
be identifiable using high-resolution structural MRI. Alternative advanced imaging 
techniques may be better suited to identify subtle brain alterations in ECMO survivors.
Diffusion Tensor Imaging (DTI) is an imaging technique that can quantify microstruc-
tural characteristics of white matter. White matter has been shown to be especially 
vulnerable in the neonatal period, a time when it is undergoing rapid development.11 
Neonatal ECMO survivors may therefore be at an increased risk for white matter abnor-
malities. Moreover, white matter integrity has been associated with neuropsychological 
outcome.11 Since white matter is important for high-speed transmission of neuronal 
signals between distant brain regions, aberrations in white matter development could 
affect the orchestration of specific cognitive functions. Thus, the long-term neuropsy-
chological impairments observed in both 8-year-old and 17-year-old ECMO survivors 
could be due to underlying white matter alterations.5-7
This study aimed to assess whether 8-to-15 year-old ECMO survivors have white 
matter alterations and whether these are partially responsible for the long-term neuro-
psychological deficits observed in these patients. We hypothesized to find white matter 
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alterations in ECMO survivors, specifically in tracts associated with (working) memory 
and attention. Identification of neurobiological correlates of long-term neuropsycho-
logical impairments following neonatal ECMO may contribute to better risk stratification 
of these impairments in neonatal ECMO survivors.
meThod
ecmo survivors 
Children born between January 1997 and December 2003 treated with venoarterial 
neonatal ECMO in the Erasmus MC in Rotterdam, the Netherlands were included. ECMO 
support was given according to the entry criteria described by Stolar et al12. For each 
patient, cannulas were placed in the right cervical region by the same surgical team. Fur-
ther recruitment details and in- and exclusion criteria are described elsewhere.10 Of 60 
eligible patients, six families were not traceable, 17 declined participation and one child 
had dental braces, leaving 36 participants. Of these, 23 had reliable DTI and structural 
data (8-15 years) (Supplementary Figure 1). Background characteristics retrieved from 
the medical records are presented in Table 1.
comparison group
Healthy children (8-18 years) were recruited through two different approaches. First, 
participating families were asked if their child had a friend who would be interested 
in participating. Second, we sent invitation letters to the parents of children attending 
a primary school in Rotterdam. In- and exclusion criteria are described elsewhere.10 
Eleven of 75 controls were excluded because of either preterm birth or because they 
were greater than six months younger/older than the youngest/oldest patient, leaving 
64 eligible controls. Of these, 54 had reliable DTI data and 43 had reliable structural data 
(Supplementary Figure 1).
Study procedure 
The study was performed in compliance with the Code of Ethics of the World Medical 
Association (Declaration of Helsinki) and approved by the Institutional Review Board at 
the Erasmus MC (MEC-2010-299). Informed consent was obtained prior to participation 
from the parents of each child and from children 12 years and older. All children had 
been administered subtests of the Dutch edition of the NEPSy-II-NL neuropsychological 
test battery (Pearson, Amsterdam).13 Only performance of the ECMO survivors was ana-
lyzed as the relationship between cognitive functioning and brain alterations is largely 
unknown following ECMO. Children between 8 and 12 years performed nine subtests, 
older children performed only six due to the age limit of three tests.13
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Table 1. Clinical characteristics of the ECMO survivors
Participants (n = 23)
IQ, mean (SD) 100 (19)
Gestational age (weeks), median (IQR) 40 (2)
Birth weight (grams), median (IQR) 3530 (810)
Diagnosis, n (%)
MAS 15 (66)
CDH 4 (17)
Other 4 (17)
Age start ECMO (hours), median (IQR) 20 (24)
ECMO duration (hours), median (IQR) 124 (100)
Highest oxygenation index prior to ECMO, median (IQR) 46 (27)
Highest mean airway pressure, median (IQR) 20 (5)
Mechanical ventilation (days), median (IQR) 11 (9)
O2 post-ECMO, n (%)
1 day – 1 week 11 (48)
>1 week - <1 month 11 (48)
>1 month 1 (4)
BPD presence, n (%)
yes 2 (9)
No 21 (91)
Nitric Oxide pre-ECMO, n (%)
yes 16 (69)
No 5 (22)
Unknown 2 (9)
Inotropic use, n (%)
yes 21 (92)
No 1 (4)
Unknown 1 (4)
Morphine use, n (%)
<1 week 4 (18)
1 week – 1 month 15 (65)
>1 month 3 (13)
Unknown 1 (4)
Muscle relaxant use, n (%)
No 2 (8)
Perioperative only, n (%) 3 (13)
1 day – week 12 (53)
>1 week 5 (22)
Unknown 1 (4)
Corticosteroids use, n (%)
yes 2 (8)
No 21 (91)
Other diagnoses consist of persistent pulmonary hypertension of the newborn (PPHN) (n = 1), pneumonia 
(n = 2), and sepsis (n = 1). abbreviations: IQ, intelligence quotient; IQR, interquartile range; MAS, meconium 
aspiration syndrome; CDH, congenital diaphragmatic hernia; ECMO, extracorporeal membrane oxygen-
ation; O2 post-ECMO, extra oxygenation need post-ECMO; BPD, bronchopulmonary dysplasia.
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neuroimaging 
Participants first underwent a mock scanning session to become familiarized with the 
MR-environment.14 MRI data were acquired on a 3 Tesla GE MR-750 system using an 
8-channel head coil (General Electric, Milwaukee, WI). A full description of these meth-
ods is provided in Supplementary File 1. Briefly for the DTI data, after data processing, 
the voxel-wise scalar maps fractional anisotropy (FA) and mean diffusivity (MD) were 
computed. FA is the degree of directionality of diffusion and ranges from 0 to 1, where a 
higher FA generally represents a greater coherence of white matter fibers. MD is the rate 
of diffusion of hydrogen averaged in all directions. Lower MD is suggestive of increased 
integrity in axonal membranes, packing, or myelin. Fully automated probabilistic fiber 
tractography was performed using the FSL plugin “AutoPtx”15 to create subject-specific, 
probabilistic representations of multiple white matter fiber bundles. Raw image quality 
was assessed using automated software16 and visual inspection, leaving 77 datasets 
(ECMO survivors = 23, comparison group = 54).
Statistical analysis 
Age at MRI, gestational age and gender differences between groups were assessed 
using independent samples t-tests and a chi-squared test, respectively. As previous 
research showed congenital diaphragmatic hernia (CDH) patients tend to have lower IQ, 
we compared IQ between patients with meconium aspiration syndrome (MAS), CDH or 
other diagnoses using ANOVA.6 
Global white matter integrity of patients and controls was analyzed first. The as-
sociation fibers and limbic system fibers (uncinate, inferior fronto-occipital fasciculus, 
superior longitudinal fasciculus, inferior longitudinal fasciculus, cingulum bundle and 
parahippocampal part of cingulum) were used to compute a measure of global FA and 
global MD. These fibers have been associated with neuropsychological functioning and 
in particular with attention and (working) memory – domains that have been shown 
to be affected in neonatal ECMO survivors.6,17 The global measures were computed by 
multiplying the FA/MD values of each tract with the average volume of each tract, and 
then dividing this by the sum of the volumes of all tracts (Formula 1). This ensured that 
tracts of different size were appropriately weighted in their contribution to the global 
mean.
Formula 1:
Global FA = 
Σ6i=1 FAtractiVoltracti
Σ6i=1 Voltracti
The same formula was used to compute global MD. Assumptions of normality were met 
for FA and MD.
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Differences between groups in global FA, MD and the diffusion metrics within 
individual white matter tracts were analyzed using ANCOVA, adjusted for age at MRI 
and gender.17 The white matter tracts were assessed in the left and right hemispheres 
separately. Global FA/MD was added as a covariate to identify differences in the indi-
vidual tracts only. The False Discovery Rate (FDR) correction19 was used once to account 
for multiple testing in all analyses of FA/MD differences between groups. Results were 
considered statistically significant at the FDR-corrected p < .05.
Multivariable linear regression models were used to evaluate the effect of five clinical 
characteristics (age start ECMO, ECMO duration, highest oxygenation index prior to 
ECMO, highest mean airway pressure and mechanical ventilation duration) on global 
FA, global MD, and the altered white matter tracts. Age at MRI was adjusted for. For all 
clinical characteristics, log transformations were applied to satisfy parametric statistics 
assumptions.
In the ECMO survivors, white matter microstructure and verbal memory were assessed 
to get a better understanding of the poor verbal memory performance in the ECMO sur-
vivors previously shown by our group.10 Separate multivariable linear regression models 
were used to evaluate the effect of global FA, global MD and the altered tracts on verbal 
memory, adjusted for age at MRI. The associations between white matter microstructure 
on the other eight NEPSy-II-NL subtests in the ECMO survivors was explored using mul-
tivariable linear regression analyses, as the relationship between cognition and white 
matter microstructure remains largely unknown in this group. FDR correction19 was used 
to account for multiple testing for every set of analyses with the same NEPSy subtest. 
Results were considered statistically significant at the FDR-corrected p < .05.
Next, hippocampal volumes were compared between groups using ANCOVA. This was 
done separately for the right and left hippocampus, adjusted for age, gender and global 
brain volume. In ECMO survivors, multivariable linear regression analyses were per-
formed to analyze the relationship between hippocampal volume and verbal memory, 
adjusted for age, gender and global brain volume.
SPSS Statistics Version 22.0 (Armonk, Ny: IBM Corp.) and the Stats package in R Statisti-
cal Software version 3.1.3 (R Core Team, 2014) were used for statistical analyses and the 
FDR correction, respectively. For all regression analyses, the regression coefficient beta 
(β) and p-values are reported. Multicollinearity was not found in the models (variance 
inflation factors < 2.518). Effect sizes were calculated using partial eta squared (hp2). 
Results were considered statistically significant at p < .05.
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reSulTS
Study population
The ECMO group consisted of 23 children (11 boys, 12 girls) with a mean age (SD) of 11.9 
(2.6) years. All ECMO survivors attended regular education, but 35% (n = 8) needed extra 
help in school. The comparison group consisted of 54 children (22 boys, 32 girls) with a 
mean age (SD) of 11.4 (2.5) years. All healthy children attended regular education. Age 
at MRI, gestational age and gender did not differ between groups (p = .34; p = .57; p = 
.57, respectively).
None of the ECMO survivors (n = 23) had abnormal neonatal cranial ultrasounds or 
suffered cardiac arrests. Other clinical characteristics are reported in Table 1. Consistent 
with previous results, mean IQ (SD) did not differ between the diagnostic groups in the 
ECMO survivors (MAS: 100 (23); CDH: 95 (8); other diagnoses: 107 (15)), p = .70.6
dTi results
ECMO survivors had significantly lower global FA (n = 23, global FA = .368) compared 
to healthy children (n = 54, global FA = .381), p = .02, hp2 = .07. Further analyses were 
performed on the individual tracts. Significantly lower FA was found in the left cingulum 
bundle (CB) of ECMO survivors, p < .001, hp2 = .13 (Table 2, Figure 1A). Because the CB is 
a large bundle in which functional differences between the anterior and posterior parts 
have been demonstrated20, we additionally analyzed the left anterior and posterior 
cingulate bundles (CBa, CBp) separately. We found significantly lower FA in patients in 
the left CBa and CBp (Table 2).
Global MD did not differ between ECMO survivors (global MD = .803) and healthy 
children (global MD = .794), p = .41, hp2 = .01. Because DTI has not been used in neonatal 
ECMO survivors before, further analyses on MD in the individual tracts were conducted. 
Higher MD was found in the left parahippocampal cingulum (PHC) in ECMO survivors, p 
< .001, hp2 = .12 (Table 2, Figure 1B).
White matter microstructure and clinical characteristics in ecmo survivors
None of the clinical characteristics significantly predicted global FA or MD. Higher 
oxygenation indices before ECMO predicted higher FA in the right CB, β = .50, p = .03. 
Longer duration of mechanical ventilation, β = .36, p = .03, and younger age at the start 
of ECMO predicted higher MD in the left PHC, β = -.62, p = .002.
White matter microstructure and neuropsychological outcome in ecmo 
survivors 
Global MD significantly predicted cued and free recall verbal memory, β = -.74, p = .01 (n 
= 17) (Figure 2). Global FA (p = .20), FA in the left CB (p = .97), and MD in the left PHC (p = 
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.21) were not related to verbal memory. None of the other subtests of the NEPSy-II were 
related to the white matter alterations (Supplementary Table 1).
hippocampal volume 
ECMO survivors had significantly smaller mean hippocampal volume (SD) than healthy 
children, in the left, p < .001, hp2 = .41 (patients = 3597 (407), n = 23; comparison group 
= 4245 (398), n = 43), and right hemispheres, p < .001, hp2 = .22 (patients = 3646 (515); 
comparison group = 4111 (490)).
Left, β = .65, p = .02, and right, β = .71, p = .01, hippocampal volumes were associated 
with verbal memory performance in ECMO survivors (n = 17).
Table 2. FA and MD group differences in white matter tracts
Tract Hemisphere
Mean FA
Controls
Mean FA
Patients puncor. p η2p
Mean MD
Controls
Mean MD
Patients puncor. p η2p
UNC Left .347 (.03) .334 (.03) .69 .83 .00 .819 (.03) .826 (.03) .92 .93 .00
Right .361 (.03) .346 (.02) .46 .71 .01 .813 (.03) .817(.02) .57 .80 .01
IFO Left .415 (.03) .401 (.02) .81 .93 .00 .808 (.03) .815 (.03) .93 .93 .00
Right .422 (.03) .407 (.03) .66 .83 .00 .808 (.03) .813 (.02) .42 .71 .01
SLF Left .367 (.03) .357 (.03) .32 .71 .01 .769 (.03) .779 (.03) .40 .71 .01
Right .367 (.03) .361 (.02) .07 .28 .04 .769 (.03) .775 (.03) .48 .71 .01
ILF Left .401 (.02) .388 (.02) .40 .71 .01 .822 (.03) .829 (.03) .68 .83 .00
Right .407 (.02) .397 (.02) .89 .93 .00 .833 (.03) .836 (.03) .22 .60 .02
CB left .399 (.05) .345 (.04) .002 .02 .13 .761 (.04) .782 (.04) .06 .28 .05
anterior .376 (.05) .321 (.04) .00 .13
Posterior .429 (.06) .381 (.04) .02 .07
Right .368 (.05) .323 (.04) .01 .10 .08 .762 (.03) .778 (.03) .12 .35 .03
PHC Left .271 (.03) .249 (.03) .11 .35 .04 .871 (.05) .916 (.06) .002 .02 .12
Right .275 (.03) .259 (.03) .39 .71 .01 .897 (.05) .932 (.06) .03 .20 .06
Results of ANCOVA’s showing differences between patients (n = 23) and controls (n = 57) on all association 
and limbic system fiber tracts. Additional analyses on the anterior and posterior parts of the cingulum were 
done only for FA in the left cingulum bundle as differences between patients and controls were found in 
this specific tract. Mean weighted average FA (SD) is given for each tract per group. The partial eta squared 
(η2p) is given as an effect size. The size of the effect is interpreted according to Cohen’s guidelines23 which 
states 0.01 to be a small effect size, 0.06 to be a medium effect size, and 0.14 to be large. Age, gender and 
global FA or MD were added as covariates in the ANCOVA’s. fdr-corrected p-values <.05 were considered 
statistically significant. Puncor. gives the uncorrected p-value. Abbreviations: FA, fractional anisotropy; MD, 
mean diffusivity; UNC, uncinate fasciculus; ILF, inferior longitudinal fasciculus; IFO, inferior fronto-occipital 
fasciculus; SLF, superior longitudinal fasciculus; CB, cingulum bundle; PHC, parahippocampal cingulum 
bundle.
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figure 1. FA/MD differences between ECMO patients and healthy controls 
Figures 1a and 1b show FA and MD (10-3 mm2/s) for the individual white matter tracts of patients and con-
trols. Effect sizes (partial eta squared) are used to show the magnitude of the difference between groups. 
Effect sizes of 0.01 are considered to be small, 0.06 to be medium, and 0.14 to be large(23). In Figure 1a, FA in 
the left CB differs significantly between patients and controls. In Figure 1b, MD in the left parahippocampal 
cingulum differs significantly between patients and controls. Abbreviations: -l, left; -r, right; FA, fractional 
anisotropy; UNC, uncinate fasciculus; ILF, inferior longitudinal fasciculus; IFO, inferior fronto-occipital fascic-
ulus; SLF, superior longitudinal fasciculus; CB, cingulum bundle; PHC, parahippocampal cingulum bundle.
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diScuSSion 
We found global white matter alterations and smaller bilateral hippocampal volume in 
school-age neonatal ECMO survivors compared to healthy children, as well as specific 
white matter alterations in the CB and PHC. Lower verbal memory performance in ECMO 
survivors was related to higher global MD and smaller bilateral hippocampal volume. 
These results suggest long-term brain alterations that persist through childhood and 
into adolescence.
Global FA was significantly lower in ECMO survivors. FA has been suggested to be a 
measure of coherence of hydrogen diffusion within microstructures (i.e. axons, micro-
tubules) and to be lower in disorganized white matter tracts.21 Lower global FA may 
indicate long-term injury to neural tracts. This is in line with earlier results showing brain 
alterations following neonatal hypoxia and ECMO treatment.9 Interestingly, global MD 
did not differ between ECMO survivors and healthy children. This may be because the 
white matter alterations are specific (i.e. disorganization of axon fibers), leaving other 
structures (i.e. cellular structures) relatively intact.11 However, this remains speculative as 
FA and MD are summary parameters that cannot give detailed histological information.
We recently demonstrated verbal memory deficits in both 17-year-old ECMO survivors 
and in the ECMO survivors that are part of this study.5,10 In the latter group, we found 
that higher global MD predicted lower verbal memory. It is unclear why MD rather than 
FA predicted verbal memory, as only global FA differed between ECMO survivors and 
healthy children. Nonetheless, our findings are in line with a previous neuroimaging 
study showing lower white matter volume and memory deficits in 11-to-13 year-old 
neonatal ECMO survivors.9
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figure 2. Verbal memory and white matter integrity 
Scatterplot showing the relationship between global Mean Diffusivity (MD) and cued and free recall verbal 
memory in neonatal ECMO patients. Verbal memory minimum and maximum scores: 0-34.
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Lower FA was found in the entire left CB in neonatal ECMO survivors, indicating aber-
rations along the entire tract. Even though global MD did not differ, ECMO survivors had 
significantly higher MD in the left PHC. The limbic system fibers (i.e. CB and PHC) have 
been found to develop rapidly in the first six months of life, causing FA to increase and 
MD to decrease.11 Because our participants were critically ill in the first weeks of life, the 
development of these fibers may be at risk.
We found white matter alterations only in the left hemisphere. Left side predominance 
of brain injury following neonatal ECMO has been previously reported using cranial 
ultrasound.4 Of note, before correcting for multiple comparisons, right hemisphere dif-
ferences in the CB and PHC were also found. Furthermore, unlike the small effect sizes 
found in the majority of the tract comparisons, differences in the right CB and PHC 
showed medium effect sizes.22 The lack of right hemisphere differences may thus be 
due to a small sample size rather than being indicative of an increased left hemisphere 
vulnerability.
CB or PHC alterations in the ECMO survivors were not associated with verbal memory. 
The CB is a large bundle involved in various cognitive functions, including working- 
and visuospatial memory and attention.23 The CB alterations may thus be specific to 
other neuropsychological deficits that have been observed following neonatal ECMO.5-7 
Furthermore, the verbal memory task used focused on episodic memory, whereas the 
parahippocampal region seems involved in semantic memory.24 As episodic memory 
has been associated with the hippocampus, a structure vulnerable to hypoxic injuries, 
hippocampal rather than CB or PHC alterations may partly explain the verbal memory 
deficits observed.9 Indeed, we found smaller bilateral hippocampal volume in ECMO 
survivors compared to controls. Moreover, smaller hippocampal volume was associated 
with worse verbal memory in ECMO survivors.
Other than verbal memory, no relationships were found between performance on 
the NEPSy-II and white matter integrity. This suggests specificity between the verbal 
memory deficit and hippocampal volume in ECMO survivors. Nonetheless, ECMO sur-
vivors have been shown to be at risk for working-memory, visuospatial memory and 
attention impairments, as well as school failure.5 Subtle neuropsychological deficits 
have been shown to be difficult to detect with the NEPSy-II25, which could explain the 
lack of findings with some of the subtests. In future studies it is therefore critical to use 
tests specifically designed to measure these types of deficits. Such outcomes should be 
combined with neuroimaging to improve our understanding of brain alterations and 
their clinical impact following neonatal ECMO.
No clinical predictors of global white matter were found, but longer duration of me-
chanical ventilation and younger age at the start of ECMO negatively influenced MD 
in the left PHC. These findings provide some support that severity of illness negatively 
influences outcome.6,9 However, we found that a higher OI prior to ECMO was associated 
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with higher FA in the right CB. As higher FA is generally associated with better organiza-
tion of white matter, these analyses should be replicated by future studies before any 
firm conclusions can be drawn.
Our study has some limitations. First, the small size of the patient group restricts our 
findings to those with moderate to large effect sizes and limits the interpretability of 
the multivariable regression analyses. Second, more elaborate neuropsychological as-
sessment offering finer details of specific neuropsychological domains is better suited 
to assess white matter alterations in ECMO survivors. Third, while we do have age, 
gender and NEPSy outcomes of the healthy controls, we do not have IQ scores of this 
group. However, because all children performed within normal ranges on the NEPSy 
and attended regular education, they are likely to have average intelligence.13 Fourth, 
all patients had been treated with VA ECMO. However, while the application of VV ECMO 
has increased, VA ECMO remains the most frequently used modality for neonatal respira-
tory or cardiac failure.1 Lastly, we have limited clinical information of the patients due to 
lack of a digital patient management system (introduced in our unit in 2003) at the time 
of treatment.
Despite the limitations, this study is the first to use DTI to study white matter mi-
crostructure in school-age neonatal ECMO survivors and show long-term global and 
specific white matter alterations in neonatal ECMO survivors. Global MD alterations and 
lower hippocampal volume were associated with worse verbal memory performance in 
patients. These results help define the underlying neurobiology involved in the long-
term neuropsychological deficits following ECMO. Furthermore, severity of illness may 
have partly influenced white matter development. The use of advanced neuroimaging 
techniques such as DTI may contribute to better risk stratification and earlier identifica-
tion of long-term neurodevelopmental impairments in critically ill infants.
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abSTracT 
objective Survivors of critical illness in early life are at risk of long-term memory and 
attention impairments. However, their neurobiological substrates remain largely un-
known.
design A prospective follow-up study.
Setting Erasmus MC-Sophia Children’s Hospital, Rotterdam, the Netherlands.
Patients Thirty-eight school-age (8-12 years) survivors of neonatal extracorporeal mem-
brane oxygenation (ECMO) and/or congenital diaphragmatic hernia (CDH) with an IQ ≥ 
80 and a below average score (z-score ≤ -1.5) on one or more memory tests.
interventions None.
measurements and main results Intelligence, attention, memory, executive function-
ing and visuospatial processing were assessed and compared with reference data. White 
matter microstructure and hippocampal volume were assessed using Diffusion Tensor 
Imaging and structural MRI, respectively. Global fractional anisotropy (FA) was positively 
associated with selective attention (β = 0.53, p = .030) and sustained attention (β = 0.48, 
p = .018). Mean diffusivity (MD) in the left parahippocampal region of the cingulum 
(PHC) was negatively associated with visuospatial memory, both immediate (β = -0.48, p 
= .030) and delayed recall (β = -0.47, p = .030). MD in the PHC was negatively associated 
with verbal memory delayed recall (left: β = -0.52, p = .021; right: β = -0.52, p = .021). Hip-
pocampal volume was positively associated with verbal memory delayed recall (left: β = 
0.44, p = .037; right: β = 0.67, p = .012). ECMO treatment or ECMO type did not influence 
the structure-function relationships.
conclusions Our findings indicate specific neurobiological correlates of attention and 
memory deficits in school-age survivors of neonatal ECMO and/or CDH. A better under-
standing of the neurobiology following critical illness, both in early and in adult life, may 
lead to earlier identification of patients at risk for impaired neuropsychological outcome 
with the use of neurobiological markers.
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inTroducTion
The number of children admitted to neonatal intensive care units has increased over the 
last decade and medical improvements have led to higher survival rates.(1) The long-
term neurodevelopment following critical illness in early life is therefore, now more 
than ever, of major concern. Previous studies have shown that growing up after critical 
illness in early life, either due to prematurity, specific forms of cardiac anomalies or 
major congenital anomalies, is associated with neuropsychological deficits and school 
problems. Attention and memory deficits have been reported in pre-adolescent and 
adolescent survivors, irrespective of underlying cause or birthweight.(2-7) However, the 
neurobiological substrates of these impairments remain largely unknown.
A clearly delimited group of critical illness survivors are children treated with neonatal 
extracorporeal membrane oxygenation (ECMO) or congenital diaphragmatic hernia 
(CDH) treated without ECMO. Recently, we showed altered global white matter micro-
structure and specific alterations in limbic system regions in 11-year-old ECMO survivors.
(8) Hippocampal volume was positively associated with verbal memory.(8) However, as 
only a limited cognitive assessment was available, specific aspects of neuropsychologi-
cal outcome in relation to brain alterations have yet to be explored. This is of interest as, 
despite a generally average IQ, not only verbal memory but visuospatial memory and 
attention deficits have been shown following ECMO and CDH treated without ECMO.
(2,5,7) 
The identification of impaired neurodevelopment currently relies solely on neuro-
psychological assessment. Understanding the neurobiological correlates of impaired 
outcome may lead to earlier identification of children at risk with the use of advanced 
neuroimaging techniques. In this study, we aimed to find neurobiological substrates of 
neuropsychological deficits in school-age (8-12 years) survivors of critical illness in early 
life by combining elaborate neuropsychological assessment with structural MRI and 
diffusion tensor imaging (DTI). We hypothesized that previously demonstrated brain 
alterations in neonatal ECMO survivors (i.e. in global white matter microstructure, white 
matter microstructure in the cingulum bundle and parahippocampal region of the cin-
gulum, and hippocampal volume(8)) would be specifically associated with memory and 
attention deficits. We expect our findings to aid in earlier identification of patients at risk 
of long-term cognitive deficits with the use of neurobiological markers.
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maTerialS and meThodS
Population 
Participants of an ongoing trial on working-memory training (NTR4571) at the Erasmus 
MC-Sophia Children’s Hospital with usable neuroimaging data at baseline were included. 
Inclusion criteria for the trial were: school-age (8-12 years) children treated with ECMO 
or treated for CDH without ECMO in the first weeks of life at the Erasmus MC-Sophia 
Children’s Hospital in Rotterdam or the Radboud University Medical Center in Nijmegen 
(the Netherlands), IQ ≥ 80 and memory impairment (z-score ≤ -1.5 on at least one (work-
ing) memory test(9)). Children who met the inclusion criteria underwent neuroimaging. 
ECMO treatment had been applied in case of reversible severe respiratory failure using 
the entry criteria by Stolar et al(10): oxygenation index > 25 with 3-hour intervals, per-
sistent low pH (< 7.15) for 3-6 hours, and non-responding to changes in therapy. Entry 
criteria for ECMO did not change over time. Exclusion criteria were: psychopharmaceutic 
drugs (e.g. methylphenidate) and/or genetic syndromes known to affect neuropsycho-
logical functioning.
This study was performed in compliance with the Code of Ethics of the World Medical 
Association (Declaration of Helsinki) and approved by the Institutional Review Board 
(MEC-2014-001). All parents and children ≥ 12 years signed an informed consent prior to 
their inclusion in the study. The neuropsychological and neuroimaging data collected at 
baseline are presented in this study.
neuropsychological assessment 
Validated neuropsychological tests, with Dutch validated reference values, were used 
to assess cognitive skills across four domains (brief test descriptions in Supplemental 
Digital Content 1): 
1. Intelligence: 
 a.  Two-subtest short-form (Block Design and Vocabulary)(11) of the Wechsler Intel-
ligence Scale for Children (WISC-III-NL)(12).
2. Attention: 
 a. Sustained attention: Dot Cancellation Test (DCT)(13).
 b.  Selective attention: Trail Making Test B (TMTB)(9), STROOP color-word test 
(STROOP)(9).
 c. Processing speed: Trail Making Test A (TMTA)(9).
3. Memory: 
 a.  Working-memory: subtest Digit Span of the WISC-III-NL(12), subtest Spatial Span 
of the Wechsler Nonverbal Scale of Ability (WNV)(14).
 b. Verbal memory: Rey Auditory Verbal Learning Test (RAVLT)(15).
 c. Visuospatial memory: Rey Complex Figure Test (RCFT)(16).
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4. Executive functioning: 
 a.  Subtests Key Search and Modified Six Elements of the Behavioral Assessment of 
the Dysexecutive Syndrome(17).
neuroimaging
All children first underwent a mock scanning session to become familiarized with the 
MR-environment.(18) MRI data were acquired on a 3 Tesla GE MR-750 system using an 
8-channel head coil (General Electric, Milwaukee, WI). A full description of the methods 
is provided in Supplemental Digital Content 2. After DTI data processing, the voxel-wise 
scalar maps fractional anisotropy (FA) and mean diffusivity (MD) were computed. FA 
indicates the degree of directionality of water diffusion and ranges from 0 to 1. MD is the 
rate of diffusion of water (hydrogen) averaged in all directions. The FSL plugin ‘AutoPtx’ 
for fully automated probabilistic fiber tractography was used to create subject-specific, 
probabilistic representations of multiple white matter bundles.(19) Automated(20) and 
visual inspection of the data left 33 DTI datasets (87%) and 35 structural MRI datasets 
(92%) with usable image quality. All scans were reviewed by a board-certified neurora-
diologist (M.S.), blinded for medical history and outcome. No serious clinically relevant 
abnormalities were reported. In one patient with a hemorrhagic infarct in the posterior 
middle cerebral artery as shown on neonatal cranial ultrasound, abnormalities (ulegy-
ria) in this region were still visible on the long-term MRI scan. Sensitivity analyses were 
performed without this child’s data. As the results did not change, the child was not 
excluded from the analyses.
Statistical analysis 
Neuropsychological test scores were converted to z-scores (individual score minus the 
population mean divided by the population SD). Scores were inverted where appropri-
ate so that higher scores always equated with better performance. Described in more 
detail in our previous study(8), global white matter microstructure was calculated using 
a weighted (by tract volume) average score of FA/MD of the association and limbic 
system fibers (uncinate, inferior fronto-occipital fasciculus, superior longitudinal fas-
ciculus, inferior longitudinal fasciculus, cingulum bundle and parahippocampal part of 
cingulum (PHC)): 
Formula 1: 
Global FA = 
Σ6i=1 FAtractiVoltracti
Σ6i=1 Voltracti
Where i denotes the tract, and Vol the volume of the tract. The same formula was used 
to calculate global MD.
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Our primary aim was to examine whether previously reported brain alterations in 
ECMO survivors (global white matter structure, FA in the cingulum bundle, MD in the 
PHC and hippocampal volume(8)) were associated with specific neuropsychological 
deficits in ECMO survivors and survivors of CDH treated without ECMO. Linear regression 
analyses were used to assess the associations between the brain regions of interest and 
neuropsychological outcome. Brain structures were analyzed in the left and right hemi-
spheres separately. If a significant association existed between an individual white mat-
ter tract and neuropsychological outcome, global FA/MD was added to identify whether 
associations were specific to an individual white matter tract above and beyond a global 
effect. The False Discovery Rate (FDR) correction(21) was applied once for each set of 
analyses between the same neuropsychological task and white matter microstructure 
outcomes (i.e. once for every six tests). The same method was used for the analyses 
between neuropsychological outcome and hippocampal volume. In post-hoc analyses, 
we adjusted for IQ to assess whether the structure-function relationships were specific 
to that neuropsychological domain or driven by general intellectual functioning.
Next, we assessed whether ECMO treatment (yes/no) or type of ECMO treatment (ve-
noarterial ECMO [VA-ECMO]/venovenous ECMO [VV-ECMO]) influenced the associations 
between the brain regions of interest and neuropsychological outcome using linear 
regression analyses.(5, 22) 
Finally, we determined if neuropsychological outcome was significantly different from 
the general population (mean z-score = 0; SD = 1) using one-sample t-tests, to inform us 
about the potential meaning of a significant structure-function relationship.
SPSS Statistics Version 22.0 (Armonk, Ny: IBM Corp.) was used for the statistical 
analyses. Normality tests were performed for all data and assumptions of ANCOVA were 
checked and met before analyses were conducted. No multicollinearity was found (vari-
ance inflation factors < 2.5 (23)). In all regression analyses, we adjusted for age at the 
time of assessment and gender.(24) Total brain volume was included in the analyses 
with hippocampal volume.(25) The standardized regression coefficient beta (β), uncor-
rected (puncor) and FDR-corrected p-values were reported. Effect sizes were calculated 
using partial eta squared (hp2) and interpreted according to Cohen’s guidelines (0.01 = 
small, 0.06 = medium, 0.14 = large)(26). Results were considered statistically significant 
at FDR-corrected p < .05.
reSulTS
Study population 
Thirty-eight children participated (15 girls, 23 boys) with a mean age (SD) of 9.7 (1.5) 
years. Twenty-six children (68%) had been treated with ECMO (MAS = 18; CDH = 2; 
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Other = 6) and 12 CDH patients (32%) had not required ECMO. Seventeen ECMO patients 
(65%) had undergone VA-cannulation and nine (35%) VV-ECMO. Patient characteristics 
retrieved from medical records are reported in Table 1.
White matter microstructure and neuropsychological outcome
Lower global FA was associated with worse selective attention, β = 0.45, p = .036, hp2 = 
0.24, and sustained attention, β = 0.48, p = .018, hp2 = 0.23 (Table 2). Lower FA in the right 
cingulum bundle was associated with worse sustained attention, β = 0.46, p = .018, hp2 
= 0.24, whereas the association with FA in the left cingulum bundle disappeared after 
correcting for multiple testing, β = 0.40, p = .046, hp2 = 0.26. These findings were no 
longer significant when global FA was added (Table 2).
Table 1. Patient characteristics
Patient characteristics All (n = 38) ECMO (n = 26) CDH non-ECMO (n = 12) 
Age at assessment (years) 9.7 ± 1.5 9.6 ± 1.7 10.0 ± 1.2
Gestational age (weeks) 40.0 ± 0.3 41 ± 1.4 39 ± 2.3
Birth weight (grams) 3410 (3205-3790) 3595 (3296-3822) 3133 (2414-3423)
Male 23 (61%) 14 (54%) 9 (75%)
Dutch ethnicity 32 (84%) 20 (77%) 12 (100%)
Days of mechanical ventilation 10 (8-16) 11 (9-17) 9 (6-16)
Neonatal brain abnormalities1 3 (9%) 3 (13%) 0
Inborn 7 (18%) 1 (4%) 6 (50%)
Diagnosis
MAS  18 (69%)  
CDH  2 (8%) 12 (100%) 
Other2  6 (23%)  
Age start ECMO (days) 2 (1-3)
Duration of ECMO (hours) 114 (89-181)
Type of ECMO
VA  16 (61%)  
VV  9 (35%)  
VV to VA conversion  1 (4%)  
Data are expressed as mean ± SD, median (IQR) or number (percentage), as appropriate.
1 Abnormalities seen on cranial ultrasound or MRI in neonatal period: hemorrhagic infarct in the posterior 
middle cerebral artery (n= 1), bilateral thalamic lesions (n=2).
2 Other diagnoses are PPHN (n=3), respiratory insufficiency due to respiratory syncytial virus (n=2), mono-
ventricular heart with transposition of the great vessels (n=1).
Abbreviations: ECMO, extracorporeal membrane oxygenation; CDH, congenital diaphragmatic hernia; 
MAS, meconium aspiration syndrome; PPHN, persistent pulmonary hypertension of the newborn.
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No associations were found between global MD and any of the neuropsychologi-
cal tests (Table 2). Higher MD in the left PHC was associated with worse visuospatial 
memory immediate recall, β = -0.48, p = .030, hp2 = 0.24, and delayed recall, β = -0.47, p = 
.030, hp2 = 0.24. MD in both the left and right PHC were also negatively associated with 
verbal memory delayed recall (left: β = -0.52, p = .021, hp2 = 0.23; right: β = -0.52, p = .021, 
hp2 = 0.26) (Table 2, Figure 1).
IQ did not affect the associations between white matter microstructure and neuropsy-
chological outcome.
Table 3. Hippocampal volume and neuropsychological outcome
Neuropsychological test 
(n= 38)
Hippocampal volume, 
left
Hippocampal volume, 
right
Intelligence
WISC-III-NL β = 0.12, puncor.= .583, p = .868 β = 0.04, puncor.= .868, p = .868 
Attention
TMT A β = -0.04, puncor.= .862, p = .862 β = -0.08, puncor.= .799, p = .862 
TMT B β = -0.20, puncor.= .364, p = .470 β = -0.19, puncor.= .470, p = .470 
Stroop interference β = 0.10, puncor.= .645, p = .900 β = 0.03, puncor.= .900, p = .900 
DCT β = 0.07, puncor.= .716, p = .950 β = -0.02, puncor.= .950, p = .950 
Verbal Memory
Digit span β = -0.10, puncor.= .624, p = .624 β = -0.42, puncor.= .073, p = .146 
RAVLT immediate β = 0.40, puncor.= .057, p = .114 β = 0.36, puncor.= .148, p = .148 
RAVLT delayed β = 0.44, puncor.= .037, p = .037 β = 0.67, puncor.= .006, p = .012 
RAVLT recognition β = 0.27, puncor.= .238, p = .238 β = 0.40, puncor.= .144, p = .238
Visuospatial memory
Spatial Span β = 0.04, puncor.= .842, p = .920 β = -0.03, puncor.= .920, p = .920
RCFT immediate β = 0.30, puncor.= .133, p = .133 β = 0.39, puncor.= .103, p = .133 
RCFT delayed β = 0.22, puncor.= .264, p = .290 β = 0.24, puncor.= .290, p = .290 
RCFT recognition β = -0.05, puncor.= .825, p = .825 β = -0.08, puncor.= .748, p = .825 
Executive Functioning
Key Search β = 0.17, puncor.= .358, p = .716 β = 0.04, puncor.= .859, p = .859 
Modified six elements β = 0.22, puncor.= .328, p = .328 β = 0.49, puncor.= .074, p = .074
Visual spatial processing
RCFT copy β = -0.00, puncor.= .987, p = .987 β = -0.04, puncor.= .889, p = .987 
Results of linear regression analyses assessing associations between neuropsychological outcome and hip-
pocampal volume in the left and right hemispheres. Puncor. gives the uncorrected p-value. P < .05 is con-
sidered statistically significant after correcting for multiple testing using the false discovery rate correction. 
Abbreviations: WISC-III-NL, Wechsler Intelligence Scale for Children Dutch version; TMT, Trail Making Test; 
DCT, Dot Cancellation Test; RAVLT, Rey Auditory Verbal Learning Test; RCFT, Rey Complex Figure Test.
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hippocampal volume and neuropsychological outcome
Smaller hippocampal volumes in the left and right hemispheres were associated with 
lower scores on verbal memory delayed recall (left: β = 0.44, p = .037, hp2 = 0.16; right: β 
= 0.67, p = .012, hp2 = 0.14) (Table 3, Figure 1). IQ did not affect these associations.
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figure 1. Associatons between brain alterations and neuropsychological outcome
yellow and orange colors indicate a positive association and blue colors indicate a negative association 
between brain regions and neuropsychological outcome. a) Parasaggital and coronal views of the left and 
right hemispheres showing the left and right hippocampal volumes(1) and the left and right parahippo-
campal regions of the cingulum(2). b) Showing the associations between verbal memory delayed recall 
and mean diffusivity in the parahippocampal region of the cingulum and the hippocampal volume in both 
hemispheres. c) Showing the associations between visuospatial memory immediate and delayed recall and 
mean diffusivity in the parahippocampal region of the cingulum in both hemispheres. *Indicates a signifi-
cant association at p < .05. Abbreviations: PHC, parahippocampal region of the cingulum.
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Treatment characteristics and neurodevelopmental outcome
The significant associations found between neuropsychological outcome and the brain 
were the same in ECMO and non-ECMO patients, and VA-ECMO and VV-ECMO patients 
(Supplemental Digital Content 3).
neuropsychological functioning compared to the norm population
Participants had an average IQ but scored significantly lower on all verbal and visuospa-
tial memory tasks (immediate recall, delayed recall and recognition). Participants also 
had significantly lower sustained attention than the reference population (Table 4).
Table 4. Overview of neuropsychological outcome
Neuropsychological test All (n = 38) P value1
Intelligence
WISC-III-NL2 100 (12) .968
Attention
TMT A -0.33 (0.95) .057
TMT B -0.03 (1.18) .954
Stroop interference -0.31 (1.00) .063
DCT -1.13 (2.01) .001
Memory
WISC-III-NL Digit span 0.21 (1.02) .219
WNV Spatial Span 0.17 (1.02) .336
RAVLT immediate -1.58 (1.10) .000
RAVLT delayed -1.90 (1.19) .000
RAVLT recognition -1.19 (1.59) .000
RCFT immediate -1.65 (0.97) .000
RCFT delayed -1.65 (1.07) .000
RCFT recognition -0.63 (1.45) .007
Executive functioning
Key Search 0.01 (1.20) .669
Modified six elements -0.08 (0.99) .652
Visual spatial processing
RCFT copy 0.14 (0.68) .205
Data are expressed as mean z-score (SD). P < .05 is considered statistically significant.
1P value of the one-sample t-test assessing the difference between the average z-score of the participants 
and the general population z-score (μ = 0).
2IQ was based on a short-form of the WISC-III-NL using two subtests, Vocabulary and Block Design.(11) Ab-
breviations: WISC-III-NL, Wechsler Intelligence Scale for Children Dutch version; TMT, Trail Making Test; DCT, 
Dot Cancellation Test; RAVLT, Rey Auditory Verbal Learning Test; RCFT, Rey Complex Figure Test.
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diScuSSion
The aim of this study was to identify neurobiological substrates of long-term impaired 
neuropsychological outcome following critical illness in early life. In CDH survivors 
treated with and without ECMO and in survivors of ECMO treatment following other 
diagnoses, specific associations were found between attention and memory deficits and 
global white matter microstructure and regions of the limbic system. These results – 
that were irrespective of ECMO or conservative ventilator management – provide more 
insight in the underlying neurobiology of long-term outcome following critical illness 
in early life. Furthermore, our findings were irrespective of general IQ. This supports a 
‘growing into deficit’ phenomenon in these patients, where subtle brain injuries ac-
quired at a young age become functionally evident when higher cognitive functioning 
is required at a later age.
The PHC and hippocampus are part of the limbic system, one of the main brain net-
works involved in memory. The PHC is bidirectionally connected to the hippocampus 
and forms a larger memory circuit together with cortical structures.(27) While the hip-
pocampus is viewed as the main hub for memory, its connections are highly important 
for intact functioning of various memory types.(27,28) In line with this, our findings 
showed higher MD, suggestive of decreased integrity in axonal membranes, packing, 
or myelin(29), in the PHC to be associated with lower visuospatial and verbal memory. 
Further, smaller hippocampal volume was associated with impaired verbal memory. 
Interestingly, studies on other types of critical illness in early life have demonstrated 
similar structure-function relationships. Hippocampal alterations and related verbal 
memory impairments were previously found by our group in a different cohort of neo-
natal ECMO survivors, but also by others in survivors of neonatal hypoxia and in patients 
with severe forms of congenital heart disease.(3,8,30) In preterm born children, infant 
hippocampal volume was negatively associated with school-age verbal memory, and 
white matter volume in the PHC with non-verbal memory.(31,32)
The present study further showed that lower global FA was related to poorer attention. 
Lower FA can be interpreted as reduced coherence of white matter fibers.(29) Global 
white matter abnormalities have been associated with lower attention in preterm born 
children as well.(33) Although we also found a significant association between lower 
FA in the cingulum bundle and worse sustained attention, this association disappeared 
when global FA was added. These findings support the notion of more widespread white 
matter network alterations underlying attention impairments.(34) 
In our study, the majority of significant structure-function relationships were found 
in the left and right hemispheres, although associations with FA in the left cingulum 
bundle disappeared after multiple testing correction. The associations with visuospatial 
memory were found only in the left PHC. Predominantly left hemispheric alterations 
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have been suggested to be due to right internal jugular vein cannulation in neonatal 
ECMO patients.(35) However, our results did not show an effect of ECMO. CDH survivors 
treated without ECMO showed structure-function relationships similar to ECMO-treated 
patients. Also, no differences were found between VA- and VV-ECMO treated patients. 
However, these findings should be interpreted with caution due to the small sample 
size. Furthermore, previous findings have shown more brain abnormalities in VA-ECMO-
treated patients compared to VV-treated patients, but associations with neuropsycho-
logical outcome were not studied.(22) Future studies with larger sample sizes, also 
including near-ECMO patients, are needed to further delineate the effects of treatment 
or diagnosis on neurodevelopment following critical illness.
Although further research is needed, our results suggest similar neuropsychological 
deficits and structure-function relationships in CDH survivors treated with and without 
ECMO and ECMO survivors following other diagnoses. This may suggest potentially simi-
lar neurodevelopmental mechanisms following various types of critical illness in early 
life.(3,30-32) The brain matures in a nonlinear fashion from childhood into adulthood, in-
dicating that the timing of microstructural changes differs per brain region.(24,36) Con-
sequently, the timing of injuries is likely to have specific effects on brain development.
(37) As the limbic system undergoes rapid development throughout the third trimester 
and neonatal period, these structures may be particularly vulnerable in critically ill new-
borns, born prematurely and at term.(38,39) Furthermore, the hippocampus is sensitive 
to both internal and external influences. Hypoxic-ischemic injury and (chronic) stress 
have been associated with hippocampal alterations in term and preterm infants.(40,41) 
White matter limbic system fibers, such as the PHC and cingulum bundle, may be more 
vulnerable to these types of injuries because of their connections with the hippocampus 
and their periventricular location.(37) Interestingly, similar long-term cognitive impair-
ments were reported in adult patients after treatment at intensive care units (ICU).(42) 
Although newborns are likely to be at higher risk of limbic system alterations due to its 
rapid development during this time, hippocampal vulnerability has been shown in the 
adult brain as well(43), but needs further exploration in adult ICU survivors.
While this study contributes to the limited research on the neurobiology of neuropsy-
chological outcome following critical illness, there are some limitations. First, our com-
parisons between ECMO and non-ECMO, and VA- and VV-ECMO treated patients should 
be interpreted with caution as the small sample size limits the interpretability of the 
regression analyses. Second, we did not have a (healthy) control group to compare our 
neuroimaging data with. Due to major differences in scanner hardware and software, we 
could not compare our data to data obtained elsewhere. We did however have norma-
tive data of the neuropsychological tests. Since we were primarily interested in finding 
potential neurobiological substrates of impaired outcome following critical illness, we 
were still able to adequately address these questions. Third, our sample includes only 
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children with a below average score on one or more memory tests and an IQ of 80 or 
above. However, since previous studies have shown that the majority of ECMO and/or 
CDH survivors have average intelligence but an increased likelihood of attention and 
memory impairments(2,5,7), we believe that this sample is representative of critical ill-
ness survivors and suits the aim of this study. Nonetheless, future studies should explore 
how below average IQ affects the structure-function relationships.
concluSion
We showed that regions of the limbic system and global white matter microstructure 
were specifically related to impaired neuropsychological outcome in school-age survi-
vors of CDH, treated with and without ECMO, and in ECMO survivors following other 
diagnoses. Our findings may lead to earlier identification of those at risk of neurodevel-
opmental impairment with the use of neurobiological markers, such as low hippocam-
pal volume. Also, a better understanding of the neurobiology will contribute to a more 
critical appraisal of potential intervention modalities. As similar neurodevelopmental 
outcomes have been found in survivors of various causes of critical illness, future re-
search should assess neurodevelopment longitudinally across different patient groups, 
using both neuroimaging and neuropsychological assessment, and compare outcomes 
to age-matched healthy controls.
Chapter 6
118
referenceS
 1. Harrison W, Goodman D. Epidemiologic Trends in Neonatal Intensive Care, 2007-2012. JAMA 
Pediatr 2015;169(9):855-862.
 2. Schiller RM, Madderom MJ, Reuser JJCM, et al. Neuropsychological follow-up after neonatal 
ECMO. Pediatrics 2016;138(5) :e20161313.
 3. Cooper JM, Gadian DG, Jentschke S, et al. Neonatal hypoxia, hippocampal atrophy, and memory 
impairment: evidence of a causal sequence. Cereb Cortex 2015;25(6):1469-1476.
 4. Beauchamp MH, Thompson DK, Howard K, et al. Preterm infant hippocampal volumes correlate 
with later working memory deficits. Brain 2008;131(Pt 11):2986-2994.
 5. Madderom MJ, Toussaint L, van der Cammen-van Zijp MH, et al. Congenital diaphragmatic 
hernia with(out) ECMO: impaired development at 8 years. Arch Dis Child Fetal Neonatal Ed 
2013;98(4):F316-322.
 6. Jerrell JM, Shuler CO, Tripathi A, et al. Long-Term Neurodevelopmental Outcomes in Children and 
Adolescents With Congenital Heart Disease. Prim Care Companion CNS Disord 2015;17(5).
 7. Madderom MJ, Schiller RM, Gischler SJ, et al. Growing Up After Critical Illness: Verbal, Visual-
Spatial, and Working Memory Problems in Neonatal Extracorporeal Membrane Oxygenation 
Survivors. Crit Care Med 2016;44(6):1182-1190.
 8. Schiller RM, van den Bosch GE, Muetzel RL, et al. Neonatal critical illness and development: white 
matter and hippocampus alterations in school-age neonatal extracorporeal membrane oxygen-
ation survivors. Dev Med Child Neurol 2017;59(3):304-310.
 9. Lezak MD, Howieson DB, Loring DW. Neuropsychological assessment, 4th ed. Oxford: Oxford 
University Press; 2004.
 10. Stolar CJ, Snedecor SM, Bartlett RH. Extracorporeal membrane oxygenation and neonatal respiratory 
failure: experience from the extracorporeal life support organization. J Pediatr Surg 1991;26(5):563-571.
 11. Kaufman AS, Kaufman JC, Balgopal R, et al. Comparison of three WISC-III short forms: Weighing 
psychometric, clinical, and practical factors. J Clin Child Psychol 1996;25(1):97-105.
 12. Kort W, Compaan EL. WISC NL III. Handleiding: NIP Dienstencentrum 1999.
 13. Vos P. Bourdon-Vos. Handleiding (manual dot cancellation test). Lisse: Swets en Zeitlinger; 1992.
 14. Wechsler D, Naglieri JA. Wechsler Nonverbal Scale of Ability San Antonio, TX: Pearson; 2006.
 15. van den Burg W, Kingma A. Performance of 225 Dutch school children on Rey’s Auditory Verbal 
Learning Test (AVLT): parallel test-retest reliabilities with an interval of 3 months and normative 
data. Arch Clin Neuropsychol 1999;14(6):545-559.
 16. Watanabe K, Ogino T, Nakano K, et al. The Rey-Osterrieth Complex Figure as a measure of execu-
tive function in childhood. Brain Dev 2005;27(8):564-569.
 17. Emslie H, Wilson FC, Burden V, et al. Behavioral assessment of the dysexecutive syndrome for 
children (BADS-C), Dutch version. Amsterdam Harcourt; 2006.
 18. White T, El Marroun H, Nijs I, et al. Pediatric population-based neuroimaging and the Generation 
R Study: the intersection of developmental neuroscience and epidemiology. Eur J Epidemiol 
2013;28(1):99-111.
 19. de Groot M, Ikram MA, Akoudad S, et al. Tract-specific white matter degeneration in aging: the 
Rotterdam Study. Alzheimers Dement 2015;11(3):321-330.
 20. Muetzel RL, Mous SE, van der Ende J, et al. White matter integrity and cognitive performance in 
school-age children: A population-based neuroimaging study. Neuroimage 2015;119:119-128.
 21. Benjamini y, Hochberg y. Controlling the False Discovery Rate - a Practical and Powerful Approach 
to Multiple Testing. J Roy Stat Soc B Met 1995;57(1):289-300.
119
Neurobiological correlates
 22. Rollins MD, yoder BA, Moore KR, et al. Utility of neuroradiographic imaging in predicting out-
comes after neonatal extracorporeal membrane oxygenation. J Pediatr Surg 2012;47(1):76-80.
 23. Allison P. Logistic regression using the SAS system: theory and application. . New york: SAS Insti-
tute; 1999.
 24. Lebel C, Walker L, Leemans A, et al. Microstructural maturation of the human brain from child-
hood to adulthood. Neuroimage 2008;40(3):1044-1055.
 25. Lin M, Fwu PT, Buss C, et al. Developmental changes in hippocampal shape among preadolescent 
children. Int J Dev Neurosci 2013;31(7):473-481.
 26. Cohen J. Statistical power analysis for the behavioral sciences, 2nd ed Hilsdale, NJ: Lawrence 
Earlbaum Associates; 1988.
 27. Eichenbaum H. How does the brain organize memories? Science 1997;277(5324):330-332.
 28. Nosarti C, Froudist-Walsh S. Alterations in development of hippocampal and cortical memory 
mechanisms following very preterm birth. Dev Med Child Neurol 2016;58 Suppl 4:35-45.
 29. Beaulieu C. The basis of anisotropic water diffusion in the nervous system - a technical review. 
NMR Biomed 2002;15(7-8):435-455.
 30. Miller SP, McQuillen PS, Hamrick S, et al. Abnormal brain development in newborns with congeni-
tal heart disease. N Engl J Med 2007;357(19):1928-1938.
 31. Thompson DK, Adamson C, Roberts G, et al. Hippocampal shape variations at term equivalent 
age in very preterm infants compared with term controls: perinatal predictors and functional 
significance at age 7. Neuroimage 2013;70:278-287.
 32. Nosarti C, Nam KW, Walshe M, et al. Preterm birth and structural brain alterations in early adult-
hood. Neuroimage Clin 2014;6:180-191.
 33. Woodward LJ, Clark CA, Pritchard VE, et al. Neonatal white matter abnormalities predict global 
executive function impairment in children born very preterm. Dev Neuropsychol 2011;36(1):22-41.
 34. Petersen SE, Posner MI. The attention system of the human brain: 20 years after. Annu Rev Neuro-
sci 2012;35:73-89.
 35. Raets MM, Dudink J, Ijsselstijn H, et al. Brain injury associated with neonatal extracorporeal mem-
brane oxygenation in the Netherlands: a nationwide evaluation spanning two decades. Pediatr 
Crit Care Med 2013;14(9):884-892.
 36. Paus T, Zijdenbos A, Worsley K, et al. Structural maturation of neural pathways in children and 
adolescents: in vivo study. Science 1999;283(5409):1908-1911.
 37. Back SA, Riddle A, McClure MM. Maturation-dependent vulnerability of perinatal white matter in 
premature birth. Stroke 2007;38(2 Suppl):724-730.
 38. Dubois J, Dehaene-Lambertz G, Kulikova S, et al. The early development of brain white matter: a 
review of imaging studies in fetuses, newborns and infants. Neuroscience 2014;276:48-71.
 39. Huang H, Zhang J, Wakana S, et al. White and gray matter development in human fetal, newborn 
and pediatric brains. Neuroimage 2006;33(1):27-38.
 40. Kuchna I. Quantitative studies of human newborns’ hippocampal pyramidal cells after perinatal 
hypoxia. Folia Neuropathol 1994;32(1):9-16.
 41. Peng NH, Bachman J, Jenkins R, et al. Relationships between environmental stressors and stress 
biobehavioral responses of preterm infants in NICU. J Perinat Neonatal Nurs 2009;23(4):363-371.
 42. Pandharipande PP, Girard TD, Jackson JC, et al. Long-term cognitive impairment after critical ill-
ness. N Engl J Med 2013;369(14):1306-1316.
 43. Bartsch T, Wulff P. The hippocampus in aging and disease: From plasticity to vulnerability. Neuro-
science 2015;309:1-16.
Chapter 6
120
SuPPlemenTary maTerial 
Supplemental digital content 1. descriptions of the neuropsychological 
tests.
Intelligence
Wechsler Intelligence Scale for Children (WISC-III-NL)
A short-form with two subtests, Block Design and Vocabulary, of the WISC-III-NL were 
used to assess general intelligence.(1) The WISC-III-NL has been shown to have good 
reliability and validity.(2) A normalized population mean of 100 with a standard devia-
tion of 15 is used.(2)
Attention 
Dot Cancellation Test
This paper-and-pencil test measures sustained attention and concentration in terms 
of speed. It consists of a paper on which figures made of three, four or five dots are 
displayed in 33 rows. The child is instructed to mark all figures with four dots, as precise 
and as fast as they can.(3) 
Stroop Color Word Test (Stroop)
The Stroop consists of three trials: in the first trial (Stroop 1) the subject must read color 
names, in the second trial (Stroop 2) name printed colors, and in the third trial (Stroop 
3) name printed colors not denoted by the color name. The test can be administered to 
children and adults in the age range 8-65 years. Selective attention is measured with this 
test, using the difference score between Stroop 2 and Stroop 3.(4, 5) 
Trail Making Test (TMT)
This paper and pencil test consists of two parts. In the first part (part A), the subject 
must draw lines to consecutively connect numbered circles on a sheet. In the second 
part (part B), the subject must consecutively but alternately connect numbered and 
lettered circles on another worksheet. The aim of the test is to finish each part as quickly 
as possible. The test can be administered to children and adults in the age range 6-89 
years. This test measures visual conceptual and visuomotor tracking as well as divided 
attention.(4, 5)
Memory 
WISC-III-NL – subtest Digit Span 
The Digit Span consists of random number sequences that increase in length and that 
the examiner reads aloud at the rate of 1 number per second. The child has to reproduce 
these numbers in the same order. Next, the sequences must be recalled backwards (3-
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5-7 becomes 7-5-3). The first part of the test measures short-term auditory memory and 
short-term retention capacity. The second part measures auditory working memory.(2) 
Wechsler Nonverbal Scale of Ability (WNV) – subtest Spatial Span
The Spatial Span requires the child to touch a group of blocks arranged on a board in a 
nonsystematic manner in the same and reverse order as demonstrated by the examiner. 
The first part of the test measures short-term visuospatial memory and short-term re-
tention capacity. The second part measures visuospatial working-memory.(6) 
Rey Auditory Verbal Learning Test (RAVLT)
The RAVLT consists of five presentations with recall of a 15-word list, a sixth recall 
trial after 30 minutes, and a seventh recognition trial. This test measures memory span, 
short- and long term verbal memory, verbal recognition, and learning curve. It can be 
administered to children and adults in the age range 6-89 years.(7, 8)
Memory and visual-spatial functioning 
Rey Complex Figure Test (RCFT)
The RCFT consists of three trials. First the child has to copy a complex figure (Copy). Then 
after 3 and after 30 minutes the figure must be drawn from memory (Recall). Next, dif-
ferent figures are shown and the child has to indicate whether these figures were in the 
original figure (Recognition). This test measures visual integration, short- and long-term 
visual-spatial memory, and visual-spatial recognition. It can be completed by children 
and adults in the age range 6-89 years.(9, 10) 
Executive functioning
Key Search
A test of strategy formation. The child is asked to demonstrate how they would search 
a field for a set of lost keys and their strategy is scored according to its efficiency and 
functionality.(11) 
Modified Six Elements
The child is asked to work on six different tasks for which they have five minutes. The 
child needs to make sure that by the end of the five minutes, all six of the tasks have 
been done and the child has done as much as possible of each task. This is a test of 
planning, task scheduling and performance monitoring.(11) 
We used Dutch versions of all tests.
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Supplemental digital content 2. neuroimaging methods.
Image Acquisition 
Prior to neuroimaging, all participants underwent a 30-minute mock scanning session 
to become familiarized with the MR-environment1. Magnetic resonance imaging data 
were acquired on a 3 Tesla GE MR-750W system using an 8 channel receive-only head 
coil (General Electric, Milwaukee, WI). In order to support the participant’s head and 
minimize head motion, cushions were placed on both sides of the child’s head inside of 
the head coil. Participants were able to watch a movie during the scans. MRI-compatible 
headphones were used to reduce the scanner noise and allow participants to listen to 
the movie’s audio track. Communication with the MR operator was also enabled through 
the headphones before and after scans. The DTI data were acquired using a single-shot, 
echo-planar imaging sequence with the following parameters: TR = 12,500 ms, TE = 72 
ms, flip angle = 90, matrix = 120 x 120, FOV = 240 mm x 240 mm, slice thickness = 2 mm, 
number of slices = 65, ASSET acceleration factor = 2. In total, 35 volumes with diffusion 
weighting (b = 900 s/mm²) and 3 volumes without diffusion weighting (b = 0 s/mm²) 
were acquired. The high-resolution structural T1-weighted images were acquired using 
an inversion recovery fast spoiled gradient recalled BRAVO sequence with the follow-
ing parameters: TR=8.77ms, TE = 3.4ms, inversion time=600ms, flip angel=10, matrix 
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220x220, FOV=220mm x220mm, ARCimaging acceleration factor of 2, slice thickness = 
1mm, and a final 1mm3 isotropic resolution.
MR-Image Preprocessing
Data were processed using the Functional MRI of the Brain’s Software Library (FMRIB, FSL) 
(2) and the Camino Diffusion MRI Toolkit within Python (version 2.7) and the Neuroimag-
ing in Python Pipelines and Interfaces package (Nipype, version 0.92)3,4. First, motion and 
eddy-current induced artifacts5 were addressed using the FSL “eddy_correct” tool6. In 
order to account for the rotations applied to the diffusion data after adjusting for these 
artifact, the resulting transformation matrices were used to rotate the “B-matrix” gradient 
direction table7,8. The FSL Brain Extraction Tool was used to remove non-brain tissue9. In 
order to minimize the limitations observed with respect to the ordinary least squares 
fit method10, the diffusion tensor was fit using the RESTORE method implemented in 
Camino11. Voxel-wise scalar maps (i.e. FA, MD) were then computed. FA is the degree of 
directionality of diffusion and ranges from 0 to 1, where a higher FA generally represents 
a greater coherence of white matter fibers. MD is the rate of diffusion of hydrogen aver-
aged in all directions. Lower MD is suggestive of increased integrity in axonal membranes, 
packing, or myelin. White matter continues to mature throughout childhood, even into 
young adulthood, causing FA to increase and MD to decrease. Abnormal brain develop-
ment typically leads to lower FA and higher MD in white matter tracts12.
Probabilistic Fiber Tractography 
Fully automated probabilistic fiber tractography was performed using the FSL plugin, 
“AutoPtx”13. Subject-specific, probabilistic representations of multiple white matter fiber 
bundles are created with this method using a combination of FSL tools from the Diffusion 
Toolkit (FDT). The Bayesian Estimation of Diffusion Parameters Obtained using Sampling 
Techniques (BEDPOSTx), accounting for two fiber orientations at each voxel, was used 
to esatimate diffusion parameters at each voxel14,15. Next, for each subject, the FA map 
was aligned to the FMRIB-58 FA template image with the FSL nonlinear registration tool 
(FNIRT). The inverse of this nonlinear warp field was computed, and applied to a series 
of predefined seed, target, exclusion, and termination masks provided by the AutoPtx 
plugin (http://fsl.fmrib.ox.ac.uk/fsl/fslwiki/AutoPtx). The FSL module “ProbtrackX” was 
then applied to conduct probabilistic fiber tracking using these supplied tract-specific 
masks (i.e., seed, target, etc.) in the native diffusion image space of each subject14. The 
connectivity distributions resulting from fiber tractography were normalized to a scale 
from 0 to 1 using the total number of successful seed-to-target attempts, and were 
subsequently thresholded to remove low-probability voxels likely related to noise. For 
each tract, the number of samples used for probabilistic tracking, and the probability 
thresholds applied to the resulting distributions (ILF: 0.005, SLF: 0.001, IFO: 0.01, UNC: 
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0.01, CB: 0.01, PHC: 0.02), were selected based on previously established values13. 
After thresholding the path distributions, weighted average DTI scalar measures were 
computed within each tract using the normalized path distributions as the weights. The 
methods used were based on those described by Muetzel et al16.
Structural Image Acquisition and Analysis 
The Freesurfer image  analysis suite version 5.3.0 (http://surfer.nmr.mgh.harvard.edu/) 
for cortical reconstruction and volumetric segmentation was used. Freesurfer computes 
structural morphometric measures using a fully-automated approach. Technical proce-
dures have been described extensively19.
Image Quality Assurance
Raw DTI image quality was assessed with both a visual inspection and with automated 
software16. For the visual inspection, maps of the sum of squares error (SSE) of the tensor 
fit were inspected for structured signal that is consistent with motion and other artifacts 
in the diffusion-weighted images (e.g., attenuated slices in diffusion-weighted images). 
Furthermore, probabilistic tractography data were inspected visually to ensure images 
were properly aligned to the template and paths were reconstructed accurately16. Data-
sets determined to be of poor quality were excluded (n = 7, ~8%).
In addition to this visual inspection, slice-wise signal intensity was examined for 
attenuation resulting from motion, cardiac pulsation and other artifacts using the auto-
mated DTIprep quality control tool (http://www.nitrc.org/projects/dtiprep/). Four (~5%) 
additional datasets were excluded based on the DTIprep results, leaving 77 DTI datasets 
(patients = 23, controls = 54) for analysis.
FreeSurfer reconstructions were evaluated for accuracy through detailed visual in-
spections. Each image was visually inspected and subjects with poor quality data were 
excluded. In subjects with small errors in the gray/white segmentation, control points, 
and white matter edits were  added to  identify and correct misclassified white matter 
regions. When the segmentation improved, the corrected images were used.
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abSTracT 
objective To test the immediate and long-term effectiveness of Cogmed Working-
Memory Training (CWMT) following ECMO and/or CDH.
design A nationwide randomized controlled trial assessing neuropsychological out-
come immediately and one year post-CWMT, conducted between October 2014-June 
2017. Researchers involved in the follow-up assessments were blinded to group alloca-
tion.
Setting Erasmus MC-Sophia Children’s Hospital, Rotterdam and Radboud University 
Medical Center, Nijmegen, the Netherlands.
Patients Eligible participants were neonatal ECMO and/or CDH survivors (8-12 years) 
with an IQ ≥ 80 and a z-score ≤ -1.5 on at least one (working)memory test at first assess-
ment.
interventions CWMT, comprising 25 sessions of 45 minutes for five consecutive weeks 
at home.
measurements and main results Participants were randomized to CWMT (n = 19) or 
no intervention (n = 24) (two dropped out after T0). Verbal working-memory (estimated 
coefficient = 0.87; p = .002) and visuospatial working-memory (estimated coefficient = 
0.96, p = .003) had significantly improved in the CWMT group at T1, but were similar 
between groups at T2 (verbal, p = .902; visuospatial, p = .416). Improvements were found 
at T2 on long-term visuospatial memory following CWMT (estimated coefficient = 0.95, 
p = .003). Greater improvements in this domain at T2 following CWMT were associated 
with better self-rated school functioning (r = .541, p = .031) and parent-rated attention 
(r = .672, p = .006).
conclusions Working-memory improvements after CWMT disappeared one year post-
training in neonatal ECMO and/or CDH survivors. Gains in visuospatial memory persisted 
one year post-intervention. CWMT may be beneficial for survivors with visuospatial 
memory deficits.
Trial registration NTR4571: http://www.trialregister.nl/trialreg/admin/rctview.asp?TC=4571.
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Neuropsychological outcome after working-memory training
inTroducTion
Growing up after neonatal critical illness has long-term neurodevelopmental conse-
quences.(1-7) Specifically, children treated with neonatal extracorporeal membrane 
oxygenation (ECMO) and/or with congenital diaphragmatic hernia (CDH) are at risk of 
specific (working)memory and attention deficits at school-age, despite average intel-
ligence.(1,3,8) These deficits become more evident as children mature, suggesting they 
‘grow into deficit’(9). This mechanism – where subtle brain injuries acquired in early life 
become evident only later in life when higher cognitive functioning is required – has 
recently been described by our group across survivors of neonatal critical illness.(10) As 
more educational problems occur following neonatal critical illness than in the general 
population(4,11), it is imperative to find intervention strategies to prevent or diminish 
impaired outcome.
Working-memory, one of the fundamental building blocks for higher cognitive 
functioning, is highly associated with academic performance(12) and may be at risk of 
impairment following neonatal ECMO.(1,13) Training programs to improve cognitive 
functioning have received increasing attention over the years, and are based on the idea 
that repetitive mental exercise of one cognitive task results in improved functioning that 
may generalize to other tasks with similar underlying skills. A widely evaluated cogni-
tive training for children with working-memory problems is Cogmed Working-Memory 
Training (CWMT).(14) Near-transfer effects, i.e. improvements on trained and untrained 
working-memory tasks, as well as far-transfer effects to non-trained cognitive functions 
have been found immediately after CWMT.(15,16) However, whether effects persist 
beyond six months post intervention remains largely unknown.(17,18) 
In this single-blind RCT, the immediate and long-term effectiveness of CWMT on 
(working)memory in school-age (8-12 years) survivors of neonatal ECMO and/or CDH 
are studied. We hypothesized that CWMT improved (working)memory and attention 
immediately after training. Furthermore, we hypothesized that these improvements 
persisted 12 months post-training.
maTerialS and meThodS
design and setting
This RCT, conducted between October 2014 and June 2017, compared CWMT to no 
training in school-age neonatal ECMO and/or CDH survivors (NTR4571). Children born 
between February 2002 and December 2007 who were treated in either of the two 
referral centers for neonatal ECMO and CDH treatment in the Netherlands (Erasmus MC, 
Rotterdam or the Radboudumc, Nijmegen) were recruited. As we have previously shown 
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similar long-term cognitive outcome in CDH patients irrespective of ECMO treatment, 
CDH patients treated without ECMO were also recruited.(2,8) ECMO had been applied 
using the entry criteria described by Stolar et al.(19), which did not change over time. 
The study took place at the Erasmus MC-Sophia Children’s Hospital. Ethical approval was 
granted by our institution’s Review Board (MEC-2014-001).
eligibility and recruitment 
Eligible participants were: neonatal ECMO and/or CDH survivors between 8-12 years at 
first assessment, IQ ≥ 80, and a z-score ≤ -1.5 on at least one (working)memory test.(20) 
Children were recruited in two ways: 1) children who underwent neuropsychological as-
sessment as part of the structured follow-up program in Rotterdam(21,22) and met the 
inclusion criteria were referred to our study or, 2) potentially eligible children received 
information by mail about the trial and were invited to contact our center. Written 
informed consent from all parents and children ≥ 12 years old was obtained. Exclusion 
criteria were: usage of psychopharmaceutic drugs (e.g. methylphenidate) and/or ge-
netic syndromes that affect neuropsychological functioning. All children had sufficient 
knowledge of the Dutch language to perform the assessments.
Eligible children were randomized into either the CWMT group or the control group 
by an independent researcher uninvolved with the neuropsychological assessments. 
Randomization was performed by drawing from sealed, opaque envelopes containing 
a paper with either ‘intervention’ or ‘no intervention’. The psychologists who conducted 
the neuropsychological assessments were blinded to group allocation.
intervention 
The CWMTRM version for 7-17-year-old children was used. Children trained at home for 
45 minutes a day, five days a week, for five consecutive weeks, after which the training 
was completed as per manufacturer’s instructions.(14) Task level adapted automatically 
to ensure the child was continuously performing at its’ maximum ability. As part of the 
program, children were supervised by a certified CWMT coach, who provided weekly 
support to the family by phone and e-mail, and closely monitored the child’s perfor-
mance via online access.
Children in the control group did not receive any training.
outcome measures 
After baseline assessment (T0), neuropsychological assessments were repeated in all 
participants one week (T1) and one year (T2) post-intervention (Figure 1). The primary 
outcome measure was verbal working-memory(23), assessed using the WISC-III-NL Digit 
Span(24), at T1. For all secondary outcome measures, please refer to Supplemental Digi-
tal Content (SDC) 1 and 2.
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Sample size calculation 
The power calculation was based on the expected difference between the CWMT group 
and control group on verbal working-memory, the primary outcome measure. Based 
on previous findings on the effect of CWMT on verbal working-memory in children 
with working-memory problems(23,25,26), we expected a difference of 0.8 SD between 
groups (considered a large effect according to Cohen’s guidelines(27)). We assumed that 
baseline scores would show a correlation of 50% with scores at T1. We calculated that a 
sample size of 25 children per group would be needed (power of 90%, alpha of .05).(28) 
Statistical analysis 
Clinical and demographic characteristics and neuropsychological outcome at baseline 
were compared between groups using independent samples t-tests and ANCOVA (nor-
mally distributed variables), Mann-Whitney U tests or Fisher’s exact tests (non-normally 
distributed continuous or categorical variables).
All analyses were based on the intention-to-treat principle. Outcome scores were 
converted to z-scores (individual score minus population mean divided by population 
SD). Scores were inverted where appropriate so that a higher score always equated 
with better performance. To assess outcome after CWMT at T1 and T2, we estimated 
linear mixed models. This method accounts for within-subject correlations and allows 
Prior to study inclusion  
Baseline neuropsychological assessment (T0) (n = 95) 
Randomization 
Intervention group (n = 20) 
CWMT 
Six weeks after START (T1) (n = 42) 
• Neuropsychological assessment 
• Questionnaires 
12 months after START (T2) (n = 35) 
• Neuropsychological assessment 
• Questionnaires 
If fulfilling inclusion criteria*  
START study (n = 45) 
•  Questionnaires (T0) 
Control group (n = 25)  
No intervention 
figure 1. Trial outline
For short descriptions of the tests and 
questionnaires used, please refer to Sup-
plemental Digital Content 2. *IQ > 80 and 
a z-score ≤ -1.5(20) on one or more mem-
ory tests. Abbreviations: CWMT, Cogmed 
Working-Memory Training.
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for missing values in the dependent variable. Based on the Akaike information criterion, 
a random intercept was included in the mixed models to account for the within-subject 
correlations. P-values for the fixed effects were calculated using t-tests with the Satter-
thwaite approximation method. Performance at baseline was constrained to be equal. 
Neuropsychological outcome was the dependent variable, and group and time-point as 
well as the group*time-point interaction term were independent variables. For analyses 
with the secondary neuropsychological outcome measures (all but verbal working-
memory at T1), the False Discovery Rate (FDR)-correction(29) was used to correct for 
multiple testing. It was applied once for each set of tests in the same neuropsychological 
domain (e.g. once for the analyses done with tests measuring attention). Additionally, 
linear mixed models were estimated with the self- and proxy-rated outcomes as depen-
dent variables.
Finally, if any sustained improvements were found on the neuropsychological out-
come measures following CWMT at T2, we assessed whether these were associated 
with subjective improvements scored by parents, teachers or children on EF, working-
memory, attention, self-esteem or school functioning. We conducted Pearson correla-
tion analyses between the change-score from T0 to T2 on neuropsychological outcome 
and these self- and proxy-reported outcomes at T2 in the CWMT group. In secondary 
analyses, no correction for multiple testing was applied.
Statistical analyses were performed using SPSS 21.0 (IBM Corporation, Armonk, Ny) 
and R Statistical Software version 3.1.3 (R Core Team, 2014)( lme4 and lmerTest packag-
es). Results of the linear mixed models were summarized using the estimated marginal 
means, which are the predicted values of the dependent variable adjusted for the ef-
fects of the independent variables. These can be interpreted as z-scores. For all analyses, 
a two-sided (FDR-corrected) p-value < .05 was considered statistically significant.
reSulTS
Of 217 invited children, 54 declined to participate and 68 did not respond. Fifty as-
sessed children were excluded because they did not meet the inclusion criteria and two 
dropped out after randomization, leaving 43 participants. Of these, 19 were assigned to 
the CWMT group and 24 to the control group (Figure 2). Age, ethnicity, gender, IQ, edu-
cation type, or clinical characteristics, such as ECMO treatment, were similar between 
groups (Table 1). See Figure 3 for baseline neuropsychological outcome.
All children in the CWMT group completed 25 sessions, except one who completed 20 
sessions. Sensitivity analyses were performed without this child’s data. As the results did 
not change, the child was not excluded from the analyses.
137
Neuropsychological outcome after working-memory training
Primary outcome measure
The CWMT group improved signifi cantly on verbal working-memory at T1 compared to 
controls (estimated coeffi  cient = 0.87; p = .002) (SDC3, Figure 4).
Secondary outcome measures
Working-memory
Verbal working-memory was similar between groups at T2 (estimated coeffi  cient 
= -0.04, p = .902) (SDC3, Figure 4A). Additional analyses were performed to evaluate 
the Digit Span Forward (DSF), i.e. short-term memory, and Digit Span Backward (DSB), 
i.e. working-memory, separately(24). Performance on the DSF and DSB improved sig-
nifi cantly at T1 in the CWMT group compared to the control group (forward: estimated 
coeffi  cient = 0.93, p = .028; backward: estimated coeffi  cient = 1.13, p = .033), whereas 
no group diff erences were found at T2 (forward: estimated coeffi  cient = -0.08, p = .860; 
backward: estimated coeffi  cient = 0.38, p = .497).
The CWMT group improved signifi cantly on visual working-memory compared to 
the control group at T1 (estimated coeffi  cient = 0.96, p = .003). However, this diff erence 
 
Assessed for eligibility (n= 217) 
Erasmus MC – Sophia, Rotterdam (n = 151)  
Radboud UMC, Nijmegen (n = 66) 
Excluded  (n=172) 
   Not meeting inclusion criteria 
(n=50) 
- IQ < 80, n = 22 
- No memory problems, n = 26 
- Other, n = 2 
   Declined to participate (n=54) 
   No contact (n=68) 
Analysed  (n= 19) 
   Excluded from analysis (n=0) 
Discontinued intervention (n=0) 
 
Lost to immediate follow-up T1 (n=0) 
 
Lost to 1-year follow-up T2 (n=3):  
   No contact (n=2) 
   Too busy (n=1) 
Allocated to intervention (n=20) 
   Received allocated intervention (n=19) 
   Did not receive allocated intervention (n=1):  
- Child could not postpone ADHD medication (n=1).  
 
Lost to immediate follow-up T1 (n=1):  
   Ill at the time of assessment (n=1) 
 
Lost to 1-year follow-up T2 (n=4) 
   No contact (n=3) 
   Too busy (n=1) 
     
Allocated to control group (n= 25) 
   Dropped out of study (n=1): 
- Did not want to wait with treatment until after 
study (n=1) 
Analysed  (n=24) 
   Excluded from analysis (n=0) 
 
Randomized (n=45) 
Allocation 
Follow-up 
Analysis 
figure 2. CONSORT fl ow diagram
T1 refers to the fi rst follow-up assessment immediately after the intervention, T2 refers to the assessment 
one year after the intervention. Abbreviations: ADHD, Attention Defi cit Hyperactivity Disorder.
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Table 1. Study population characteristics
Characteristics
All 
(n = 43)
Controls 
(n = 24)
CWMT 
(n = 19) P-value 
a) Demographic 
Age (years) 10 ± 2 10 ± 2 10 ± 1 .275
Gender .812
Male 24 (56%) 13 (54%) 11 (58%)
Ethnicity .127
Dutch 37 (86%) 19 (79%) 18 (95%)
Maternal education levela .407
Low 7 (16%) 3 (13%) 4 (21%)
Moderate 13 (30%) 7 (29%) 6 (32%)
High 23 (54%) 14 (58%) 9 (47%)
Type of education child .953
Regular 27 (63%) 14 (58%) 13 (68%)
Regular with help 13 (30%) 9 (38%) 4 (21%)
Special education 3 (7%) 1 (4%) 2 (11%)
IQ 100 ± 12 98 ± 12 101 ± 12 .359
b) Clinical
Birthweight (grams) 3596 ± 479 3474 ± 338 3772 ± 605 .765
Gestational age (weeks) 40 ± 1 40 ± 2 41 ±1 .492
Mechanical vent. (days) 11 (9-17) 12 (9-17) 10 (9-17) .677
CLD presence 6 (15%) 3 (13%) 3 (19%) .423
Abnormal CUS .969
yes 3 (9%) 2 (9%) 1 (9%)
No 29 (91%) 19 (91%) 10 (91%)
Unknownb 11 3 8
CDH-non-ECMO 12 (28%) 6 (50%) 6 (50%) .646
ECMO treatmentc 31 (72%) 18 (75%) 13 (68%) .643
Type of ECMO .357
VA 21 (66%) 10 (56%) 11 (84%)
VV 9 (31%) 8 (44%) 1 (8%)
VV conversion to VA 1 (3%) 0 (0%) 1 (8%)
Age start ECMO (days) 2 (1-3) 2 (1-4) 1 (1-2) .077
Hours on ECMO 110 (90-182) 119 (87-196) 104 (90-182) .824
N (%), mean ± SD or median (interquartile range) is reported where appropriate for the group as a whole 
(‘All’ in column 1), the control group (Controls in column 2) and the CWMT group (CWMT in column 3) 
separately. Dutch refers to children with two native Dutch parents. aBased on the highest level of education 
completed by the mother(41).
bIn CDH-non-ECMO patients, cranial ultrasounds were not routinely performed in our centers.
cDiagnoses underlying ECMO treatment were congenital diaphragmatic hernia (n=2), meconium aspiration 
syndrome (n=22), persistent pulmonary hypertension of the newborn (n = 4), infant respiratory distress 
syndrome (n = 2), and cardiac anomaly (n=1).
Abbreviations: CWMT, Cogmed Working-Memory Training; IQ, Intelligence Quotient; CLD, chronic lung 
disease; CUS, cranial ultrasound; CDH, congenital diaphragmatic hernia; ECMO, extracorporeal membrane 
oxygenation; VA, venoarterial; VV, venovenous
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disappeared at T2 (estimated coefficient = 0.29, p = .416) (SDC3, Figure 4A). An improve-
ment in Spatial Span Forward was found in the CWMT group at T1 compared to controls 
(estimated coefficient = 1.12, p < .001), but not at T2 (estimated coefficient = -0.15, p = 
.613). Spatial Span Backward did not differ between the CWMT group and controls (T1: 
estimated coefficient = 0.43, p = .146; T2: estimated coefficient = 0.61, p = .056).
Memory 
The CWMT group improved on short-term visuospatial memory at T1 and T2 compared 
to the control group, but this difference did not reach significance. Long-term visuospa-
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figure 3. Neuropsychological outcome at baseline for the CWMT group and the control group 
Mean z-score is given per group. Scores of the CWMT group are presented in blue, scores of the control 
group are presented in black. Independent samples T-test was used to identify differences between the 
groups. *Significant difference between the groups. Abbreviations: CWMT, Cogmed Working-Memory 
Training; RAVLT, Rey Auditory Learning Test; RCFT, Rey Complex Figure Test; DCT, Dot Cancellation Test; TMT, 
Trail Making Test; STROOP, Stroop Color Word Test.
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figure 4. Neuropsychological outcome immediately and one year after CWMT in ECMO and/or CDH sur-
vivors
Blue lines represent the CWMT group, black lines represent the control group. Panel A shows verbal work-
ing-memory, visuospatial working-memory, and visuospatial memory at baseline (T0), immediately after 
(T1) and one year after CWMT (T2). A red dot represents a significant group by time effect, showing a sig-
nificant improvement in the CWMT group compared to the control group at that time-point. Panel B shows 
the significant correlations between the change in z-scores from T0 to T2 in long-term visuospatial memory 
and z-scores on the self- and parent-reported outcomes on school functioning and attention in the CWMT 
group at T2. Abbreviations: CWMT, Cogmed Working Memory Training; ECMO, extracorporeal membrane 
oxygenation; CDH, congenital diaphragmatic hernia.
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tial memory improved significantly in the CWMT compared to the control group at T2 
(estimated coefficient = 0.95, p = .003) (SDC3, Figure 4A).
Verbal memory did not change (SDC3).
Other neuropsychological outcomes
Attention, processing speed, EF, and visuospatial processing were similar between 
groups at T1 and T2 (SDC3).
Proxy- and self-reported outcomes
Parents, but not teachers, of the CWMT group scored EF at T2 higher than the control 
group (estimated coefficient = 0.57, p = .034). Parent- and teacher-rated working-
memory did not differ between groups (Figure 4B, SDC4).
Parents and teachers scored the child’s behavior within the average range in both 
groups at all time-points (SDC4). Parents, but not teachers, of the CWMT group reported 
fewer problems with attention and hyperactivity at T2 compared to controls (estimated 
coefficient = 0.58, p = .042)(SDC4).
Children in the CWMT group reported better quality of life at T2 than the control group 
(estimated coefficient = 0.92, p = .034). Parents did not report changes in (psychosocial) 
quality of life following CWMT (SDC4).
Children in the CWMT group reported better school functioning at T2 than controls, 
but this difference did not reach significance. Proxy-reported school functioning was 
similar in both groups (SDC4).
neuropsychological improvement and subjective outcome following cWmT
Larger gains in long-term visuospatial memory from T0 to T2 were associated with 
higher scores on school functioning scored by children in the CWMT group at T2 (r = 
.541, p = .031), and better parent-reported attention and hyperactivity at T2 (r = .672, 
p = .006) (Figure 3B). No other associations were found between visuospatial memory 
improvement and the subjective outcomes (not shown).
diScuSSion 
This nationwide single-blind randomized controlled trial confirmed our hypothesis by 
showing that school-age neonatal ECMO and/or CDH survivors who completed CWMT 
significantly improved on working-memory immediately post-intervention. How-
ever, this improvement did not persist one year post-intervention. We found positive 
far-transfer effects of CWMT to long-term visuospatial memory, persisting one year 
post-intervention. These children reported better school functioning and their parents 
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reported fewer problems with inattention and hyperactivity. As over half of our cohort 
had visuospatial memory deficits at baseline, these improvements following CWMT are 
highly relevant for this particular population.
Our findings of improved verbal and visuospatial working-memory immediately after 
CWMT are in line with the effects demonstrated in other groups.(30-33) The ability to 
memorize digits for a short period of time and manipulate them are directly trained 
in CWMT.(31) However, after one year, working-memory performance had returned to 
baseline. This suggests that active training of working-memory is needed to maintain 
improved functioning in these domains. A period of retraining after CWMT completion 
may lead to more sustained effects, but this remains speculative. Although studies with 
follow-up assessments more than six months post-intervention are scarce, gains in 
working-memory performance have been found to persist seven months(30) and one 
year post-training(25). The inconsistency in results may be due to differences in popula-
tion and the type of neuropsychological deficits that exists between populations. For 
example, working-memory was within the average range in our population at baseline, 
in contrast to the children with working-memory deficits studied in the two other long-
term studies.(25,30) 
Short- and long-term verbal and visuospatial memory are at major risk of impairment 
following neonatal ECMO and/or CDH.(1,3) In this school-age cohort, more than half 
of the children had such memory deficits at baseline. However, short- and long-term 
verbal memory did not change following CWMT. CWMT consists of mostly visual and 
visuospatial training tasks, and as such may not target verbal (working)memory enough 
to result in far-transfer effects.(31) In line with this, children in the CWMT group did show 
sustained improvement on long-term visuospatial memory one year after the interven-
tion, resulting in average performance at this time. Visuospatial memory is important for 
everyday life and gains in this domain are therefore of great significance.
Greater sustained improvements in the CWMT group in long-term visuospatial 
memory were associated with better self-reported school functioning and less proxy-
reported problems with attention at T2. These findings suggest that the improvements 
on visuospatial memory extend to daily life. However, these results should be inter-
preted with caution due to the small sample size in combination with the number of 
analyses. The generalizability of cognitive improvements to everyday life and school 
performance has received considerable attention over the last few years. Studies 
reported both improved attention in daily life following CWMT(34) and no benefits to 
educational performance(35). In our study, teachers did not report any improvements 
following CWMT. However, they did not report any problems at baseline either. Future 
studies that include objective measures of academic performance such as reading or 
mathematical ability are needed in both preschool and school-age neonatal ECMO and/
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or CDH survivors following CWMT to get a better impression of its impact on school 
functioning and daily life.
Attention and (working)memory share similar pathways in the brain.(36) In addition to 
(working)memory, attention may therefore also improve through CWMT. Sustained at-
tention deficits have been previously found following neonatal ECMO and/or CDH(1,3), 
and were confirmed in this cohort. Although we found faster processing speed following 
CWMT at T2, significance disappeared after multiple testing correction. Selective and 
sustained attention did not improve post-CWMT. Neuroimaging studies in children with 
ADHD or childhood cancer, found improvements in attention immediately post-CWMT 
to be associated with fronto-parietal networks.(32,37-39) However, attention deficits 
following neonatal ECMO and/or CDH were found to be associated with global white 
matter microstructure and cingulum bundle alterations.(3,5) CWMT therefore may not 
target the networks responsible for attention deficits in this population. Our group is 
currently studying the effectiveness of CWMT following neonatal ECMO and/or CDH us-
ing advanced neuroimaging techniques. Such findings could enhance our understand-
ing of how CWMT affects the brain in these survivors.
This is the first study investigating the effectiveness of CWMT following neonatal 
ECMO and/or CDH, demonstrating high feasibility of such a training in this group. How-
ever, our study has some limitations. First, we used a non-active control group for ethical 
considerations against subjecting children to an intensive training without potential 
benefits, which limits our ability to attribute our findings to the specific characteristics of 
the CWMT training. The self- and proxy-rated outcomes should therefore be interpreted 
with caution. Nonetheless, various studies have found improved outcome following 
CWMT when compared to a non-adaptive training program which also included weekly 
phone calls from a certified Cogmed training coach.(25,31,34,40) Second, our sample 
size was smaller than anticipated. We did not extend our inclusion time because we 
did not want our control group to wait longer than needed to complete CWMT if it 
was proven to be beneficial. Finally, our primary outcome measure was based on initial 
reports of neuropsychological outcome in the study population that showed working-
memory problems(2,7,11) and on previous studies on CWMT(23,25,26). However, on-
going research testing all major neuropsychological domains demonstrated primarily 
short- and long-term memory problems in these children.(8) Given these new insights, 
a different primary outcome measure than working-memory would have been more 
appropriate for this population.
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concluSion
We found improved working-memory immediately after CWMT in school-age neona-
tal ECMO and/or CDH survivors, but this did not sustain until one year post-training. 
Sustained far-transfer effects on long-term visuospatial memory were found follow-
ing CWMT. Given the high risk of visuospatial memory deficits in these children and 
the importance of memory in daily life, CWMT shows clinical utility for children with 
visuospatial memory deficits. Future studies with advanced neuroimaging techniques 
and objective measures of academic performance are needed to further delineate the 
effectiveness of CWMT in neonatal ECMO and/or CDH survivors.
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Supplemental digital content 1. Outcome measures
Domain Test Respondent T0 T1 T2
Neuropsychological assessment
Working-memory Subtest Digit Span of the WISC-III-NL; 
Subtest Spatial Span of the WNV
Child; 
Child
*
*
*
*
*
*
Verbal memory RAVLT Immediate and Delayed recall Child * * *
Visuospatial Memory RCFT Immediate and Delayed recall and Recognition Child * * *
Sustained attention DCT Child * * *
Selective attention TMT section B; 
STROOP colour-word test 
Child
Child 
*
*
*
*
*
*
Processing speed TMT section A Child * * *
Executive functioning Subtests Key Search and Modified Six Elements of the 
BADS-C-NL
Child * * *
Visuospatial processing RCFT Copy Child * * *
Questionnaires
Executive functioning BRIEF total score Parents + Teacher * * *
Working-memory Subscale of BRIEF * * *
Behaviour SDQ Parents + Teacher * * *
Attention and hyperactivity Subscale of SDQ * * *
Quality of life PedsQL Child + Parents * * *
School functioning Subscale of PedsQL * * *
Psychosocial quality of life CHQ Parents * * *
Self-esteem Subscale of CHQ * * *
Overview of outcome measures assessed at the different time points of the study. T0 is the baseline assess-
ment, T1 is six weeks after baseline, and T2 is 12 months after baseline. The primary outcome measure was 
working-memory assessed by Digit Span.
Abbreviations: WISC-III-NL, Wechsler Intelligence Scale for Children; WNV, Wechsler Non Verbal Scale of 
Ability; RAVLT, Rey Auditory Learning Test; RCFT, Rey Complex Figure Test; DCT, Dot Cancellation Test; TMT, 
Trail Making Test; BADS-C-NL, Behavioural Assessment of the Dysexecutive Syndrome; BRIEF, Behaviour 
Rating Inventory of Executive Functioning; SDQ, Strengths and Difficulties Questionnaire; PedsQL, Paediat-
ric Quality of Life Inventory; CHQ, Child Health Questionnaire.
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Supplemental digital content 2. descriptions of the outcome measures.
Intelligence 
Wechsler Intelligence Scale for Children (WISC-III-NL)
A short-form with two subtests, Block Design and Vocabulary, of the WISC-III-NL were 
used to assess general intelligence.1 The WISC-III-NL has been shown to have good reli-
ability and validity.2 A normalized population mean of 100 with a standard deviation of 
15 is used.2
Primary outcome measures
Verbal working-memory 
WISC-III-NL – subtest Digit Span 
The Digit Span consists of random number sequences that increase in length and that 
the examiner reads aloud at the rate of 1 number per second. The child has to reproduce 
these numbers in the same order. Next, the sequences must be recalled backwards (3-
5-7 becomes 7-5-3). The first part of the test measures short-term auditory memory and 
short-term retention capacity. The second part measures auditory working memory.2 
Secondary outcome measures
Visuospatial working-memory 
Wechsler Nonverbal Scale of Ability (WNV) – subtest Spatial Span
The Spatial Span requires the child to touch a group of blocks arranged on a board in 
a non-systematic manner in the same and reverse order as demonstrated by the exam-
iner. The first part of the test measures short-term visuospatial memory and short-term 
retention capacity. The second part measures visuospatial working-memory.3 
Verbal memory 
Rey Auditory Verbal Learning Test (RAVLT)
The RAVLT consists of five presentations with recall of a 15-word list, a sixth recall 
trial after 30 minutes, and a seventh recognition trial. This test measures memory span, 
short- and long term verbal memory, verbal recognition, and learning curve. It can be 
administered to children and adults in the age range 6-89 years.4,5
Visuospatial memory and visuospatial processing
Rey Complex Figure Test (RCFT)
The RCFT consists of three trials. First the child has to copy a complex figure (Copy). Then 
after 3 and after 30 minutes the figure must be drawn from memory (Recall). Next, dif-
ferent figures are shown and the child has to indicate whether these figures were in the 
original figure (Recognition). This test measures visual integration, short- and long-term 
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visual-spatial memory, and visual-spatial recognition. It can be completed by children 
and adults in the age range 6-89 years.6,7 
Attention 
Dot Cancellation Test
This paper-and-pencil test measures sustained attention and concentration in terms 
of speed. It consists of a paper on which figures made of three, four or five dots are 
displayed in 33 rows. The child is instructed to mark all figures with four dots, as precisely 
and as fast as they can.8 
Stroop Colour Word Test (Stroop)
The Stroop consists of three trials: in the first trial (Stroop 1) the subject must read colour 
names, in the second trial (Stroop 2) name printed colours, and in the third trial (Stroop 
3) name printed colours not denoted by the colour name. The test can be administered 
to children and adults in the age range 8-65 years. Selective attention is measured with 
this test, using the difference score between Stroop 2 and Stroop 3.9,10 
Trail Making Test (TMT)
This paper and pencil test consists of two parts. In the first part (part A), the subject 
must draw lines to consecutively connect numbered circles on a sheet. In the second 
part (part B), the subject must consecutively but alternately connect numbered and 
lettered circles on another worksheet. The aim of the test is to finish each part as quickly 
as possible. The test can be administered to children and adults in the age range 6-89 
years. This test measures visual conceptual and visuomotor tracking as well as divided 
attention.9,10
Executive functioning 
Key Search of the Behavioural Assessment of the Dysexecutive Syndrome (BADS-C-NL) 
A test of strategy formation. The child is asked to demonstrate how they would search 
a field for a set of lost keys and their strategy is scored according to its efficiency and 
functionality.11 
Modified Six Elements of the BADS-C-NL
The child is asked to work on six different tasks for which they have five minutes. The 
child needs to make sure that by the end of the five minutes, all six of the tasks have 
been done and the child has done as much as possible of each task. This is a test of 
planning, task scheduling and performance monitoring.11 
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Questionnaires
Behaviour Rating Inventory of Executive Functioning (BRIEF)
To evaluate the perception of the parents and teachers of the child’s executive function-
ing, including working-memory, the BRIEF was used. This questionnaire can be used for 
children between the ages 5 and 18 years. The Dutch version of the BRIEF has been 
validated and includes Dutch norm scores.12
Child Health Questionnaire (CHQ)
The Dutch version of the CHQ (CHQ-PF50) measures physical and psychosocial function-
ing of the child and is filled out by the parents. The CHQ comprises 14 subscales. In ad-
dition to the overall score on psychosocial functioning, the domain score on self-esteem 
is used. The Dutch version of the CHQ is validated and includes Dutch norm scores.13 
Paediatric Quality of Life Inventory (PedsQL)
The PedsQL measures health-related quality of life and is filled out by the parents as well 
as the child. The PedsQL measures various domains, such as social functioning, physical 
functioning, psychosocial functioning, emotional functioning and school functioning. 
The overall score to measure quality of life and school functioning are used. The PedsQL 
includes Dutch norms for children between 4 and 16 years.14 
Strength and Difficulties Questionnaire (SDQ)
The child’s behaviour can be evaluated by the parents and teacher using the SDQ. This 
questionnaire can be used for children between 4 and 16 years. The child’s psychosocial 
development is evaluated using questions about both positive and negative behav-
iours. The follow-up version of the SDQ was used at the post-intervention assessments 
to obtain ratings of the behaviour of the child over the last month. The SDQ consist 
of five subscales and a total score. The total score as well as the score on the subscale 
hyperactivity/inattention is used. The Dutch version of this test has been validated and 
includes Dutch norm scores.15
We used Dutch versions of all tests and questionnaires.
referenceS 
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Supplemental digital content 3. Neuropsychological outcome immediately and one year after CWMT in 
neonatal ECMO and/or CDH survivors
Measures Variable Estimated coefficient 95% CI P-value
Working-memory
Digit Span CWMT*Time-point:
T0 Reference Reference - 
T1 0.87 0.21 to 1.42 .002 
T2 -0.04 -0.63 to 0.55 .902 
Spatial Span CWMT*Time-point:
T0 Reference Reference - 
T1 0.96 0.47 to 1.45 .003 
T2 0.29 -0.24 to 0.82 .416 
Verbal memory
RAVLT immediate CWMT*Time-point:
T0 Reference Reference - 
T1 0.02 -0.67 to 0.70 .960 
T2 0.22 -0.51 to 0.96 .731 
RAVLT delayed CWMT*Time-point:
T0 Reference Reference - 
T1 0.52 -0.04 to 1.08 .268 
T2 0.45 -0.15 to 1.04 .280 
Visuospatial memory
RCFT Immediate CWMT*Time-point:
T0 Reference Reference - 
T1 0.37 -0.17 to 0.91 .232 
T2 0.60 0.02 to 1.17 .094 
RCFT Delayed CWMT*Time-point:
T0 Reference Reference - 
T1 0.53 0.01 to 1.06 .094 
T2 0.95 0.38 to 1.51 .006 
RCFT recognition CWMT*Time-point:
T0 Reference Reference - 
T1 0.46 -0.23 to 1.15 .232 
T2 -0.09 -0.83 to 0.65 .808 
Sustained attention
DCT CWMT*Time-point:
T0 Reference Reference - 
T1 0.02 -0.76 to 0.80 .961 
T2 -0.03 -0.87 to 0.80 .961 
Selective attention
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Supplemental digital content 3. Neuropsychological outcome immediately and one year after CWMT in 
neonatal ECMO and/or CDH survivors (continued)
Measures Variable Estimated coefficient 95% CI P-value
TMT section B CWMT*Time-point:
T0 Reference Reference - 
T1 0.31 -0.29 to 0.91 .950 
T2 0.11 -0.53 to 0.76 .950 
STROOP CWMT*Time-point:
T0 Reference Reference - 
T1 -0.06 -0.64 to 0.51 .950 
T2 0.02 -0.62 to 0.66 .950 
Processing speed
TMT section A CWMT*Time-point:
T0 Reference Reference - 
T1 0.21 -0.36 to 0.77 .475 
T2 0.66 0.05 to 1.27 .068 
Executive functioning
BADS-C-NL Key Search CWMT*Time-point:
T0 Reference Reference - 
T1 -0.55 -1.21 to 0.10 .151 
T2 -0.21 -0.91 to 0.49 .557 
BADS-C-NL Modified Six 
Elements
CWMT*Time-point:
T0 Reference Reference - 
T1 0.49 -0.12 to 1.09 .151 
T2 0.72 0.02 to 1.42 .151 
Visuospatial processing
RCFT copy CWMT*Time-point:
T0 Reference Reference - 
T1 -0.10 -0.54 to 0.34 .664 
T2 0.15 -0.33 to 0.62 .664 
Results of linear mixed model analyses showing the effect of CWMT on neuropsychological outcome at 
T1 and T2. All estimated coefficients are reported as z-scores. The control group was used as the reference 
group and the baseline assessment T0 as the reference time-point. FDR-correction(26) was applied to cor-
rect for multiple testing. FDR-correction was applied once for each set of tests in the same neuropsycho-
logical domain (i.e. once for the tests measuring attention). An fdr-corrected p-value <.05 is considered 
to be statistically significant.
Abbreviations: CWMT, Cogmed Working Memory Training; ECMO, extracorporeal membrane oxygenation; 
CDH, congenital diaphragmatic hernia; T1, six weeks after baseline; T2, 12 months after baseline; RAVLT, Rey 
Auditory Verbal Learning Test; RCFT, Rey Complex Figure Test; DCT, Dot Cancellation Test; TMT, Trail Making 
Test; BADS-C-NL, Behavioural Assessment of the Dysexecutive Syndrome.
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Supplemental digital content 4. Proxy- and self-reported outcomes after CWMT in ECMO and/or CDH 
survivors
Variable Estimated coefficient 95% CI P-value
Self-report 
School functioning* 
(PedsQL)
CWMT*Time-point:
T0 Reference Reference - 
T1 0.11 -0.69 to 0.90 .787 
T2 0.71 -0.15 to 1.56 .104 
Quality of life (PedsQL) CWMT*Time-point:
T0 Reference Reference - 
T1 0.46 -0.42 to 1.33 .304 
T2 0.75 -0.16 to 1.71 .101 
Proxy-report - Parent
School functioning* 
(PedsQL)
CWMT*Time-point:
T0 Reference Reference - 
T1 0.24 -0.25 to 0.72 .335 
T2 0.10 -0.42 to 0.62 .704 
Quality of Life (PedsQL) CWMT*Time-point:
T0 Reference Reference - 
T1 0.22 -0.25 to 0.68 .355 
T2 0.40 -0.10 to 0.89 .113 
Working-memory 
(BRIEF)
CWMT*Time-point:
T0 Reference Reference - 
T1 -0.21 -0.78 to 0.37 .478 
T2 0.51 -0.11 to 1.13 .108 
Executive Functioning 
(BRIEF)
CWMT*Time-point:
T0 Reference Reference - 
T1 -0.09 -0.58 to 0.40 .706 
T2 0.57 0.04 to 1.09 .034 
Psychosocial Quality of 
Life (CHQ)
CWMT*Time-point:
T0 Reference Reference - 
T1 -0.16 -0.69 to 0.38 .565 
T2 -0.15 -0.74 to 0.43 .608 
Self-esteem (CHQ) CWMT*Time-point:
T0 Reference Reference - 
T1 0.01 -1.05 to 1.08 .979 
T2 0.13 -1.03 to 1.29 .821 
Hyperactivity/attention 
(SDQ)
CWMT*Time-point:
T0 Reference Reference - 
T1 0.33 -0.18 to 0.84 .197 
T2 0.58 0.02 to 1.13 .042 
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Supplemental digital content 4. Proxy- and self-reported outcomes after CWMT in ECMO and/or CDH 
survivors (continued)
Variable Estimated coefficient 95% CI P-value
Behaviour (SDQ) CWMT*Time-point:
T0 Reference Reference - 
T1 0.30 -0.16 to 0.76 .193 
T2 0.38 -0.11 to 0.88 .128 
Proxy-report - Teacher
Working-memory 
(BRIEF)
CWMT*Time-point:
T0 Reference Reference - 
T1 0.07 -0.80 to 0.94 .873 
T2 0.23 -0.70 to 1.15 .627 
Executive Functioning 
(BRIEF)
CWMT*Time-point:
T0 Reference Reference - 
T1 0.06 -0.53 to 0.66 .836 
T2 0.03 -0.50 to 0.67 .913 
Hyperactivity/attention 
(SDQ)
CWMT*Time-point:
T0 Reference Reference - 
T1 0.05 -0.54 to 0.63 .878 
T2 0.12 -0.50 to 0.73 .704 
Behaviour (SDQ) CWMT*Time-point:
T0 Reference Reference - 
T1 0.21 -0.27 to 0.69 .392 
T2 0.16 -0.34 to 0.67 .516 
Results of linear mixed model analyses showing the effect of CWMT on proxy- and self-reported outcomes 
at T1, as well as at T2. The control group was used as the reference group and the baseline assessment T0 as 
the reference time-point. All estimated coefficients are reported as z-scores. P-value <.05 is considered to 
be statistically significant. Abbreviations: T1, six weeks after baseline; T2, 12 months after baseline; CWMT, 
Cogmed Working Memory Training; BRIEF, Behaviour Rating Inventory of Executive Functioning; PedsQL, 
Paediatric Quality of Life Inventory; SDQ, Strengths and Difficulties Questionnaire; CHQ, Child Health Ques-
tionnaire.
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abSTracT 
objective To test the effect of Cogmed Working-Memory Training (CWMT) on white 
matter microstructure following neonatal ECMO and/or CDH.
design A nationwide randomized controlled trial assessing white matter microstructure 
immediately post-CWMT (T1) and its association with neuropsychological outcome im-
mediately and one year (T2) post-CWMT, conducted between October 2014-June 2017. 
Researchers involved in the follow-up assessments were blinded to group allocation.
Setting Erasmus MC-Sophia Children’s Hospital, Rotterdam and Radboud University 
Medical Center, Nijmegen, the Netherlands.
Patients Eligible participants were neonatal ECMO and/or CDH survivors (8-12 years) 
with an IQ ≥ 80 and a z-score ≤ -1.5 on at least one (working)memory test at first assess-
ment.
interventions CWMT, comprising 25 sessions of 45 minutes for five consecutive weeks 
at home.
measurements and main results Participants were randomized to CWMT (n = 14) or 
non-training (n = 20). Global fractional anisotropy (FA) increased significantly in the 
CWMT group compared to the non-training group (estimated coefficient = .007, p = 
.015). Increased FA (estimated coefficient = .009, p = .033) and decreased mean diffusiv-
ity (estimated coefficient = -.010, p = .018) were found in the left superior longitudinal 
fasciculus in the CWMT group compared to the non-training group at T1. Children in the 
CWMT who improved with at least 1 SD on verbal working-memory from T0 to T1 had 
significantly higher FA in the left SLF at T1 (n = 6; FA left SLF at T1 = .408±.01) compared 
to children that did not show this improvement after CWMT (n = 6; FA left SLF at T1 = 
.384±.02), F(1,12) = 6.22, p = .041, hp2 = .47. No other structure-function relationships 
were found after CWMT.
conclusions White matter microstructure is affected by CWMT in school-age survivors 
of neonatal ECMO and/or CDH. Our findings demonstrate that white matter microstruc-
ture and associated cognitive outcomes are malleable in these children.
Trial registration NTR4571: http://www.trialregister.nl/trialreg/admin/rctview.asp?TC=4571.
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inTroducTion 
Survivors of neonatal extracorporeal membrane oxygenation (ECMO) and/or congenital 
diaphragmatic hernia (CDH) are at increased risk of specific attention and memory defi-
cits that begin during the school-age years and extend into adolescence.1,2 These deficits 
have been found to be specifically associated with global white matter microstructure 
alterations and with specific alterations in limbic regions of the brain, namely the hip-
pocampus, cingulum and parahippocampal part of the cingulum.3-5 Using a single-blind 
randomized controlled trial, we recently found that school-age survivors of neonatal 
ECMO and/or CDH trained with Cogmed working-memory training (CWMT6) showed 
significant improvements in verbal and visuospatial working-memory immediately 
post-intervention compared to untrained controls (chapter 7). However, this improve-
ment was not maintained at the one year post-intervention assessment. Interestingly 
however, improvements in visuospatial memory delayed recall were found to persist 
one year post-intervention compared to controls (chapter 7). Given the fact that more 
than 50% of these survivors have visuospatial memory deficits later in life1 and consid-
ering the importance of memory for both academic performance and participation in 
society, this is a promising finding.
Several studies in adults have shown plasticity in white matter microstructure im-
mediately following working-memory training.7,8 In particular, the superior longitudinal 
fasciculus (SLF) has shown plastic changes following working-memory training, likely 
because it connects parietal and frontal cortical regions, which have been shown to 
be important for working-memory.9 Given the increased plasticity of a child’s brain 
compared to that of an adult10, white matter microstructure changes may be more wide-
spread following CWMT in children compared to adults. However, this has remained 
unstudied until now.
The aim of this study was to investigate the neurobiological plasticity following 
CWMT using diffusion tensor imaging (DTI) in school-age survivors of neonatal ECMO 
and/or CDH that were part of a nationwide single-blind randomized controlled trial. We 
hypothesized that white matter microstructure, and in particular the SLF, would change 
following CWMT. Furthermore, we assessed whether if there were changes in white mat-
ter microstructure, these were associated with the cognitive improvements observed 
following CWMT (chapter 7).
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meThodS
design and population
This nationwide randomized controlled trial, conducted between October 2014 and June 
2017, compared CWMT to no training in school-age neonatal ECMO and/or CDH survivors 
(NTR4571). Inclusion criteria for the trial were: school-age children (8-12 years) treated 
with ECMO or treated for CDH without ECMO in the first weeks of life at the Erasmus 
MC-Sophia Children’s Hospital in Rotterdam or the Radboud University Medical Center 
in Nijmegen (the Netherlands), IQ ≥ 80 and memory impairment (z-score ≤ -1.5 on one 
or more memory tests11). Exclusion criteria were: usage of psychopharmaceutic drugs 
(e.g. methylphenidate) and/or genetic syndromes that are known to affect neuropsycho-
logical functioning. Eligible children were randomized into either the CWMT group or the 
non-training group by an independent researcher not involved with the assessment of 
the children (please refer to Figure 1 for the trial outline). The MRI exam and neuropsy-
chological assessments were performed by researchers blinded to group allocation.
Ethical approval was granted by the Erasmus MC Medical Ethical Review Board (MEC-
2014-001). All families received an application package with written informed consent 
for the parents and children ≥ 12 years of age that was discussed with the family and 
filled out before participating in the trial. The complete trial methods are described 
elsewhere (chapter 7).
Prior to study inclusion  
Baseline neuropsychological assessment (T0)  
Randomization 
Intervention group  
CWMT 
Six weeks after START (T1) 
• Neuropsychological assessment 
• Questionnaires 
• MRI exam 
12 months after START (T2) 
• Neuropsychological assessment 
• Questionnaires 
If fulfilling inclusion criteria*  
START study 
•  Questionnaires (T0)  
• MRI exam (T0) 
Control group  
No intervention 
figure 1. Trial outline
For short descriptions of the tests and ques-
tionnaires used, please refer to Supplemen-
tal File 1. For description of the MR methods 
please refer to Supplemental File 2. *IQ > 
80 and a z-score ≤ -1.5(20) on one or more 
memory tests. Abbreviations: CWMT, Cog-
med Working-Memory Training.
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intervention 
Children in the CWMT group completed the CWMTRM version for children from the ages 
7 to 17 years. Children trained at home for 45 minutes a day, five days a week, for five 
consecutive weeks, as recommended in the manufacturer’s instructions.6 The level of 
the tasks adapted automatically to ensure that the child was continuously performing at 
the maximum of his or her ability. As part of the program, each child was supervised by a 
certified CWMT coach, who provided support to the family and feedback on the training 
results once a week over the phone and by e-mail. The CWMT coach was able to closely 
monitor the child’s performance via online access.
Children in the non-training group did not receive any training.
outcome measures 
After the standardized, neuropsychological assessment at baseline to determine eligi-
bility, eligible participants underwent an MRI exam (T0). After six weeks, the MRI exam 
was repeated in all participants (T1). At the same time, the neuropsychological assess-
ment was repeated, and again after one year following the baseline measurement (T2, 
neuropsychological assessment only). The neuropsychological outcomes are described 
elsewhere (chapter 7; please refer to Supplemental File 1 for brief descriptions of all 
cognitive tests).
All children first underwent a mock scanning session to become familiarized with 
the MRI-scanner environment.12 MRI data were acquired on a 3 Tesla GE MR-750 system 
using an 8-channel head coil (General Electric, Milwaukee, WI). A full description of the 
sequences and scanning protocol is provided in Supplemental File 2. After DTI image 
preprocessing, voxel-wise scalar maps of fractional anisotropy (FA) and mean diffusivity 
(MD) were computed. FA provides a rotationally invariant measure of diffusion, with 0 
being completely isotropic (equal in all directions) and 1 being completely anisotropic 
(diffusion along only one axis). MD is the rate of diffusion of water (hydrogen) averaged 
in all directions. The FSL plugin ‘AutoPtx’ for fully automated probabilistic fiber trac-
tography was used to create subject-specific, probabilistic representations of multiple 
white matter bundles.13 Automated14 and visual inspection of the neuroimaging data 
resulted in 61 DTI datasets (87%) with usable image quality. All scans were reviewed by a 
certified neuroradiologist (M.S.), blinded for medical history and outcome.
Statistical analysis 
Clinical and demographic characteristics and neuropsychological outcome at base-
line were compared between groups using independent samples t-tests and ANOVA 
(normally distributed variables), Mann-Whitney U or Fisher’s exact tests (non-normally 
distributed continuous or categorical variables, respectively).
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First, we assessed whether white matter microstructure changed as a result of CWMT. 
Our primary aim was to assess changes in the SLF as it is involved in working-memory 
and has previously been shown to be affected by CWMT.9 Linear mixed models were 
estimated to assess whether white matter microstructure changed in the CWMT group 
compared to the non-training group at T1. This method accounts for within-subject cor-
relations and allows for missing values in the dependent variable. Outcome at baseline 
was constrained to be equal. The brain diffusion measures were included as dependent 
variables, and group and time-point as well as the group by time-point interaction term 
were included as independent variables. Results of the linear mixed models were sum-
marized using the estimated marginal means (the predicted values of the dependent 
variable adjusted for the effects of the independent variables) of the group by time-
point interaction.
Second, we analyzed changes in global FA and global MD following CWMT using 
linear mixed models. Described by our group in more detail elsewhere5, global white 
matter microstructure was calculated using a weighted (by tract volume) average score 
of FA/MD of the association and limbic system white matter tracts (uncinate, inferior 
fronto-occipital fasciculus, SLF, inferior longitudinal fasciculus, cingulum bundle and 
parahippocampal part of cingulum) (Equation 1), known to be involved with cognitive 
functioning in children14,15: 
Equation 1: 
Global FA = 
Σni=1 FAtractiVoltracti
Σni=1 Voltracti
where i denotes the tract, Vol denotes the volume of the tract, and n is the number of 
tracts. The same formula was used for global MD, replacing FA for each tract with the 
MD measure.
If global FA or global MD changed significantly following CWMT, additional analyses 
were performed with the individual white matter tracts. The same setup of linear mixed 
models were used to now assess whether white matter microstructure in the individual 
tracts (independent variables) changed in the CWMT group compared to the non-training 
group at T1. Brain structures were analyzed in the left and right hemispheres separately 
as laterality differences have been shown in the organization of working-memory and 
specific cognitive functions.16 In all linear mixed models, we adjusted for age at T1 and 
gender.17 For the additional analyses on group differences in the individual white matter 
tracts, the False Discovery Rate (FDR)18 correction was applied to account for multiple 
testing. These results were considered statistically significant at the FDR-corrected p < 
.05.
Our previous findings showed that children trained with CWMT improved significantly 
on verbal working-memory, visuospatial working-memory and visuospatial memory 
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delayed recall compared to non-trained children (chapter 7). For our second aim, we 
therefore assessed whether changes in white matter microstructure following CWMT (if 
any) were associated with the cognitive improvements in the CWMT group using uni-
variate linear regression models. The dependent variable was the brain parameter at T1 
in the CWMT group and the independent variable was the cognitive outcome measure, 
dichotomized to: improved (>1 SD improvement from T0 to T1) versus not improved (<1 
SD improvement from T0 to T1). In these analyses, we adjusted for FA/MD at baseline, age 
at T1 and gender. Neuropsychological test scores were converted to z-scores (individual 
score minus the population mean divided by the population SD). Scores were inverted 
where appropriate so that a higher score always equated with better performance.
Statistical analyses were performed using SPSS 21.0 (IBM Corporation, Armonk, Ny) 
and the Stats, lme4 and lmerTest packages in R Statistical Software version 3.1.3 (R Core 
Team, 2014). The estimated marginal means are reported by group and time-point for 
the linear mixed model analyses. Effect sizes were calculated in the linear regression 
models using partial eta squared (hp2) and interpreted according to Cohen’s guidelines 
(0.01 = small, 0.06 = medium, 0.14 = large).19 
reSulTS 
Of 34 eligible children with useable DTI data, 14 were in the CWMT group (13 with an 
MRI at both T0 and T1) and 20 in the non-training group (18 with an MRI at both T0 and 
T1) (please refer to Supplemental Figure 1 for the CONSORT flow diagram). Demographic 
and clinical characteristics did not differ between the CWMT group and the non-training 
group (Table 1). There were no differences in global white matter microstructure or 
white matter microstructure on any of the tracts at baseline between the two groups 
(data not shown).
White matter microstructure following cWmT 
Using a linear mixed model analysis, we found significant group by time interactions 
with FA in the left SLF significantly higher in the CWMT group compared to the non-
training group at T1 (estimated coefficient = .009, p = .033), and lower MD in the left SLF 
in the CWMT group compared to the non-training group at T1 (estimated coefficient = 
-.010, p = .018)(Table 2).
There was a significant group by time interaction with higher global FA in the CWMT 
group compared to the non-training group at T1 (estimated coefficient = .007, p = .015). 
Additional linear mixed model analyses in the individual tracts showed a significant 
group by time interaction with higher FA in the right uncinate fasciculus in the CWMT 
group compared to the non-training group at T1 (estimated coefficient = .013, p = .029). 
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Table 1. Study population characteristics
Characteristics
All 
(n = 34)
Control 
(n = 19)
CWMT 
(n = 15) P-value 
a) Demographic 
Age (years) 10 ± 2 10 ± 2 10 ± 1 .821
Gender .728
Male 21 (62%) 10 (67%) 11 (62%)
Handedness
Right 28 (82%) 16 (84%) 12 (80%) .749
Ethnicity .355
Dutch 29 (85%) 15 (79%) 14 (93%)
Maternal education levela .242
Low 5 (15%) 2 (11%) 3 (20%)
Moderate 11 (32%) 5 (26%) 6 (40%)
High 18 (53%) 12 (63%) 6 (40%)
Type of education child .228
Regular 23 (68%) 13 (68%) 10 (67%)
Regular with help 9 (26%) 6 (32%) 3 (20%)
Special education 2 (6%) 0 (0%) 2 (13%)
IQ 101 ± 12 100 ± 12 102 ± 12 .576
b) Clinical
Birthweight (kilograms) 3.5 (3.2-2.8) 3.5 (3.3-3.8) 3.4 (3.0-4.0) .650
Gestational age (weeks) 40 (39-41) 40 (40-41) 40 (40-42) .483
Mechanical vent. (days) 10 (8-16) 11 (8-16) 10 (9-16) .762
Chronic lung diseaseb 3 (9%) 2 (11%) 1 (8%) .787
Abnormal CUSc 3 (9%) 2 (12%) 1 (9%) .823
CDH-non-ECMO 11 (32%) 5 (26%) 6 (40%) .646
ECMO treatmentd 23 (68%) 14 (74%) 9 (60%) .475
Type of ECMO .176
VA 15 (65%) 8 (57%) 7 (78%)
VV 7 (30%) 6 (43%) 1 (11%)
VV conversion to VA 1 (4%) 0 (0%) 1 (22%)
Age start ECMO (days) 1 (1-2) 2 (1-4) 1 (1-2) .557
Hours on ECMO 109 (85-180) 114 (84-185) 104 (84-161) .831
N (%), mean ± SD or median (interquartile range) is reported where appropriate. Dutch refers to children 
with two native Dutch parents. aBased on the highest level of education completed by the mother(38). 
bChronic lung disease defined as oxygen dependency at 28 days of life29. cAbnormal CUS: hemorrhagic 
infarct posterior cerebral artery (n=1), focal densities thalami (n=2). dDiagnoses underlying ECMO treat-
ment in the neonatal period were congenital diaphragmatic hernia (n=2), meconium aspiration syndrome 
(n=17), persistent pulmonary hypertension of the newborn (n = 2), infant respiratory distress syndrome 
(n = 1), and cardiac anomaly (n=1). Abbreviations: CWMT, Cogmed Working Memory Training; IQ, Intel-
ligence Quotient; CUS, cranial ultrasound; CDH, congenital diaphragmatic hernia; ECMO, extracorporeal 
membrane oxygenation; VA, venoarterial; VV, venovenous.
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However, this finding did not survive the correction for multiple testing (pFDR = .173). 
Furthermore, a significant group by time interaction was found with higher FA in the 
left cingulum bundle in the CWMT group compared to the non-training group at T1 
(estimated coefficient = .019, p = .037), but this finding did not remain significant after 
correcting for multiple testing either (pFDR = .173)(Table 2).
Global MD did not significantly change following CWMT (estimated coefficient = -.007, 
p =.055)(Table 2).
White matter microstructure and neuropsychological improvement 
following cWmT 
Children in the CWMT group who improved with at least 1 SD on verbal working-memory 
from T0 to T1 had significantly higher FA in the left SLF at T1 (n = 6; FA left SLF at T1 = 
.408±.01) compared to children that did not show this improvement after CWMT (n = 6; 
FA left SLF at T1 = .384±.02), F(1,12) = 6.22, p = .041, hp2 = .47 (Figure 2). This association 
was not found in the non-training group where two children improved with at least 1 SD 
from T0 to T1 (p = .175), indicating that the association between the increase in FA in the 
left SLF and improvement in verbal working-memory is related to CWMT.
Table 2. FA and MD group differences in white matter tracts immediately after CWMT
Tract Hemisphere Mean FA
T1 Non-training
Mean FA T1 
CWMT
p pFDR Mean MD T1
Non-training
Mean MD T1 
CWMT
p
SLF left .390 (.01) .396 (.01) .033 .781 (.01) .770 (.01) .018
Right .387 (.01) .392 (.01) .250 .783 (.01) .762 (.01) .183
Global - .401 (.01) .406 (.01) .015 .811 (.01) .800 (.01) .055
UNC Left .368 (.01) .381 (.01) .119 .298
Right .378 (.01) .392 (.01) .029 .173
IFO Left .442 (.01) .451 (.01) .296 .360
Right .438 (.01) .447 (.01) .052 .173
ILF Left .423 (.01) .424 (.01) .201 .337
Right .427 (.01) .429 (.01) .202 .337
CB Left .382 (.01) .396 (.01) .037 .173
Right .351 (.01) .347 (.01) .324 .360
PHC Left .276 (.01) .286 (.01) .296 .360
Right .295 (.01) .293 (.01) .910 .910
Group*time-point interaction terms of the linear mixed model analyses showing differences in white mat-
ter microstructure between children in the CWMT group (n = 14) and non-training group (n = 20) directly 
after the intervention. Mean weighted average FA (SD) is given for each tract per group. Results are sig-
nificant at p-value < .05. The FDR-correction18 was applied once for the set of additional analyses on the 
individual white matter tracts (i.e. once for 10 tests). Pfdr < .05 was considered statistically significant. Ab-
breviations: FA, fractional anisotropy; MD, mean diffusivity; UNC, uncinate fasciculus; ILF, inferior longitu-
dinal fasciculus; IFO, inferior fronto-occipital fasciculus; SLF, superior longitudinal fasciculus; CB, cingulum 
bundle; PHC, parahippocampal cingulum bundle.
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Significant improvements in visuospatial working-memory or visuospatial memory 
delayed recall found after CWMT were not associated with the training-induced changes 
in white matter microstructure in the CWMT group.
diScuSSion 
In this single-blind randomized controlled trial, we found significant white matter 
microstructural changes in school-age survivors of neonatal ECMO and/or CDH who 
were trained with CWMT compared to non-trained survivors. We found both global and 
specific changes in white matter microstructure immediately post-intervention in the 
CWMT group compared to the non-training group. Specific changes in FA in the left 
SLF were associated with better verbal working-memory after CWMT. These findings 
demonstrate that neurobiological plasticity exists in survivors of neonatal critical illness 
despite significant alterations found in white matter microstructure in these children 
compared to healthy controls.3,5 
Our findings of specific changes in the SLF, a white matter tract connecting the frontal 
and parietal cortices9, following CWMT confirm previous findings of changes in connec-
tivity in frontopatietal regions following working-memory training in healthy school-
age children (8-11 years) as well as in childhood cancer survivors (12 years).20,21 Although 
most studies have focused on brain activity using fMRI and/or were performed in adults, 
the frontoparietal network has been consistently shown to be affected by working-
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figure 2. Associations between cognitive improvement and changes in white matter microstructure fol-
lowing CWMT
Results from univariate linear regression analyses showing a significant association between an improve-
ment of >1 SD on verbal working-memory and an increase in fractional anisotropy in the SLF after CWMT. 
Children who improved with at least 1 SD on verbal working-memory (n=6) after CWMT, had significantly 
higher FA in the left SLF at T1 than children that did not show this improvement (n=6). *Indicates a signifi-
cant association at p < .05. Abbreviations: CWMT, Cogmed Working-Memory Training.
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memory training.22-24 Furthermore, we found that the training-induced changes in the 
left SLF were significantly associated with improvements in verbal working-memory. Pre-
dominantly left hemispheric alterations have been previously found following neonatal 
ECMO5, which have been suggested to be due to right internal jugular vein cannulation 
in neonatal ECMO patients.25 Because of this, there may be more room for improvement 
in the left hemisphere, which could explain the training-induced changes in the left 
hemisphere only. However, we have previously shown that, although more significant 
alterations were found in the left hemisphere, right-hemispheric alterations were found 
in these children compared to healthy children as well3, making this clarification unlikely. 
The majority of children in our cohort was right handed (80%) and right-handedness 
is generally associated with left-hemispheric dominance for language.26 This therefore 
may also explain the association between verbal working-memory improvements and 
the left-sided changes in white matter microstructure. These results confirm previous 
findings that have shown that working-memory functioning is lateralized, i.e. verbal 
working-memory corresponds with the left hemisphere and visuospatial working-
memory with the right hemisphere.16,27 However, children in the CWMT group improved 
significantly on visuospatial working-memory (chapter 7), yet we did not find any 
changes in the right SLF. In previous neuroimaging studies following CWMT in children 
as well as adults, both right-lateralized and left-lateralized changes in the frontal and 
parietal cortices have been demonstrated.9,21 These contrasting findings may be due to 
the type of image acquisition and analysis employed, such as region-of-interest versus 
whole-brain analyses, making it difficult to draw definitive conclusions.
In addition to changes in the left SLF, we found that global FA increased in the CWMT 
compared to the non-training group from T0 to T1. In the majority of the white mat-
ter tracts assessed, FA increased following CWMT. This global change may be due to 
the relatively high plasticity of the child’s brain.10 Increased FA may indicate enhanced 
orchestration in communication between neural circuits, which, in turn, may lead to 
enhanced cognitive functioning.8 However, these global changes were not associated 
with any cognitive improvements following CWMT. In the same cohort, we previously 
showed an association between lower global FA and sustained attention deficits, a 
domain consistently found to be impaired following neonatal ECMO and/or CDH.3 
However, we did not find any direct relationships between the changes in global FA and 
sustained attention following CMWT. Future research is needed to better understand 
the clinical relevance of changes in global white matter microstructure following CWMT 
in children.
We have previously shown improvements in long-term visuospatial memory both im-
mediately and one year after CWMT in this cohort (chapter 7). These cognitive improve-
ments may be due to changes in brain activity or connectivity that were not detectable 
using DTI.9 However, in the same cohort, we previously showed that impaired delayed 
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visuospatial memory was specifically associated with increased MD in the parahip-
pocampal part of the cingulum.3 A previous study using DTI in adults following CWMT 
did find training-induced changes in the parahippocampal cingulum.9 In our cohort, 
the improvements in delayed visuospatial memory were most apparent one year 
post-intervention (chapter 7). Potential changes in the parahippocampal and temporal 
brain regions therefore may not have been detectable immediately following CWMT. In 
line with this, a recent study in a population-based cohort of school-age children (6-10 
years) has shown downstream effects of behavior on the brain instead of the commonly 
assumed direction of brain shaping behavior.28 Such a downstream mechanism may 
explain why we see cognitive improvements immediately following CWMT without 
corresponding changes in the brain. Unfortunately, this remains speculative as no MRI 
was made after one year. Future studies conducting multimodal neuroimaging both im-
mediately and longitudinally over the course of the year post-intervention are needed 
to better understand neuroplasticity following working-memory training.
This is the first study to assess and demonstrate neuroplasticity following CWMT in 
neonatal ECMO and/or CDH survivors. Despite this, our study has some limitations. 
First, our small sample size limits the interpretability of our findings, in particular the 
analyses on associations between brain changes and cognitive improvement in the 
CWMT group. However, since the association between increased FA in the SLF and 
improved verbal working-memory had a large effect size (0.47)19, coupled with prior 
literature supporting this link9, 23, we regard this to be a reliable finding. Second, we used 
a non-active control group for ethical considerations against subjecting children to an 
intensive training without potential benefits, which limits our ability to attribute our 
findings to the specific characteristics of the CWMT training. However, neuroplasticity 
has been demonstrated following working-memory training even when compared to a 
non-adaptive training program.9,20 Third, we were not able to conduct an MRI exam one 
year post-intervention, limiting our understanding of neuroplasticity following CWMT. 
Future studies that combine neuroimaging and neuropsychological assessment at 
multiple time points following CWMT are needed. Lastly, the indices extracted using DTI 
are not specific to any white matter property and therefore specific biological changes 
may be missed. In the future, studies using more sensitive neuroimaging techniques, 
such as MRI with higher magnetic field strength (e.g. 7 Tesla), will further increase our 
understanding of neuroplasticity following cognitive training.
concluSion
Our findings demonstrate both global and specific changes in white matter microstruc-
ture immediately after CWMT in school-age survivors of neonatal ECMO and/or CDH 
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compared to non-trained survivors. Specific changes in FA in the left SLF were associated 
with better verbal working-memory after CWMT. These results suggest that white mat-
ter microstructure and associated cognitive outcomes are malleable in these children. 
Future studies on the effectiveness of cognitive interventions need to include follow-up 
assessments both immediately and one year after the training to further increase our 
understanding of neuroplasticity following neonatal critical illness.
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SuPPlemenTary maTerial 
Supplemental file 1. descriptions of the neuropsychological tests.
Intelligence 
Wechsler Intelligence Scale for Children (WISC-III-NL)
A short-form with two subtests, Block Design and Vocabulary, of the WISC-III-NL were 
used to assess general intelligence.1 The WISC-III-NL has been shown to have good reli-
ability and validity.2 A normalized population mean of 100 with a standard deviation of 
15 is used.2
Verbal working-memory 
WISC-III-NL – subtest Digit Span 
The Digit Span consists of random number sequences that increase in length and that 
the examiner reads aloud at the rate of 1 number per second. The child has to reproduce 
these numbers in the same order. Next, the sequences must be recalled backwards (3-
5-7 becomes 7-5-3). The first part of the test measures short-term auditory memory and 
short-term retention capacity. The second part measures auditory working memory.2 
Visuospatial working-memory 
Wechsler Nonverbal Scale of Ability (WNV) – subtest Spatial Span
The Spatial Span requires the child to touch a group of blocks arranged on a board in 
a non-systematic manner in the same and reverse order as demonstrated by the exam-
iner. The first part of the test measures short-term visuospatial memory and short-term 
retention capacity. The second part measures visuospatial working-memory.3 
Verbal memory 
Rey Auditory Verbal Learning Test (RAVLT)
The RAVLT consists of five presentations with recall of a 15-word list, a sixth recall 
trial after 30 minutes, and a seventh recognition trial. This test measures memory span, 
short- and long term verbal memory, verbal recognition, and learning curve. It can be 
administered to children and adults in the age range 6-89 years.4,5
Visuospatial memory and visuospatial processing
Rey Complex Figure Test (RCFT)
The RCFT consists of three trials. First the child has to copy a complex figure (Copy). Then 
after 3 and after 30 minutes the figure must be drawn from memory (Recall). Next, dif-
ferent figures are shown and the child has to indicate whether these figures were in the 
original figure (Recognition). This test measures visual integration, short- and long-term 
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visual-spatial memory, and visual-spatial recognition. It can be completed by children 
and adults in the age range 6-89 years.6,7 
Attention 
Dot Cancellation Test
This paper-and-pencil test measures sustained attention and concentration in terms 
of speed. It consists of a paper on which figures made of three, four or five dots are 
displayed in 33 rows. The child is instructed to mark all figures with four dots, as precisely 
and as fast as they can.8 
Stroop Colour Word Test (Stroop)
The Stroop consists of three trials: in the first trial (Stroop 1) the subject must read colour 
names, in the second trial (Stroop 2) name printed colours, and in the third trial (Stroop 
3) name printed colours not denoted by the colour name. The test can be administered 
to children and adults in the age range 8-65 years. Selective attention is measured with 
this test, using the difference score between Stroop 2 and Stroop 3.9,10 
Trail Making Test (TMT)
This paper and pencil test consists of two parts. In the first part (part A), the subject 
must draw lines to consecutively connect numbered circles on a sheet. In the second 
part (part B), the subject must consecutively but alternately connect numbered and 
lettered circles on another worksheet. The aim of the test is to finish each part as quickly 
as possible. The test can be administered to children and adults in the age range 6-89 
years. This test measures visual conceptual and visuomotor tracking as well as divided 
attention.9,10
Executive functioning 
Key Search of the Behavioural Assessment of the Dysexecutive Syndrome (BADS-C-NL) 
A test of strategy formation. The child is asked to demonstrate how they would search 
a field for a set of lost keys and their strategy is scored according to its efficiency and 
functionality.11 
Modified Six Elements of the BADS-C-NL
The child is asked to work on six different tasks for which they have five minutes. The 
child needs to make sure that by the end of the five minutes, all six of the tasks have 
been done and the child has done as much as possible of each task. This is a test of 
planning, task scheduling and performance monitoring.11 
We used Dutch versions of all tests.
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Assessed for eligibility (n= 217) 
Excluded  (n=172) 
   Not meeting inclusion criteria (n=50) 
   Declined to participate (n=54) 
   Other reasons (n=68) 
Analysed  (n=14)
   Excluded from analysis due to poor MRI  
quality (n=1) 
Discontinued intervention (n=0) 
 
Lost to immediate follow-up (n=1) 
   Malfunctioning equipment (n=1) 
 
 
 
Allocated to intervention (n=20) 
   Received allocated intervention (n=19) 
   Did not receive allocated intervention (n=1):  
Just started with ADHD medication (n=1).  
 
No MRI exam (n=4) 
   Braces (n=3) 
   Pacemaker (n=1) 
 
 
Lost to immediate follow-up (n=4):  
   Ill at the time of assessment (n=1) 
   Poor data quality at T0 (n=2) 
   Braces (n=1) 
Allocated to control group (n= 25) 
   Dropped out of study (n=1): 
Did not want to wait with treatment until 
after study (n=1) 
 
No MRI exam (n=1) 
   Claustrophobia (n=1) 
Analysed  (n=20) 
   Excluded from analysis due to poor MRI 
quality (n=1) 
 
Allocation 
Analysis 
Follow-Up 
Randomized (n=45) 
Supplemental figure 1. CONSORT flow diagram
Abbreviations: ADHD, Attention Deficit Hyperactivity Disorder.
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Supplemental file 2. neuroimaging methods.
Image Acquisition 
Prior to neuroimaging, all participants underwent a 30-minute mock scanning session 
to become familiarized with the MR-environment1. Magnetic resonance imaging data 
were acquired on a 3 Tesla GE MR-750W system using an 8 channel receive-only head 
coil (General Electric, Milwaukee, WI). In order to support the participant’s head and 
minimize head motion, cushions were placed on both sides of the child’s head inside of 
the head coil. Participants were able to watch a movie during the scans. MRI-compatible 
headphones were used to reduce the scanner noise and allow participants to listen to 
the movie’s audio track. Communication with the MR operator was also enabled through 
the headphones before and after scans. The DTI data were acquired using a single-shot, 
echo-planar imaging sequence with the following parameters: TR = 12,500 ms, TE = 72 
ms, flip angle = 90, matrix = 120 x 120, FOV = 240 mm x 240 mm, slice thickness = 2 mm, 
number of slices = 65, ASSET acceleration factor = 2. In total, 35 volumes with diffusion 
weighting (b = 900 s/mm²) and 3 volumes without diffusion weighting (b = 0 s/mm²) 
were acquired.
MR-Image Preprocessing 
Data were processed using the Functional MRI of the Brain’s Software Library (FMRIB, FSL) 
(2) and the Camino Diffusion MRI Toolkit within Python (version 2.7) and the Neuroimag-
ing in Python Pipelines and Interfaces package (Nipype, version 0.92)3,4. First, motion 
and eddy-current induced artifacts5 were addressed using the FSL “eddy_correct” tool6. 
In order to account for the rotations applied to the diffusion data after adjusting for 
these artifact, the resulting transformation matrices were used to rotate the “B-matrix” 
gradient direction table7,8. The FSL Brain Extraction Tool was used to remove non-brain 
tissue9. In order to minimize the limitations observed with respect to the ordinary 
least squares fit method10, the diffusion tensor was fit using the RESTORE method 
implemented in Camino11. Voxel-wise scalar maps (i.e. FA, MD) were then computed. 
FA is the degree of directionality of diffusion and ranges from 0 to 1, where a higher 
FA generally represents a greater coherence of white matter fibers. MD is the rate of 
diffusion of hydrogen averaged in all directions. Lower MD is suggestive of increased 
integrity in axonal membranes, packing, or myelin. White matter continues to mature 
throughout childhood, even into young adulthood, causing FA to increase and MD to 
decrease. Abnormal brain development typically leads to lower FA and higher MD in 
white matter tracts12.
Probabilistic Fiber Tractography 
Fully automated probabilistic fiber tractography was performed using the FSL plugin, 
“AutoPtx”13. Subject-specific, probabilistic representations of multiple white matter fiber 
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bundles are created with this method using a combination of FSL tools from the Diffusion 
Toolkit (FDT). The Bayesian Estimation of Diffusion Parameters Obtained using Sampling 
Techniques (BEDPOSTx), accounting for two fiber orientations at each voxel, was used 
to esatimate diffusion parameters at each voxel14,15. Next, for each subject, the FA map 
was aligned to the FMRIB-58 FA template image with the FSL nonlinear registration tool 
(FNIRT). The inverse of this nonlinear warp field was computed, and applied to a series 
of predefined seed, target, exclusion, and termination masks provided by the AutoPtx 
plugin (http://fsl.fmrib.ox.ac.uk/fsl/fslwiki/AutoPtx). The FSL module “ProbtrackX” was 
then applied to conduct probabilistic fiber tracking using these supplied tract-specific 
masks (i.e., seed, target, etc.) in the native diffusion image space of each subject14. The 
connectivity distributions resulting from fiber tractography were normalized to a scale 
from 0 to 1 using the total number of successful seed-to-target attempts, and were 
subsequently thresholded to remove low-probability voxels likely related to noise. For 
each tract, the number of samples used for probabilistic tracking, and the probability 
thresholds applied to the resulting distributions (ILF: 0.005, SLF: 0.001, IFO: 0.01, UNC: 
0.01, CB: 0.01, PHC: 0.02), were selected based on previously established values13. 
After thresholding the path distributions, weighted average DTI scalar measures were 
computed within each tract using the normalized path distributions as the weights. The 
methods used were based on those described by Muetzel et al16.
Image Quality Assurance 
Raw DTI image quality was assessed with both a visual inspection and with automated 
software16. For the visual inspection, maps of the sum of squares error (SSE) of the tensor 
fit were inspected for structured signal that is consistent with motion and other artifacts 
in the diffusion-weighted images (e.g., attenuated slices in diffusion-weighted images). 
Furthermore, probabilistic tractography data were inspected visually to ensure images 
were properly aligned to the template and paths were reconstructed accurately16. Data-
sets determined to be of poor quality were excluded (n = 7, ~8%).
In addition to this visual inspection, slice-wise signal intensity was examined for 
attenuation resulting from motion, cardiac pulsation and other artifacts using the auto-
mated DTIprep quality control tool (http://www.nitrc.org/projects/dtiprep/). Four (~5%) 
additional datasets were excluded based on the DTIprep results, leaving 77 DTI datasets 
(patients = 23, controls = 54) for analysis.
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Summary
Over the last decade, knowledge has emerged that children growing up after neonatal 
critical illness, irrespective of underlying diagnosis, are at risk of memory impairment 
and school problems. Strikingly, these problems are manifest even when intelligence is 
normal. In this review, we propose a common neurodevelopmental pathway following 
neonatal critical illness by demonstrating that the survivors of preterm birth, congenital 
heart disease, and severe respiratory failure, share an increased risk of long-term mem-
ory deficits and associated hippocampal alterations. Rather than being a consequence 
of underlying diagnosis, we suggest that this shared vulnerability is most likely related 
to common conditions associated with neonatal critical illness. These include hypoxia, 
neuroinflammation, stress, exposure to anaesthetics, or a complex interplay of these 
factors at different postconceptional ages. Future work should be aimed at improving 
early identification of patients at risk and evaluating intervention modalities, such as 
cognitive or exercise training.
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inTroducTion
Over the last decade, the number of children admitted to neonatal intensive care units 
has increased significantly worldwide.1,2 Due to medical improvements, the majority of 
these children now survive to discharge1,2, necessitating our focus to broaden from pre-
vention of mortality to long-term outcome. Fortunately, a significant number of children 
survive without overt brain abnormalities, such as cerebral haemorrhage or periven-
tricular leukomalacia.3-5 However, knowledge has emerged that children growing up 
after neonatal critical illness, irrespective of gestational age or underlying diagnosis, 
are at risk of neuropsychological impairments and school problems. Strikingly, these 
problems exist even when intelligence is within the average range.6-9 
Memory deficits are frequently reported following neonatal critical illness. The hip-
pocampus is the critical hub for memory formation.10 Interestingly, the hippocampus is 
particularly vulnerable to conditions associated with critical illness, such as hypoxia and 
neuroinflammation.11,12 We therefore speculate that a common neurodevelopmental 
pathway exists across critically ill neonates, where early hippocampal alterations result 
in long-term memory deficits. This ‘growing into deficit’ phenomenon13 – where subtle 
brain injuries acquired in early life only become evident later in life when those brain 
regions are required for higher cognitive functioning – can potentially be delineated 
following three major causes of neonatal critical illness: preterm birth, congenital heart 
disease (CHD), and severe respiratory failure (necessitating neonatal extracorporeal 
membrane oxygenation (ECMO) treatment).
In this review, we describe the abnormalities in long-term memory functioning, and 
summarize findings on memory and its neurobiological substrates, specifically those 
pertaining to the hippocampus, in children following preterm birth, CHD and neonatal 
ECMO treatment. Next, we evaluate why the hippocampus may be particularly vulner-
able in these children. Taken together, we propose a common neurodevelopmental 
pathway following neonatal critical illness. We conclude with the potential clinical 
implications and future directions of research.
Search STraTegy and SelecTion criTeria
PubMed was searched for articles published between January 1, 2000 and June, 2017 with 
the search terms in the title or abstract: (“brain imaging” OR “brain” OR “neuroimaging” OR 
“magnetic resonance imaging” OR MR* OR hippocamp* OR “limbic”) AND (“memory” OR 
“learning”) AND ((“preterm” OR “preterm birth” OR “premature birth”) OR (“congenital heart 
disease” OR complex heart anomal* OR “complex heart disease”) OR (“neonatal respiratory 
failure” OR “acute respiratory failure” OR “neonatal extracorporeal membrane oxygenation” 
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OR “neonatal ECMO”)). This search resulted in 348 references. We reduced the number to 
258 by restricting findings to human studies. Studies that did not assess the hippocampus 
specifically and/or did not assess memory, and studies including patients with severe 
neurologic abnormalities or genetic syndromes known to affect neurodevelopmental 
outcome were excluded. Searches were supplemented by hand searching of reference 
lists of published articles. The final reference list was generated on the basis of relevance 
to the scope of this review. In total, 27 studies were included.
memory and The hiPPocamPuS folloWing neonaTal criTical illneSS 
Despite generally average intelligence, the incidence of academic difficulties is strik-
ingly high following preterm birth, CHD and severe respiratory failure.6,7,9,14-16 This is 
highly suggestive of an alternative explanation related to specific neuropsychological 
deficit rather than general intellectual functioning (Table 1). Memory deficits can greatly 
affect daily activities and academic achievement, and have been reported in 19-41% of 
children born preterm7,19, in 28-64% of children with CHD20, and in 50-70% of children 
with severe respiratory failure, treated with or without neonatal ECMO18, compared to 
16% in the general population.17 These deficits become particularly evident as children 
get older, suggesting that they ‘grow into their deficits’.
Memory encoding, consolidation and retrieval are highly dependent on the hippocam-
pus and its connections, which are embedded within the brain’s limbic system.10 The hip-
pocampus is thought to be highly involved in the ability to store and retrieve information 
about an event as well as about the context in which the event took place, and in the de-
Table 1. Neuropsychological impairments following neonatal critical illness
IQ Attention Verbal 
memory
Visuospatial 
memory
Executive 
functioning
Visuospatial 
processing
Academic 
difficulties
Preterm x x x x x x x
CHD x x ? x x x
Neonatal ECMO1 x x x * x
CDH x x x x
Frequently reported neuropsychological impairments following neonatal critical illness, an impairment 
regarded to be significantly lower than healthy controls. In case of intelligence (normal mean IQ(SD) = 
100(15), reported mean IQ score of ≤ 85 (i.e. ≤ -1 SD) is regarded impaired.
1Neonatal ECMO treatment applied in case of severe respiratory failure, such as meconium aspiration syn-
drome or congenital diaphragmatic hernia.
*Only working-memory impairments.
? Indicates equally impaired and normal outcomes reported in studies.
Abbreviations: IQ, intelligence quotient; CHD, congenital heart disease; ECMO, extracorporeal membrane 
oxygenation; CDH, congenital diaphragmatic hernia.
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layed recall of verbal and visuospatial information.10,21 In utero, changes in hippocampal 
morphology occur and the hippocampus is thought to resemble adult shape by 25 weeks 
of gestation. A crucial period of hippocampal development is in the first two years of life 
when it undergoes a growth spurt. Hippocampal volume is thought to peak between 9 
years and 11 years of age, after which it resembles adult size (Figure 1).22 Various stud-
ies have examined memory and the underlying neurobiology of memory impairments 
following neonatal critical illness and have shown that, just as in healthy children and 
adults10,11, the hippocampus is essential for memory functioning in survivors of neonatal 
critical illness (please refer to the online Appendix for an overview of these studies).
Preterm birth
Preterm birth is defined as birth before 36 completed weeks of gestation and accounts 
for 10% of all births in high-income countries.2 Preterm birth is increasing in Europe and 
is the major cause of death in neonates.2 However, survival of preterm infants is also 
increasing2, and hence long-term outcomes are becoming increasingly important.
In school-age and adolescent survivors of preterm birth, impairments in speed 
of information processing, attention, visuospatial processing, language, executive 
functioning, and memory have been reported.7 Short-term and long-term verbal and 
visuospatial memory deficits have been identified, even in young adults who were 
born preterm.7,21,23-25 The neurobiological substrates of memory have been assessed in 
various developmental stages following preterm birth (online appendix). In infancy, 
left and right hippocampal volumes as well as shape were altered in preterm neonates 
compared to term-born controls at term-equivalent age.26,27 Although hippocampal 
shape in infants was not related to memory function, bilateral hippocampal volume 
was positively associated with verbal memory at seven years of age.23 Preterm children 
have consistently altered hippocampal shape and smaller left and right hippocampal 
volumes than do term-born controls between 7 years and 11 years of age.19,23,28-30 Stud-
ies that have also assessed the association between the hippocampus and memory are 
scarce, but have shown no association between hippocampal alterations and memory 
impairments in school-age survivors.19,29 This absence of association might be due to 
figure 1. Schematic overview of the major phases of hippocampal development 
Hippocampal morphological and positional changes occur in utero. A growth spurt occurs between the 
perinatal months and two years of age. Peak volume reached between 9-11 years, resembling adult size.
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the type of memory tests used or the involvement of other brain regions in the assessed 
memory functions, or both. In adolescents and young adults who were born preterm, 
alterations have been found in the hippocampus and surrounding brain regions, such 
as the hippocampal fornix and parahippocampal gyrus, have been found. In these stud-
ies, consistent associations were demonstrated between the hippocampal alterations, 
as well as alterations to the areas surrounding the hippocampus, that were associated 
with impaired memory.24,25,31-33 One study, however, found hippocampal alterations but 
normal memory performance.28 These findings might reflect brain plasticity or compen-
satory mechanisms, causing other brain regions to take over the function of the affected 
regions in the preterm brain.21 
One study found similar hippocampal volumes in school-age children born preterm 
and term-born controls, despite poor memory outcome in preterm children.34 These 
memory impairments may be explained by alterations in other unassessed brain areas 
responsible for memory functioning. However, methodological issues, such as small 
sample size, assessment of only one type of memory, and use of two different MRI scan-
ners within the same cohort, might also explain these contradictory results. The severity 
of prematurity could also affect findings as previous studies have shown positive as-
sociations between gestational age and hippocampal volume.35-37
congenital heart disease
Children with CHD who have been critically ill in the neonatal period and have had 
major cardiac surgery are at risk of significant neurodevelopmental problems later in 
life. The Boston Circulatory Trial assessed children with dextro-transposition of the great 
arteries (d-TGA) who underwent the arterial switch operation and found below average 
academic achievement, visuospatial skills, working-memory and attention at school-age 
and during adolescence. These impairments were found despite normal intelligence.8,38 
A meta-analysis in 5-8 year-olds who had heart surgery for CHD found similar impair-
ments in executive functioning, attention and visuomotor integration. Furthermore, 
generally lower verbal memory was identified in survivors compared to healthy controls, 
whereas non-verbal memory was normal.16 In CHD children tested four years after heart 
surgery treated with tight glucose control, worse working-memory and immediate 
verbal memory were found compared to healthy controls.16 A study in children with 
d-TGA between the ages 8-16 years, reported specific deficits in both verbal and visual 
delayed memory.39 Similar deficits have been found in adolescent survivors of CHD of 
differing complexity as well, even persisting into young adulthood.20 A small number of 
studies have examined memory and its neurobiological correlates in survivors of CHD 
(online appendix). Smaller bilateral hippocampal volumes were demonstrated in 40% of 
school-age children who had d-TGA and cyanosis when compared to healthy controls. 
Hippocampal reductions were associated with worse verbal and visuospatial memory.39 
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Furthermore, 13-year-old children who had cardiopulmonary bypass surgery in infancy 
had smaller bilateral hippocampal volumes as well as volume loss in other parts of the 
limbic system’s grey matter than did healthy controls.40 
It is important to note that underlying cardiac anomaly and treatment may influence 
neurodevelopmental outcome. For instance, adolescents who underwent the Fontan 
and Norwood procedures scored below the population norm on general memory, 
whereas patients who underwent a different operation had normal outcomes.15 Al-
though assessed in a small sample size, cyanotic CHD patients had more pronounced 
hippocampal volume loss than acyanotic patients. Memory was not assessed.40
neonatal ecmo in case of severe respiratory failure
Since the first neonatal ECMO treatment applied in 1975, nearly 40,000 neonates 
were treated with ECMO worldwide.41 The annual number of neonatal ECMO runs has 
decreased over the years and treatment has shifted from respiratory to cardiac runs. 
However, the most frequent underlying diagnoses for neonatal ECMO remain meconium 
aspiration syndrome (MAS) and congenital diaphragmatic hernia (CDH). The survival rate 
following MAS is over 90%. CDH is a rare congenital anatomical malformation associated 
with significant mortality and morbidity due to pulmonary hypoplasia and pulmonary 
hypertension. In the most severe cases of CDH necessitating treatment with ECMO, 
mortality rates are 49%.41 Over the past decade, standardised treatment protocols for 
CDH patients have reduced mortality and the need for ECMO.42 
In school-age neonatal ECMO survivors, extensive neuropsychological assessment has 
shown mainly attention, verbal and visuospatial memory deficits.17 Similar deficits were found 
in adolescent survivors, while other domains remained relatively unaffected.9 Interestingly, 
memory deficits have also been found in children with CDH who were not treated with ECMO.37 
Studies have examined the neurobiological substrates of long-term neuropsychologi-
cal outcome following severe respiratory failure with neonatal ECMO treatment (online 
appendix). We found global white matter microstructure alterations and regional altera-
tions in the limbic system in school-age neonatal ECMO survivors compared to healthy 
controls.43 Specifically, hippocampal volume reductions were associated with worse 
delayed verbal memory in the neonatal ECMO survivors.17 White matter microstructure 
alterations in the parahippocampal region of the cingulum – a white matter tract con-
necting the medial temporal lobe with the parietal and occipital lobes – were associated 
with worse visuospatial and verbal memory.17 Similar structure-function relationships 
were demonstrated in CDH patients not treated with ECMO.17 In line with these findings, 
in school-age survivors of acute hypoxic respiratory failure, either treated with conven-
tional ventilator management or ECMO, smaller hippocampal volumes were identified 
when compared to healthy controls. These were associated with impaired memory for 
everyday events, and verbal and visuospatial memory deficits.37
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hiPPocamPal VulnerabiliTy and neonaTal criTical illneSS 
The above-described findings demonstrate that memory deficits are associated with 
hippocampal alterations following neonatal critical illness, irrespective of underlying 
diagnosis. These hippocampal alterations are likely a result of both the timing and type 
of insults critically ill neonates are exposed to. The brain, including the hippocampus 
and the rest of the limbic system, develops rapidly in the third trimester and throughout 
the neonatal period.44 During this period, critically ill infants are at risk of exposure to hy-
poxia, neuroinflammation, stress, and clinical procedures requiring general anaesthesia. 
The hippocampus has been found to have a selective vulnerability to these conditions 
associated with critical illness. The hippocampus consists of the cornu ammonis (CA) 
regions 1 (CA1) and 3 (CA3), the dentate gyrus (DG) and subiculum (Sub). Animal and in 
vitro models of the hippocampus have demonstrated that these subregions show dif-
ferential vulnerability11,45, which might explain why it is affected by such a wide range of 
conditions (Figure 2). In the next section, we will explore why the hippocampus shows 
a pronounced and selective vulnerability to hypoxia, neuroinflammation, stress, and 
anaesthetics.
hypoxia 
Cerebral hypoperfusion and/or hypoxemia resulting in hypoxia are common complica-
tions in preterm infants, or (near) term infants with CHD, or severe respiratory failure, 
either treated with or without neonatal ECMO. Studies using animal and in vitro models 
have demonstrated that the hippocampus shows more pronounced changes follow-
figure 2. Vulnerability of the hippocampus to conditions associated with neonatal critical illness
Differential vulnerability of the hippocampal cornu ammonis (CA) regions 1 (CA1) and 3 (CA3), the den-
tate gyrus (DG) and subiculum (Sub) to hypoxic-ischaemia, neuroinflammation, stress and anaesthetics is 
shown.
193
A common neurodevelopmental pathway
ing hypoxia-ischaemia than other brain structures (reviewed by Schmidt-Kastner).47 
Furthermore, differential vulnerability for hypoxia-ischaemia in the hippocampal sub-
regions has been suggested; CA1 seems more vulnerable to acute hypoxic-ischaemia 
than CA3 and DG, in which relative sparing has been found. However, prolonged periods 
of cerebral ischaemia have been shown to damage CA3 and DG as well.47 Differential 
vulnerability within the hippocampus is suggested to result from regional differences in 
antioxidant enzymes, inflammatory reaction and/or in the distribution of glutamatergic 
N-methyl-D-aspartate (NMDA) receptors.11 This variation in vulnerability might also lead 
to different types of memory impairments since differential functional organisation 
within the hippocampal formation has been suggested as well.44 However, this needs 
further study in humans.
In addition to the hippocampus, its surrounding white matter, and in particular the 
periventricular white matter, seems specifically susceptible to hypoxic-ischaemic insults. 
Using animal models, premyelinating oligodendrocytes (pre-OLs) in cerebral white mat-
ter have been identified as selectively targeted by oxidative stress. These cells account 
for approximately 90% of the total oligodendroglial population at 28 weeks of gestation 
and approximately 50% at term.48 Increased regional susceptibility of the periventricular 
white matter is suggested to be due to the distribution of these pre-OLs and relative un-
derdevelopment of distal arterial fields in these areas.48,49 Therefore, neonates exposed 
to hypoxic-ischaemic injuries, even at term, might be at increased risk of myelin and 
axonal disruptions resulting in white matter abnormalities, which have been shown to 
correlate with impaired neurodevelopmental outcome.50 
inflammation 
Critical illness is often accompanied by a marked proinflammatory response to under-
lying factors such as stress, infection or hypoxia-ischaemia.51 The hippocampus has 
been shown to be involved in the regulation of inflammation due to its high density 
of microglia. Microglia in the (immature) central nervous system respond rapidly to 
infection or injury. In case of deleterious conditions, microglia in the hippocampus show 
a dynamic process of neuroprotective and pro-inflammatory responses, producing pro-
inflammatory and neurotoxic factors. Using rodent models, the latter mechanism has 
been shown to negatively affect hippocampal neurogenesis and cellular composition 
in the developing brain.52 Clinical studies in neonates have shown an elevated risk of 
brain injury following inflammation51, but its specific effects on the hippocampus need 
further research. Behavioural effects of inflammatory damage to the hippocampus have 
been studied, though mostly using experimental models, demonstrating an association 
between pro-inflammatory cytokines in the hippocampus and memory impairments.52 
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elevated glucocorticoid levels
Endogenous glucocorticoids
Environmental stressors from the neonatal ICU have been found to elicit physiological 
stress responses in critically ill infants and affect brain structure and function.53 In re-
sponse to stress, the brain’s hypothalamus-pituitary-adrenal (HPA) axis is activated, caus-
ing the release of cortisol into the blood by the adrenal gland. The hippocampus is a key 
regulator in this system by reducing HPA axis activity following stress exposure. Cortisol 
binds to mineralocorticoid receptors (MRs) and glucocorticoid receptors (GRs), which 
are highly expressed in the hippocampus and excess cortisol results in hippocampal 
dendritic atrophy and inhibited neurogenesis.54 Animal models have shown pronounced 
effects of acute stress on CA1. However, in reaction to chronic and/or multimodal stress 
(e.g. hours-long light, loud noise), which might be more similar to experiences in the 
NICU, the CA3 region showed synapse reductions, leading to poorer object recognition 
memory.55 One study54 showed that stressors in the neonatal ICU environment were 
associated with altered brain microstructure and functional connectivity within the 
temporal lobes, but not in the frontal lobe of the brain, in preterm infants (born <30 
weeks). Although memory functioning was not assessed, increased stress exposure 
resulted in more neurobehavioral problems at term-equivalent age.56 Stress may also be 
experienced by the mother during pregnancy in case of prenatally identified congenital 
anomalies and/or in the NICU period. Increased pre- and postnatal maternal stress has 
shown to affect infants’ hippocampal growth in the first six months of life.54 Maternal 
stress exposure is thought to have ‘programming’ effects on the foetal HPA axis activity. 
Increased maternal cortisol secretion may partly reach the foetus, increasing foetal HPA 
activity by reducing the number of MRs and GRs in the hippocampus.54 Although more 
research in humans is needed, maternal stress may contribute to an increased risk of 
long-term memory impairments in critically ill neonates.54
Exogenous glucocorticoids
Studies in preterm born children have shown that postnatal treatment with dexametha-
sone – a corticosteroid used especially in preterm children to accelerate lung develop-
ment – negatively affected hippocampal morhpology.23,26 However, dexamethasone 
might not affect children treated with neonatal ECMO and CHD as much, as corticoste-
roids are generally used less frequently in these patients.43 
anaesthetics 
Possible negative effects on the developing brain of prolonged, general anaesthesia has 
recently resulted in an FDA warning regarding its use in children younger than three 
years.57 Although clinical studies in humans are scarce and findings are mostly based on 
experimental studies, hippocampal development may be affected by the use of com-
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monly used anaesthetic agents, resulting in long-term memory deficits. Commonly used 
anaesthetics bind either to γ-aminobutyric acid (GABA) or NMDA receptors. The GABA 
and NDMA receptor systems are crucial for neuronal connection and communication 
in the developing brain, and if unavailable lead to neuroapoptosis.57 Various types of 
anaesthesia, such as midazolam, propofol and ketamine, have been suggested to disrupt 
memory formation through its effects on the hippocampus.58 Memory formation and 
recall are dependent on a system of persistent strengthening of synapses following high 
levels of stimulation, called Long-Term Potentiation (LTP). LTP, which mainly happens in 
the hippocampus, relies heavily on NMDA. In a rat model, midazolam was found to af-
fect pyramidal neurons in the CA1 region and memory by suppression of LTP.59 However, 
translating findings from animal models to the developing human brain is restricted60 and 
research in humans and/or specific disease models is crucial. In very preterm neonates 
(24-32 weeks of gestation), high exposure to midazolam was negatively associated with 
hippocampal growth from birth to term-equivalent age, adjusted for clinical confound-
ers including gestational age, days of mechanical ventilation, and number of surgeries.61 
However, memory outcome was not assessed. In school-age children who underwent 
general anaesthesia before one years of age, significantly worse memory recall was found 
compared to untreated controls, whereas IQ remained unaffected.57 The association be-
tween memory deficits and altered hippocampal morphology was not assessed.
a common neurodeVeloPmenTal PaThWay folloWing neonaTal 
criTical illneSS 
In this Review we present evidence to suggest a shared vulnerability of the hippocam-
pus that is associated with long-term memory impairments across critically ill neonates. 
On the basis of this evidence, we speculate that a final common neurodevelopmental 
pathway exists following neonatal critical illness (Figure 3). It is important to note that 
the patient groups described in this review have varying brain development trajectories 
due to variations in illness onset (e.g. congenital anomaly developing in utero versus 
postnatal sepsis necessitating neonatal ECMO), gender, and gestational age. These 
factors are likely to interact with the exposure to harmful conditions associated with 
neonatal critical illness, and may influence how and when the hippocampus is affected. 
The exact pathophysiological mechanisms of the hippocampal alterations in each of 
these patient groups remains unknown and needs further research.
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clinical imPlicaTionS and fuTure direcTionS 
In the previous sections, the shared memory impairments and the role of the hippo-
campus across critically ill infants was highlighted. In this section, we describe how the 
findings outlined in this review guide the direction of future research and contribute 
to the realisation of early identification of patients at risk as well as the development of 
targeted intervention or treatment modalities.
early risk prediction
Currently, the identification of patients at risk of school problems relies solely on neuro-
psychological assessment. However, evaluating higher-order cognitive functions such 
as memory cannot be reliably conducted until school-age.7 The identification of patients 
at risk of academic problems is as such often too late. The neuropsychological deficits, 
that may have remained unidentified or unspecified, may by then have already led to 
school problems. Neuropsychological assessment should therefore be primarily used as 
a diagnostic tool, rather than as a prediction tool. Patients at risk should be identified 
before academic difficulties are present. In order to do so, early predictors of long-term 
memory impairments, favourably measurable in infancy, are needed.
Firstly, hippocampal volume alterations, if detected in infancy, could potentially serve 
as such a predictor of impaired long-term memory. MRI is a non-invasive neuroimaging 
technique and therefore a useful tool to assess the hippocampus in infants. Findings 
figure 3. A common neurdevelopmental pathway following neonatal critical illness
Neonatal critical illness survivors share an increased risk of hippocampal alterations due to vulnerability to 
common conditions associated with neonatal critical illness, leading to long-term memory deficits.
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in preterm infants have shown that MRI can be reliably performed without sedation 
and that infant hippocampal volumes, measured at term-equivalent age, correlate with 
memory outcomes both at two years and seven years of age.23,27 Future studies are 
needed to find cut-off points to separate normal from abnormal hippocampal volume in 
infancy using a healthy control group. Furthermore, differences in the timing and type 
of hippocampal injury are likely to exist across critically ill infants because of differences 
in brain development associated with disease aetiologies. For instance, brain alterations 
have been found as early as in the third trimester in CHD patients5 and the immature 
preterm brain may respond differently than the term brain to the strenuous conditions 
associated with neonatal critical illness.49 Longitudinal studies are therefore imperative 
to accurately delineate the longitudinal hippocampal growth trajectories across these 
patient groups. Also, given the rapid hippocampal growth during the first two years of 
life22, longitudinal studies will help to determine the best time to assess hippocampal 
morphology as an early predictor of memory.
Up to this point, the hippocampus has been primarily quantified through volumetry 
using structural MRI. This method has been shown to be very robust and useful to ac-
curately parcellate hippocampal volume. In future studies, it would be interesting to 
focus on details in the hippocampal parcellation by obtaining finer resolution images 
and multi-contrast imaging, or using alternative modalities such as diffusion imaging. 
This may contribute to a better understanding of the differential vulnerability of the hip-
pocampal subregions, and, if combined with neuropsychological assessment, its sug-
gested differential involvement in various memory processes.11,45 However, importantly, 
MRI does not provide information on the exact anatomical or molecular mechanisms 
underlying the hippocampal alterations. The specific contribution of the risk factors 
outlined in this review to the hippocampal alterations and long-term memory deficits 
therefore remains speculative.
Secondly, hypoxia is consistently shown to affect hippocampal morphology. The 
severity of cerebral hypoperfusion sustained in the perinatal period may therefore be 
another risk factor of long-term memory problems following neonatal critical illness. 
Adequate ways to monitor cerebral metabolism, haemodynamics and autoregulation in 
the NICU are urgently needed since current methods, such as transcranial Doppler ultra-
sonography or near-infrared spectroscopy, do not have enough resolution for targeting 
the brain region of interest in this context.
Treatment opportunities
Although the hippocampus is a highly vulnerable brain structure, it has also been 
shown to exhibit more plasticity and capability of long-term neurogenesis than other 
brain structures.11 This makes it a promising target for intervention strategies to improve 
long-term memory following neonatal critical illness.
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Neuroprotection 
Another group of critically ill neonates at high risk of hypoxic-ischaemic injuries are 
survivors of perinatal asphyxia. In contrast to the patient groups described in this review, 
in a significant number of neonates with perinatal asphyxia overt, chronic neurologi-
cal abnormalities are present as well as long-term severe morbidities such as cerebral 
palsy and intellectual disability.62 Whole body therapeutic hypothermia is the standard 
of care in full-term neonates with perinatal asphyxia and has shown to improve neu-
rologic outcomes.63 Using animal and in vitro models, mild to moderate therapeutic 
hypothermia has been shown to reduce hippocampal cell death following an hypoxic 
or ischaemic insult.64 However, while patients with perinatal asphyxia experience an 
acute phase of hypoxia65, more prolonged exposure to hypoxia may exist in the patient 
groups described in this review. Furthermore, hypothermia likely does not protect the 
hippocampus against the other types of harmful conditions associated with critical ill-
ness. Future randomized controlled trials are needed to assess if and to what extent 
therapeutic hypothermia affects the hippocampus and memory in these groups before 
it can be recommended as a routine neuroprotective strategy.
Stress prevention 
As demonstrated, stress may negatively affect the hippocampus and memory.54 Reduc-
ing stress exposure during NICU stay could therefore be beneficial for critically ill infants 
as well as relatively feasible in clinical practice. Indeed, decreasing light and sound in 
the NICU, as well as encouraging physical parent-infant contact during hospital stay, 
have been shown to positively affect development.66 Future studies assessing whether 
such stress reduction measures specifically influence hippocampal development and 
memory improvements in neonatal critical illness survivors are needed.
Cognitive interventions
Studies evaluating ‘brain training’ or computerized cognitive training programs have 
increased over the last decade. However, its effectiveness remains controversial. Cog-
nitive training programs are based on the idea that repetitive mental exercise of one 
cognitive task will result in improved functioning that may generalize to other tasks with 
a similar underlying system. A widely evaluated cognitive training for both children and 
adults is Cogmed working-memory training.67 Studies have fairly consistently shown 
improvements in the trained verbal and visuospatial working-memory skills, but less 
consistently in untrained functions such as delayed memory recall.68 Working-memory, 
the main targeted function of Cogmed, relies primarily on frontal-parietal networks.67 
It is unclear how, or if, Cogmed influences the plastic nature of the hippocampus. 
Neuroimaging studies assessing the exact effects of Cogmed on hippocampal function 
and different types of memory are needed in survivors of neonatal critical illness. Cur-
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rently, randomized controlled trials are being performed with school-age survivors of 
neonatal ECMO (Trial Registration Number: NTR4571) and children and adolescents with 
CHD (Clinical Trial Numbers: NCT03023644 and NCT02759263). Other types of cognitive 
training programs used specifically for memory rehabilitation may be effective but need 
further research in neonatal critical illness survivors.69 
An important part of effectively using cognitive intervention is the identification of 
neonatal critical illness survivors that have significant memory deficits, and are thus in 
need of treatment. While early identification of these patients is ideal, in today’s practice, 
identifying children with such deficits remains reliant on neuropsychological assess-
ment at school-age. It is therefore crucial to conduct neuropsychological assessment in 
which, in addition to intelligence, specific neuropsychological outcomes are the primary 
focus following neonatal critical illness.
Exercise interventions
Exercise might enhance memory and learning by targeting the hippocampus. Greater 
aerobic fitness has been associated with hippocampal volume as well as improvements 
in memory in children.70 Whether improvements persist in the long-term remains largely 
unknown and needs further study in survivors of neonatal critical illness.
concluSion
With this review, we propose a common neurodevelopmental pathway following neo-
natal critical illness by demonstrating that survivors of preterm birth, CHD, and severe 
respiratory failure share an increased risk of long-term memory deficits and related 
hippocampal alterations. Rather than being a consequence of underlying diagnosis, we 
suggest the shared vulnerability to be related to common complications or conditions as-
sociated with neonatal critical illness. These include hypoxia, neuroinflammation, stress, 
anaesthetics, or a complex interplay of these factors at different postconceptional ages. 
Our findings underline the need of broadening our focus from prevention of mortality 
to long-term outcome of critically ill infants. Follow-up should incorporate standardized 
assessment of specific neuropsychological functions, such as memory, at school-age. 
Early identification of patients at risk may be feasible using infant hippocampal volumes 
assessed with non-invasive structural MRI. Future prospective studies on memory reha-
bilitation with the use of cognitive or exercise training are needed in neonatal critical 
illness survivors. Lastly, increased awareness of the vulnerability of the hippocampus 
and memory deficits following neonatal critical illness is crucial to prepare survivors for 
future academic problems and participation in society.
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Summary
Inadequate pain and/or stress management in preterm and term born infants has 
been associated with increased morbidity and even mortality. However, exposure to 
analgosedatives during early infancy may also be one of the risk factors for subsequent 
neurodevelopmental impairment, at least in animal studies. Since infants admitted to 
neonatal or pediatric intensive care units may receive very high amounts of these drugs 
for prolonged periods of time and the majority of these infants nowadays survive to dis-
charge, this is of major concern. A balanced approach that incorporates the assessment 
and quantification of both wanted effects as well as unwanted side effects is therefore 
needed. In this paper, the optimum dose determination of commonly used analgoseda-
tive drugs as well as their potential long-term effects on the developing human brain 
and neuropsychological functioning are reviewed.
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inTroducTion
Over the last decades, phenomena such as pain, stress, and anxiety/agitation have 
intrigued a variety of clinicians and scientists. The paradigm that immaturity protects 
neonates from pain and its negative effects has been questioned years ago by Anand et 
al. who demonstrated that untreated perioperative pain was associated with increased 
morbidity and even mortality.1 These negative effects have been described in greater 
detail in recent reviews, showing that insufficient pain management in (pre)term infants 
during painful interventions alters physiological responses, pain thresholds and pain 
or stress-related behavior.1-3 However, evidence showing a link between exposure to 
analgosedatives (analgesics and sedatives) in early infancy and subsequent neurode-
velopmental impairment is accumulating as well.4-6 As the majority of infants admitted 
to neonatal or pediatric intensive care units now survive to discharge7,8, this is of major 
concern. Although there may be long-term effects of anesthetic agents on the brain as 
well, this has been extensively described and reviewed in the past few years2,9-13 due to a 
recent FDA warning about its use in children younger than three years14, and is therefore 
beyond the scope of the current review.2,9-13
The balance between adequate pain management and the risk of long-term neuro-
developmental impairments reads like a catch-22, but at least indicates that a balanced 
approach that incorporates assessing and quantifying both wanted effects as well as 
unwanted side effects is needed. To avoid both pain and stress with all negative conse-
quences as well as over-exposure (too much or too long) to analgosedatives, health care 
providers should select the most appropriate intervention (either pharmacological or 
non-pharmacological) based on the best available evidence for a given indication, with 
adjustments to reach the most effective and shortest exposure.15 Over the last five years, 
a number of guidelines have been published and trials have been performed to find the 
optimum dosage for analgosedative drugs.16-20 However, we need to be aware that the 
level of evidence is unfortunately still limited. Data on maturational pharmacokinetics 
(PK) are a crucial, yet first, step of a drug development program, especially in neonates 
and young infants. Therapeutic dose-finding studies, even for commonly used drugs, 
are needed to come up with a valid study design in neonates and infants before com-
parative phase 3 efficacy and safety trials can be conducted.21 
In pain management of infants admitted to the neonatal or pediatric intensive care 
unit, the ultimate goal is to achieve adequate pain management with minimal short 
and long-term side effects. In reaching this goal, it is imperative to also increase our 
understanding of how exposure to sedatives and analgesia may affect the developing 
brain. Based on the existing literature combined with our own research, we will sum-
marize the present knowledge and level of evidence of a number of commonly used 
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analgosedative drugs which serve as model drugs and their potential long-term effects 
on the developing brain and neuropsychological functioning in humans.
doSe deTerminaTion of common analgoSedaTiVe drugS 
analgesics 
Morphine
Morphine is the most commonly used intravenous opioid to provide potent analgesia 
in neonates, infants and children. However, age-related differences in both pharmacoki-
netic (PK) and pharmacodynamic (PD) responses during development pose challenges 
for selection of an appropriate dose. As sensitivity of the central nervous system to mor-
phine is increased in neonates, a lower initial dose of morphine is recommended which 
is then adjusted based on individual responses. In addition, the elimination half-life of 
morphine is more than twice as long as that observed in adults (6-12 hours in neonates 
versus 3-4 hours in adults22), due to immaturity of the neonatal hepatic drug metaboliz-
ing enzyme system. Morphine clearance increases in accordance with the maturation of 
the glomerular filtration rate and by 1 year of age, the ratio of plasma to cerebral spinal 
fluid concentration is comparable to that of adults. A number of studies have described 
optimal dosage of morphine. Four studies only included neonates23-26 and four studies 
consisted of data solely based on children27-30 (ranging from 10-40 µg/kg). The use of 
morphine is, especially in the preterm, still a matter of debate. In the cohort of Simons et 
al., preterm neonates in need of mechanical ventilation and with a median gestational 
age of 29 weeks, received either morphine 10 µg/kg per hour or placebo, and additional 
morphine in case of pain or distress.31 In the NEOPAIN study of Anand et al., ventilated 
preterm born children received placebo or morphine as well, but in different dosages. 
The doses of morphine used in this study were based on gestational age; children born 
at 23-26 weeks of gestation received 10 µg/kg per hour; 27-29 weeks received 20 µg/kg 
per hour; and 30-32 weeks received 30 µg/kg per hour.32 From these two randomized 
controlled trials it was concluded that the routine use of intravenous morphine is not 
beneficial in the short term in ventilated preterm newborns.31,32
Fentanyl
Fentanyl is commonly used due to its high lipid solubility and potency. Its half-life time 
is short compared to morphine (ranging between 188-570 minutes in infants and neo-
nates versus 219 minutes in adults33), but longer than its derivatives sufentanil, alfentanil 
or remifentanil.33 In the search for optimal dosing, using population pharmacokinetic 
(pop-PK) approaches, large variations were observed in the dose of fentanyl used across 
studies (ranging between 1-5 µg/kg). In four studies, neonates were included (range 
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1-71 days) with weight ranging between 1.4 kg and 4.0 kg.34-37 Two studies included 
only infants and children (range 1 month-4.5 years) with weight ranging between 3.7 
kg and 17.3 kg.38,39 Only one study included neonates, infants, children and adolescents, 
although the total number of included subjects (n=17) was limited.36 Intravenous bolus 
administration was used in most studies (n=5) followed by continuous infusion (n=2), 
whereas one study only applied continuous infusion.34 Only limited PK data are available 
in preterm neonates33, which warrants future research.
Acetaminophen 
Acetaminophen (paracetamol) is the most commonly prescribed analgesic to treat mild 
to moderate pain to be administered by rectal, oral or intravenous route. In an attempt 
to avoid or reduce opioid exposure, intravenous acetaminophen is increasingly used 
in preterm and term-born neonates.15 Pooled data with subsequent external validation 
of intravenous acetaminophen PK in neonates are available.40,41 The same holds true 
for the maturation of the different routes (glucuronidation, sulfation and oxidation) 
involved in acetaminophen metabolism.42 Flint et al.43 recently reported a gestational-
age-dependent increase in glucuronidation without evidence for saturation of a specific 
pathway as there was a proportional increase in exposure of acetaminophen and its 
metabolites in extreme preterm neonates between 24 and 32 gestational age. Despite 
the availability of these PK data, intravenous acetaminophen is still used off label for 
specific subpopulations (limited from term neonates onwards in Europe, and still off 
label in children under the age of 2 years in the United States).
As reported by Laughon et al.44, this is because efficacy could not be documented in 
the registration studies perhaps because we miss ‘common’ models similar to the third 
molar surgery model, to assess the analgesic effect of non-steroidal anti-inflammatory 
drugs, including acetaminophen, in adults. The relevance of the study model is also 
reflected in the fact that the available observations on acetaminophen analgesia during 
procedures (heel prick, retinopathy of prematurity screening) suggest that acetamino-
phen is a very poor procedural analgesic anyhow.45 In contrast, there is a proven and clini-
cally relevant (-66%) morphine sparing effect of intravenous acetaminophen after major 
neonatal non-cardiac surgery.46 The morphine sparing effect has also been observed in 
a retrospective analysis on morphine consumption in very low gestational age infants 
(<32 weeks) before and after introduction of intravenous acetaminophen.47 Intravenous 
acetaminophen is also effective for moderate pain relief following traumatic delivery or 
medical conditions, with an effect compartment concentration similar to children and 
adults.48 
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Sedatives
Propofol 
Propofol is used in many clinical settings in both adult and pediatric populations. How-
ever, given the increased risk of metabolic derangements and organ system failures, 
known as propofol infusion syndrome, propofol should preferably only be used for 
short-duration sedation.49 Gestational and postnatal age both contribute to propofol 
clearance, with very fast maturation of clearance in early infancy. This implicates that 
neonates in the first week of postnatal life are at an increased risk for accumulation 
during either intermittent bolus or continuous administration of propofol, irrespective 
of the age or weight at birth.50 This PK knowledge was subsequently integrated in a 
propofol dose-finding study (effective dose for 50% of patients, ED50) through 8 patient 
strata (postmenstrual and postnatal age) to attain optimal effects for endotracheal 
intubation in neonates for the INSURE (intubation, surfactant administration, extubation) 
indication.51,52 It turned out that the ED50 dose for preterm neonates varied between 0.7 
and 1.4 mg/kg. This is significantly lower than initially suggested in literature.53,54 Even 
with these lower doses, clinical recovery was accompanied by permissive hypotension 
(no clinical shock and no treatment).51
Midazolam and clonidine 
A recent Cochrane analysis found no arguments for the use of midazolam as drug of 
choice for sedation in newborns compared with other medications because it did not 
seem to make the participants more sedated, nor did it reduce anxiety or pain, or made it 
the procedure easier to perform.55 However, the evidence was rated to be of low-quality 
as many trials did not explain how participants were randomized to either midazolam or 
a different treatment.55 In a systematic review, Vet et al.56 identified 25 studies evaluating 
the level of sedation in pediatric intensive care unit (PICU) patients receiving continuous 
sedation, the most frequently used drug being midazolam. Of these studies, 23 used 
sedation level as the secondary outcome, and concluded that the level of sedation in 
critically ill children is often suboptimal. In particular, over sedation was found to be 
more common than under sedation, which has been associated with adverse long-term 
outcomes.56 
As an alternative for midazolam, many institutions nowadays prefer clonidine. Three 
randomized controlled trials assessing the use of clonidine in the PICU have recently 
been published. The first compared the opioid and sedative sparing effect of placebo 
versus clonidine (fixed at 1 mcg/kg/h; median duration: 168 hours) in ventilated medical 
and surgical patients.57 The trial indicated decreased sedative and analgesic require-
ments in neonates, although this was not found in older children of up to two years 
of age. In the clonidine group, a mild and well-tolerated decrease in systolic and mean 
blood pressure was observed compared to the placebo group, while heart rate was 
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similar between groups.57 In a pilot multicenter trial, the opioid and benzodiazepine 
sparing effects of oral clonidine (5mcg/kg every 6 hours) compared to placebo were 
analyzed. The incidence of significant hypotension and bradycardia was similar between 
groups.58 The SLEEPS study, compared the efficacy of clonidine (0.75-3 µg/kg/hour) and 
midazolam (50-200 µg/kg/hour) for sedation in ventilated children (1 month-15 years), 
concluding non-inferiority of clonidine to midazolam.59 Alternative ways of providing 
sedation such as the concept of daily sedation interruption have not been shown to 
be effective in critically ill children.60 In neonates, a recent Cochrane systematic review 
found only one trial that met the inclusion criteria to assess the efficacy and safety of 
clonidine used in term and preterm newborn infants for sedation during ventilation, and 
this evidence was therefore deemed insufficient.61 
Dexmedetomidine
An increasing number of publications deals with the use of dexmedetomidine mainly 
in the pediatric ICU population – in particular for sedation in hemodynamic unstable 
patients, such as post-cardiac surgery. A recent review of the use of dexmedetomidine in 
the pediatric population showed that evidence favoring dexmedetomidine in children 
is mainly extrapolated based on adult studies, small randomized controlled trials, and 
observational studies.62,63 Pediatric trials are therefore needed with a specific focus on 
newborns and infants, taking into account the major side-effects documented in the 
literature for dexmedetomidine being hypotension and bradycardia for which continu-
ous cardiac monitoring is needed. Apart from its sedative effect, dexmedetomidine is 
also used as an adjuvant analgesic drug as recently published in a systematic review by 
Schnabel et al.64. As many studies deal with optimal dosing and comparative effective-
ness of dexmedetomidine, evaluating long-term effects of dexmedetomidine on the 
developing brain are essential as well.
neurodeVeloPmenT folloWing common analgoSedaTiVe drugS 
Despite a generally average intelligence, the incidence of academic difficulties is ex-
tremely high following neonatal critical illness.65-70 This finding is highly suggestive of 
an alternative explanation related to specific neuropsychological deficits rather than 
general intellectual functioning. Although a complex interplay of deleterious factors 
associated with neonatal critical illness is likely to be the underlying cause of these long-
term neuropsychological deficits, an important first step is to evaluate different potential 
contributors independently. Recently, more studies have evaluated the negative effects 
of analgosedatives on the developing brain.71-73 This is of interest because the adjust-
ment of pain management in order to minimize short and long-term side effects may 
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improve neuropsychological outcome following neonatal critical illness. Therefore, the 
clinical endpoints of our review were defined as specific neuropsychological functions, 
such as memory, attention and executive functioning.
The ontogeny of the nervous system is based on a complex pattern of cell prolif-
eration, migration, differentiation and selective cell survival and includes apoptosis 
and synaptogenesis. Its development relates to a balance of ongoing excitatory and 
inhibitory signals.74 Furthermore, the brain matures in a nonlinear fashion from child-
hood into adulthood, indicating that the timing of microstructural changes differs per 
brain region.75,76 Consequently, the timing of injuries is likely to also have specific effects 
on the development of the brain.77 Exposure of nociceptive and non-nociceptive ner-
vous circuits to analgosedatives during this period may modulate receptor-signaling-
related brain development, as demonstrated by various animal experimental studies.74 
Alterations are in part drug and dose dependent, and there is an age-related window of 
vulnerability for apoptosis on the one hand or dendritic changes on the other hand.74 
Moreover, the balance between pain and exposure to analgosedatives may also play 
an important role.2 Specifically, the limbic system undergoes rapid development in the 
third trimester and neonatal period.78 Embedded within the brain’s limbic system, the 
hippocampus and its connections are essential for memory encoding, consolidation 
and retrieval.79 Given the high incidence of memory deficits following neonatal critical 
illness80, this gray matter structure may be particularly vulnerable in these children. In 
utero, hippocampal morphology and positional changes occur and the hippocampus 
is thought to resemble adult shape at 25 weeks of gestation. A critical period of hip-
pocampal development is from the third trimester throughout the first two years of life 
when it undergoes a growth spurt.81 The hippocampus and other limbic system regions 
may therefore be particularly vulnerable in critically ill preterm and term newborns.78,82
In the next section, studies describing the effects of commonly used sedatives and 
analgesics on the developing brain and neuropsychological functioning later in life fol-
lowing neonatal critical illness are summarized.
analgesics 
Worldwide, opioids such as morphine and fentanyl are regularly used in preterm and 
term born neonates during admission to the NICU.73 Neonatal opioid therapy to miti-
gate the effects of painful and stressful procedures may affect the developing brain as 
well.71,83,84 Interestingly, animal models have demonstrated some neuroprotective effects 
of morphine as a pre-treatment for pain and in case of certain levels of pain or stress.71,84 
However, concerns have been raised as a result of studies showing that opioids such as 
morphine may induce apoptosis in human microglial cells and neurons, and long-term 
changes in brain function and memory.71,85 
213
Analgosedatives and neurodevelopmental outcome
Morphine 
The long-term effects of morphine administration in preterm born children are com-
prehensively evaluated in follow-up studies among children from two well-defined 
cohorts.31,32 Follow up studies of the cohort of Simons et al. found that morphine ex-
posure was significantly, negatively correlated with only one IQ subtest at the age of 
5 years.86 At 8/9 years of age, however, this negative effect disappeared and morphine 
was even positively correlated with executive functioning.5 In line with these findings, 
a third study did not find major negative effects in children from this cohort who did 
receive morphine compared to healthy term born children without neonatal morphine 
exposure at10 years of age with respect to neuropsychological functioning or pain 
sensitivity.87 However, whether morphine itself or the underlying condition causes long-
term adverse events remains a topic of debate.88,89
With regards to brain morphology, van den Bosch et al. found strong, negative cor-
relations between neonatal opioid exposure and volumes of pain-related brain regions, 
total gray volume and cerebral white matter at school-age in children born preterm (26-
36 weeks). However, neuropsychological outcome of those born preterm did not differ 
from the norm population and was not associated with morphine exposure.87 In contrast, 
Ferguson et al. demonstrated differences at term-equivalent age and during childhood 
in head circumference between 14 morphine treated and 5 placebo treated children 
born at 23-32 weeks of gestation.90 At 5-7 years, overall IQ and academic achievement 
did not differ between these groups, however, short-term memory was significantly 
worse in children treated with morphine compared to the placebo-treated children.90 A 
recent neuroimaging study assessing the effects of morphine on brain development in 
preterm infants (24-32 weeks), demonstrated that increased neonatal morphine expo-
sure was associated with smaller cerebellar volume at term equivalent age, but not with 
cerebral volume.89 Furthermore, greater morphine exposure was associated with poorer 
cognitive and motor outcomes at 18 months.89 
A few follow-up studies have been conducted in term-born survivors of neonatal critical 
illness as well. In a neuroimaging study by van den Bosch et al. school-age ECMO survivors 
were less sensitive to the detection of cold but showed similar pain sensitivity and chronic 
pain compared to healthy controls. Importantly, no differences in brain activation during 
pain or in pain-related brain regions were observed.91 However, associations with morphine 
and midazolam exposure were not assessed in this study.91 Children treated with neonatal 
ECMO are often exposed to prolonged continuous opioids and sedatives in the absence of 
major pain.91 This may contribute to the long-term neuropsychological deficits and brain 
alterations observed in these patients at school-age and even in adolescence.66,67,92 In 
8-year-old ECMO survivors, specific attention problems were found irrespective of gener-
ally average intelligence.65 However, outcome at eight years was not associated with the 
time children had been exposed to opioids or other sedatives.65 
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Fentanyl 
Fentanyl is another commonly used analgesic in the NICU and may have effects on the 
developing brain as well. In preterm infants (23-30 weeks), higher cumulative fentanyl 
dose was associated with a higher incidence of cerebellar hemorrhage as well as lower 
cerebellar diameter.93 However, two studies that have analyzed the association between 
cumulative fentanyl dose and developmental outcome at 2 years of age found no rela-
tion between the two.93,94 This may be due to the fact that at 2 years of age, only general 
mental functioning can be assessed. The cerebellum has been shown to be involved in 
various higher-order cognitive functions, such as visuospatial processing, attention, and 
executive functioning.95 As these higher-order cognitive functioning cannot be reliably 
assessed before school-age68, long-term neuropsychological follow-up of these children 
is imperative to better understand the impact of morphine and fentanyl exposure on 
neurodevelopmental outcome in these children.
Acetaminophen 
The safety and potential long-term effects of acetaminophen warrant additional ex-
ploration. The shift from opioids to acetaminophen is largely driven by the perceived 
better safety profile.15 This is likely the case when we compare short term aspects like 
hemodynamics or respiratory depression following either opioid or acetaminophen 
administration.74 However, intriguingly, a recent Cochrane review concluded that ac-
etaminophen given after assisted vaginal birth may lead to an increased response to 
later painful exposures.96 Data on long term safety following acetaminophen exposure 
are based on epidemiological association type studies. These associations suggest a 
link between fetal exposure and subsequent risks for atopy, fertility or neurobehavioral 
problems and these links are further supported by animal experimental observations.45 
In particular when it comes to neurodevelopment, concerns have been raised about 
an increased risk of attention-deficit-hyperactivity disorder, autism spectrum symptoms 
and neurocognitive deficits following early exposure to acetaminophen, although most 
studies are based on prenatal exposure or animal studies (reviewed by De Fays et al.4 
and Avella-Garcia et al.97). A recent study on the long-term effects of acetaminophen in 
mice, showed that adverse effects on adult behavior and cognitive function occurred in 
both male and female mice exposed to paracetamol on postnatal days (PND) 3 and 10, 
but not when exposed on PND 19. These neurodevelopmental time points in mice cor-
respond to the beginning of the third trimester of pregnancy and the time around birth 
in humans. These findings suggest particular sensitivity of the brain in the preterm and 
neonatal brain.98 Future clinical studies are needed before conclusions can be drawn 
on the effect of neonatal exposure to acetaminophen on long-term neuropsychological 
outcome.
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Sedatives
Propofol and midazolam 
Exposure to propofol and midazolam in the neonatal period has been suggested to 
negatively affect the developing brain in animals and humans.6,99 Although studies in 
humans are scarce, findings from experimental studies suggest that, in particular, hip-
pocampal development and long-term memory are affected after exposure to these 
agents.100,101 Interestingly, studies have shown long-term hippocampal alterations and 
associated memory deficits across survivors of neonatal critical illness, irrespective of 
gestational age or underlying disease.92,102,103 The hippocampus is the brain’s central 
hub for memory encoding, consolidation and retrieval.79 Benzodiazepines, such as 
midazolam, potentiate the neuronal inhibitory pathways or inhibit the excitatory 
pathways by binding to gamma-Aminobutyric acid (GABA) or glutamatergic N-methyl-
D-aspartate (NMDA) receptors in the brain.6,99 In the hippocampus, NMDA receptors are 
highly involved in Long-Term Potentiation (LTP), a system of persistent strengthening of 
synapses following high levels of stimulation, that results in the ability to form memo-
ries.100,104 If these NMDA receptors become occupied due to the presence of for instance 
midazolam, memory formation will be disrupted.14 
In preterm infants, the acute effects of midazolam on the brain have been studied 
directly. Injection with midazolam led to a decrease in middle cerebral artery blood 
flow velocity and transient cerebral hypoperfusion.72 As the hippocampus is selectively 
vulnerable to cerebral hypoperfusion105, this may contribute to the specific effects of 
midazolam on the hippocampus, and thus on memory. A recent clinical study in 
preterm-born neonates (24-32 weeks of gestation) evaluated how midazolam exposure 
affected the hippocampus using MRI. They demonstrated a selective, negative effect 
of midazolam on hippocampal growth from birth to term-equivalent age, even after 
adjusting for the number of invasive procedures and other common clinical care prac-
tices.6 Long-term outcome studies are needed to evaluate whether the hippocampal 
growth reductions in response to midazolam exposure are associated with memory 
deficits, and whether this exists in both preterm and term born survivors.
Dexmedetomidine
Interestingly, rodent studies have shown that dexmedetomidine and clonidine may 
reduce anesthetic-induced apoptosis, specifically in the hippocampus106, and diminish 
subsequent cognitive decline.107 However, future clinical studies are needed to assess 
whether these agents are neuroprotective in neonates as well.
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diScuSSion 
Although animal studies have fairly consistently demonstrated brain development to be 
negatively affected by various classes of drugs, such as anesthetics, benzodiazepines and 
to some extent opioids71,85, associations in survivors of neonatal critical illness seem less 
obvious.6,14 This may be due to differences between animal and human studies, resulting 
in more contradicting conclusions in humans (for a review on this matter, please refer 
to van den Bosch et al.2). Nonetheless, our findings seem to suggest a link between the 
use of analgesics such as morphine and fentanyl, and cerebellar volume in critically ill 
infants.89,93 Concerning sedatives, direct links between midazolam exposure and hippo-
campal alterations have been described in preterm infants.6 Commonly used sedatives 
such as midazolam and propofol bind either to GABA or NMDA receptors. The GABA and 
NDMA receptor systems are crucial for neuronal connection and communication in the 
developing brain, and if unavailable lead to neuroapoptosis.14 These agents have been 
suggested to disrupt memory formation through its effects on the hippocampus.104 
Memory formation and recall are dependent on LTP, a system of persistent strengthen-
ing of synapses following high levels of stimulation. LTP, which mainly happens in the 
hippocampus, relies heavily on NMDA. Although based on animal studies, midazolam 
was found to affect pyramidal neurons in the CA1 region and memory by suppression 
of LTP.100 This mechanism may be underlying the negative effects of midazolam found 
on the hippocampus in preterm infants6, and may subsequently lead to memory deficits 
later in life in these children. (Please also refer to a recent review on other proposed 
mechanisms underlying the effects of analgosedatives and anesthetics on the brain 
by van den Bosch et al.2.) As both the cerebellum and hippocampus are important for 
higher-order cognitive functioning and seem to be targeted by analgosedatives, dam-
age to these brain regions may be (partly) underlying the long-term deficits following 
neonatal critical illness.79,95 
The indications that exposure to analgosedatives in neonates and infants may affect 
specific brain regions responsible for higher-order cognitive functioning warrant future 
research. Specifically, as these functions, such as memory, do not fully develop until later 
in childhood, it is imperative that long-term neuropsychological outcomes are mea-
sured when studying the effect of analgosedatives following neonatal critical illness. 
Therefore, studies described in this review that only include the assessment of general 
intellectual ability at 24 months (corrected age), e.g. with the commonly used Bayley 
Scales of Infant and Toddler Development–Third Edition108, as well as general intellectual 
outcome at a later age are less informative in this respect. Future studies on the effect 
of commonly used analgosedatives that include neuropsychological assessment and 
neuroimaging later in childhood are needed to more reliably assess the potential clinical 
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effect of cerebellar and hippocampal alterations on cognitive outcome before definitive 
conclusions can be drawn.
Problematically, analgosedatives will remain a necessary treatment as the experience 
of pain itself has shown to negatively impact neurodevelopment as well. Ranger et al. 
showed that pain related stress predicted cortical thickness at 7 years in preterm born 
children, independent of morphine exposure. Also, a higher number of painful (skin-
breaking) procedures in preterm born children was found to be associated with reduced 
white and subcortical gray matter.2,109 In addition to pain, studying the association 
between analgosedatives and neurodevelopmental outcome is likely to be affected by 
differences in dosages. Moreover, critically ill infants are exposed to other factors such as 
stress, hypoxia-ischemia and neuroinflammation during a vulnerable and critical period 
of brain development. A complex interplay amongst these factors may lead to (subtle) 
brain injuries early in life, which become evident only later in life when those brain 
regions are required for higher cognitive functioning. In particular, the hippocampus, 
the main hub for memory formation in the brain, has been found to show pronounced 
vulnerability to factors associated with critical illness, including exposure to sedatives.6,80 
This ‘growing into deficit’ phenomenon110, where early hippocampal alterations lead to 
memory deficits later in life, has recently been identified by our group across survivors 
of neonatal critical illness.80 To what extent exposure to analgosedatives contribute to 
early brain injury in these patients needs further research that combines information 
on analgosedative exposure and exposure to confounding factors, such as pain, with 
neuroimaging and elaborate neuropsychological assessment.
Elaborate neuropsychological assessment is essential as an increasing number of 
studies has found that survivors of neonatal critical illness are at risk of specific memory 
and attention deficits, rather than intellectual disability.66-68,111 The majority of clinical 
studies described in the current review only used general neurodevelopmental out-
come measures such as intelligence at pre- or school-age. Therefore, it is difficult to draw 
any definitive conclusions on how and to what extent analgosedatives affect the brain 
in critically ill neonates. Better understanding of the association between the brain, 
cognition and analgosedatives exposure in early life is needed to optimize adequate 
pain management in neonates. Future studies combining elaborate neuropsychological 
assessment with multimodal neuroimaging techniques, such as (functional) MRI and 
Diffusion Tensor Imaging, are therefore needed.
In this vulnerable population, there is a significant need for early predictors of long-
term neuropsychological deficits and school problems. As of now, identification of 
patients at risk relies solely on neuropsychological assessment which cannot be reliably 
conducted until school-age.68 By this time, the cognitive deficits may have already ham-
pered school performance in a number of children.67 Predictors that can be measured 
as early as during first admission (‘biomarkers’) are therefore of utmost importance. A 
Chapter 10
218
better understanding of how and to what extent analgosedatives affect the brain may 
contribute to identifying which patients are most at risk. Within this context, interaction 
with age and developmental stage are essential. Furthermore, given the high incidence 
of memory deficits following neonatal critical illness80,112, early identification of patients 
at risk of memory deficits may become possible using hippocampal volume as a neuro-
biological marker. The hippocampus can be accurately and non-invasively delineated 
using structural MRI and is the brain’s critical hub for long-term memory formation.79,81 
Because of these features, the hippocampus is an important target for future studies 
aimed at improving long-term outcomes following neonatal critical illness. In preterm 
infants, studies have shown that MRI can be reliably performed without sedation and 
that infant hippocampal volumes, measured at term-equivalent age, correlated with 
memory outcomes later in childhood.113,114 However, it is important to note that even 
the more advanced MR techniques are not sensitive enough to provide us with informa-
tion on the exact anatomical or molecular mechanisms underlying neuropsychological 
deficits. The exact contribution of exposure to analgosedatives on neuropsychological 
outcome therefore remains speculative.
In neonatal pain management, the ultimate goal is to achieve adequate pain manage-
ment with minimal short and long-term side effects. The search for the lowest, most 
effective exposure to analgosedatives becomes even more relevant when taking into 
account their potential effect on long-term neurocognitive outcome.6,14,71,85 For both 
new compounds as well as for the already used drugs, dose-finding studies (phase 2) 
can be very instructive before conducting phase 3 efficacy and safety trials.74 The earlier 
mentioned study on morphine sparing acetaminophen in neonates and infants46 used a 
much lower dose of morphine in neonates and infants and still resulted in further reduc-
tion of the morphine maintenance dose (-66%) in cases co-exposed to acetaminophen. 
Similarly, the ED50 of propofol (0.5-1.5 mg/kg) to enable endotracheal intubation turned 
out to be significantly lower compared to the routine practices.51,53,54 Furthermore, the 
increased use of (new) drugs such as dexmedetomidine will only result in evidence-
based pharmacotherapy when assessed using appropriate and comparative effective-
ness trials. Together with advanced analysis techniques such as pop-PK and physiology 
based/PK on sparse datasets, we will reach a higher level of evidence-based dosing of 
analgosedative drugs in neonates. The same holds true for future application of prin-
ciples of pharmacovigilance studies. This is especially of interest since experimental 
studies have suggested that dexmedetomidine may have neuroprotective effects as 
well.106,107 
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concluSion
Indications from both animal and clinical studies that early exposure to analgosedatives 
may have long-term effects on the brain and cognition warrant future research. As the 
number of critically ill neonates admitted to intensive care units grows worldwide and 
more and more of these patients survive to discharge due to medical improvements7,8, 
the long-term outcome after surviving neonatal critical illness can no longer be ignored. 
It is therefore of utmost importance that we continue to gain insight into how pharma-
cotherapy affects the developing brain. In future studies, potential long-term sequelae 
should be primary outcome parameters and this information should be used when 
optimizing pain management in neonates.
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aimS and main findingS
In this thesis, the long-term neurodevelopmental sequelae following two common 
causes of neonatal critical illness were studied: severe respiratory failure in need of 
neonatal extracorporeal membrane oxygenation (ECMO) treatment and congenital dia-
phragmatic hernia (CDH). To improve (early) identification of patients at risk, we aimed 
to delineate the specific neuropsychological profile and its underlying neurobiology in 
these survivors. Our results showed that survivors of neonatal ECMO and/or CDH have 
specific memory and attention deficits, despite average intelligence (chapters 2, 3, 4). 
These deficits are associated with alterations in the brain’s limbic system, in particular the 
hippocampus, and global white matter microstructure (chapters 5 & 6). The second aim 
of our thesis was to evaluate whether Cogmed Working-Memory Training (CWMT) could 
be an effective treatment strategy in school-age survivors of neonatal ECMO and/or CDH 
with (working)memory deficits. We found that CWMT may be beneficial for patients who 
have visuospatial memory deficits by showing long-term gains in this domain following 
CWMT (chapter 7). Furthermore, we found training-induced changes in white matter 
microstructure immediately following CWMT, demonstrating neuroplasticity in these 
children (chapter 8). Our findings taken together led to the postulation of a common 
neurodevelopmental pathway across survivors of neonatal critical illness, where early 
hippocampal alterations result in memory deficits later in life. This ‘growing into deficit’ 
phenomenon seems to exist across survivors of neonatal critical illness, irrespective of 
underlying diagnosis or gestational age, and may be due to common factors associated 
with neonatal critical illness such as hypoxia-ischemia, neuroinflammation, stress and 
exposure to common analgosedatives (chapters 9 & 10).
The work presented in this thesis has shown that, even in absence of major neuro-
logical abnormalities such as hemorrhage or periventricular leukomalacia, the brain of 
critically ill neonates is vulnerable. Our results have increased our understanding of the 
long-term neurodevelopmental sequelae following neonatal critical illness. Inevitably, 
our findings have also proven to us that ‘the more we know, the more we do not know’ 
(Aristotle). Two important issues remain: 
1) The need for predictors or risk stratification tools to identify patients at risk early, 
i.e. before the neuropsychological deficits affect school performance and daily life 
activities.
2) Treatment strategies that prevent or specifically target (all) altered brain regions 
and/or neuropsychological deficits following neonatal ECMO and/or CDH.
In the following section, our main findings will be placed into a broader perspective. 
Furthermore, directions of future research will be discussed, aimed at improving early 
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identification of children at risk as well as prevention or reduction of long-term neuro-
developmental impairment following neonatal critical illness.
idenTificaTion of PaTienTS aT riSk 
neuropsychological assessment 
Over the last decade, increasing awareness and knowledge has emerged about the 
long-term neuropsychological outcome following neonatal ECMO and/or CDH1-3, which 
inspired the work presented in this thesis. In initial reports on long-term neuropsy-
chological outcome in school-age survivors of neonatal ECMO and/or CDH, sustained 
attention deficits and a high incidence of school problems were found, despite normal 
intelligence.1-4 However, elaborate assessment of all major neuropsychological domains 
was lacking. In this thesis, we showed that general intellectual outcome was normal in 
the majority of survivors of neonatal ECMO and/or CDH from two, five, to eight years 
of age (chapter 2). Using elaborate neuropsychological assessment, we replicated the 
findings on sustained attention deficits, but also found specific short- and long-term 
memory deficits in over half of these children at school-age (chapter 3). Strikingly, using 
a similar test battery, we demonstrated similar deficits in short- and long-term visuo-
spatial and verbal memory in a group of 17-year-old adolescent survivors of neonatal 
ECMO, while other neuropsychological domains remained relatively unaffected (chapter 
4). Although longitudinal assessment will be needed to increase our understanding of 
the neurodevelopmental trajectories following neonatal ECMO and/or CDH, this was 
the first study that performed elaborate neuropsychological assessment in adolescent 
survivors, indicating that memory deficits following neonatal critical illness are per-
sistent from childhood into adolescence. Confirming earlier findings by our group in 
different cohorts of neonatal ECMO and CDH survivors1,2, we found that a significantly 
higher number of survivors were in need of extra help in school compared to the general 
population at both 8 and 17 years of age (chapters 2 & 4), We found that these school 
problems were related to the specific neuropsychological deficits, rather than to general 
intellectual outcome (chapter 2).
Comparing our findings to neuropsychological outcome in other children who sur-
vived a period of neonatal critical illness without serious neurological sequelae shows 
striking similarities. Although lower IQ has been reported in children born preterm (< 37 
weeks of gestation)5, intelligence has generally been shown to be within the low aver-
age to average range across survivors of neonatal critical illness.5-7 In children growing 
up after preterm birth and complex cardiac anomalies, impairments have been dem-
onstrated across multiple neuropsychological domains, such as attention, visuospatial 
processing, executive functioning, and memory and learning.5-10 Just as in survivors of 
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neonatal ECMO and/or CDH, memory deficits, both short- and long-term verbal and 
visuospatial memory are among the most frequently reported neuropsychological 
sequelae. Following preterm birth, memory deficits have been found to persist from 
childhood into adolescence and even into young adulthood.5,11-14 In survivors of cardiac 
anomalies of differing complexity, short- and long-term verbal and visuospatial memory 
deficits have been demonstrated as well, becoming increasingly evident with age.6,8,15 
Unsurprisingly, the incidence of school problems is strikingly high across these patient 
groups5-7, making long-term neuropsychological sequelae following neonatal critical 
illness a major concern.
While intelligence is generally in the low-average to average range in these children, 
the assessment of IQ often remains the main outcome parameter in the few long-term 
follow-up protocols that are available.16,17 This is problematic as specific neuropsycho-
logical deficits are difficult to pick up using a global outcome measure such as an IQ 
test.18 As such, problems in school and/or daily life remain misunderstood and targeted 
intervention strategies cannot be implemented. Standardized, problem-oriented neu-
ropsychological follow-up that includes all major neuropsychological functions is there-
fore highly recommended following neonatal critical illness. Important to note is that, 
as we have shown that IQ at 5 years of age is highly predictive of IQ at 8 years of age, it 
may be sufficient to conduct a full-scale IQ test at 5 years and a short-form test at 8 years 
of age to increase efficiency.19 As higher-order cognitive functions, such as attention and 
memory, continue to develop throughout childhood and into adolescence11,20, follow-
up assessments should take place both at school-age and into adolescence. In line with 
this, assessment of general intellectual ability at 24 months (corrected age), e.g. with the 
commonly used Bayley Scales of Infant and Toddler Development–Third Edition21, will 
not identify those patients at risk of neuropsychological deficits. Preferably, we would 
like to identify children at risk of memory and attention deficits at this time, i.e. well 
before the neuropsychological deficits have interfered with school performance and 
activities in daily life. Studies using eye-tracking in infants to assess long-term memory 
and attention show promising results.22,23 Future longitudinal studies are needed in 
survivors of neonatal critical illness that compare memory and attention assessed with 
eye-tracking in infancy to outcomes from neuropsychological assessment later in child-
hood to determine the utility of outcomes in infancy as early predictors.
neuroimaging
Our findings of specific attention and memory deficits emerging in childhood and per-
sisting into adolescence following neonatal ECMO and/or CDH, suggested a ‘growing 
into deficit’ phenomenon where subtle brain injuries acquired at a young age become 
functionally evident over time when demands on cognitive functioning increases.24 This 
‘growing into deficit’ is nested within different developmental processes that occur in the 
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brain (e.g. myelination, synaptic pruning and neurogenesis25). An important next step in 
understanding neurodevelopment following neonatal critical illness was therefore to 
study the underlying neurobiology of long-term neuropsychological impairments.
Using Diffusion Tensor Imaging (DTI) in neonatal ECMO survivors, we demonstrated 
global as well as specific white matter alterations in the cingulum bundle and parahip-
pocampal part of the cingulum in school-age neonatal ECMO survivors compared to 
healthy controls (chapter 5). White matter microstructure has previously been found to 
be particularly vulnerable in the neonatal period, a time when it is undergoing rapid 
development.26 In particular the limbic system fibers (i.e. cingulum bundle and parahip-
pocampal part of the cingulum) develop rapidly in the first six months of life, causing 
fractional anisotropy (FA) to increase and mean diffusivity (MD) to decrease in these 
tracts.26 As our subjects were critically ill in the first weeks of life, the development of 
these specific fibers may therefore be at increased risk.
Since white matter is important for high-speed transmission of neuronal signals 
between distant brain regions, aberrations in white matter development could affect 
the orchestration of specific cognitive functions.26 Indeed, in another cohort of school-
age survivors of neonatal ECMO and/or CDH in which we combined neuroimaging with 
neuropsychological assessment, we found that lower global FA, potentially indicative 
of reduced coherence of white matter fibers27, was associated with sustained attention 
deficits (chapter 6). Global white matter abnormalities have been found in preterm 
born infants with attention deficits as well.28 This shared vulnerability in both preterm 
and term-born neonates may be due to the increased susceptibility of white matter, 
in particular in the periventricular regions, to hypoxic-ischemic insults – a common 
complication in critically ill infants. Using animal models, premyelinating oligodendro-
cytes (pre-OLs) in cerebral white matter have been found to be selectively targeted by 
oxidative stress. These cells account for approximately 90% of the total oligodendrog-
lial population at 28 weeks of gestation and approximately 50% at term.29 Increased 
regional susceptibility of the periventricular white matter is suggested to be due to the 
distribution of these pre-OLs and relative underdevelopment of distal arterial fields to 
these areas.29,30 Neonates exposed to hypoxic-ischemic injuries, both born preterm and 
at term, may therefore be at increased risk of myelin and axonal disruptions, resulting 
in white matter abnormalities. As more widespread white matter networks have been 
found to be underlying attention, this may explain the attention deficits in these 
children.31 In addition to the association between global white matter alterations and 
attention, we found that higher MD in the parahippocampal part of the cingulum, sug-
gestive of decreased integrity in axonal membranes, packing, or myelin27, was related 
to long-term visuospatial memory deficits in survivors of neonatal ECMO and/or CDH 
(chapter 6). This is in line with earlier findings demonstrating that the parahippocampal 
part of the cingulum, which is bidirectionally connected to the hippocampus, forms 
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a larger memory circuit together with cortical structures and is thus highly important 
for intact functioning of various memory types.32 Taken together, our results suggest 
that white matter microstructure alterations acquired early in life may have long-lasting 
implications in survivors of neonatal critical illness.
Given the high incidence of memory deficits (chapters 3 & 4), we also investigated the 
hippocampus using structural MRI in school-age neonatal ECMO survivors compared to 
healthy controls. The hippocampus, a gray matter structure within the brain’s limbic sys-
tem, is the critical hub for memory formation and rapidly develops within the first two 
years of life.33,34 We found smaller bilateral hippocampal volume in the ECMO survivors 
compared to healthy controls, which was negatively associated with the ability to recall 
information from a story that the children had just heard, a measure of episodic memory 
(chapter 5). In a different cohort of school-age survivors of both neonatal ECMO as well 
as CDH treated without ECMO, we found these same structure-function relationships 
(chapter 6). Interestingly, neither the underlying diagnosis (such as meconium aspira-
tion syndrome or CDH) or the type of ECMO-cannulation (venoarterial or venovenous) 
affected these associations (chapter 6). Although these findings should be interpreted 
with caution due to the small sample size, they suggest that factors other than diagnosis 
and treatment determine long-term neurodevelopmental outcomes in these patients.
Placing our findings in a broader perspective, we found that other groups of critically 
ill infants without overt neurological abnormalities had similar neurodevelopmental 
outcomes. As described previously, memory deficits are frequently reported across 
survivors of neonatal critical illness, such as in children following preterm birth and com-
plex cardiac anomalies.5,6,8,11-15 We therefore wondered whether these memory deficits 
would be associated with hippocampal alterations in these patients as well (chapter 
9). In school-age children who experienced neonatal hypoxia, structural MRI combined 
with memory assessment demonstrated specific smaller bilateral hippocampal volumes 
associated with memory deficits in patients compared to healthy controls.35 These struc-
ture-function relationships existed in both children treated with and without ECMO35, 
confirming findings in our study population (chapter 6). In this population, the term “de-
velopmental amnesia” has been used to describe markedly impaired event, or episodic, 
memory and relatively preserved fact, or semantic, memory following hypoxic-ischemic 
insults sustained within the first year of life.36,37 This has been suggested to be due to 
relatively selective bilateral hippocampal pathology.36,38 This pattern of memory deficits 
and hippocampal pathology, despite relatively intact intellectual abilities, is remarkably 
similar to the significant impairments in delayed recall and hippocampal volume loss 
observed following neonatal ECMO and/or CDH (chapter 6), as well as to other groups 
of critically ill infants. In children born preterm, abnormalities in the hippocampus with 
impaired long-term memory have been reported as well.12,39-42 In children with complex 
congenital heart disease, smaller bilateral hippocampal volumes were demonstrated 
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in 40% of school-age children who had dextro-Transposition of the Great Arteries and 
cyanosis compared to healthy controls. These hippocampal reductions were associated 
with memory deficits.43 In line with this, 13-year-old children who had undergone car-
diopulmonary bypass surgery in infancy had smaller bilateral hippocampal volumes as 
well as volume loss in other parts of the limbic system’s gray matter compared to healthy 
controls.44 43,44 The findings reported in these four common causes of neonatal critical ill-
ness taken together led to the postulation of a common neurodevelopmental pathway 
following various types of neonatal critical illness, where early hippocampal alterations 
result in memory deficits later in life, irrespective of underlying disease or gestational 
age (chapter 9). As memory problems can greatly affect daily life activities and academic 
achievement, this is of major concern. Early identification of patients at risk of memory 
deficits may become possible using hippocampal volume as a neurobiological marker. 
The hippocampus can be accurately and non-invasively delineated using structural MRI 
and is the brain’s critical hub for long-term memory formation.33,34 Because of these 
features, the hippocampus is an important target for future studies aimed at improving 
long-term outcomes following neonatal critical illness. In preterm infants, studies have 
shown that MRI can be reliably performed without sedation and that infant hippocam-
pal volumes, measured at term-equivalent age, correlated with memory outcomes later 
in childhood.12,45 A critical period of hippocampal development is in the first two years 
of life when it undergoes a growth spurt.34 The hippocampus would thus ideally be 
measured after the first two years of life. However, unless with the use of sedation, it will 
be difficult to perform a reliable MRI scan at this time, let alone desirable for the patient. 
Since sedatives may have an additive negative effect on the developing brain (chapter 
10), this should be avoided. Furthermore, the rapid development of the hippocampus 
within the first two years of life likely interacts with the exposure to deleterious factors 
associated with neonatal critical illness. Therefore, longitudinal assessment may lead to 
finding the optimal time to assess hippocampal volume and identify specific periods of 
sensitivity. Such longitudinal data should be coupled with memory assessment later in 
childhood to evaluate the utility of hippocampal volume as a prediction tool.
Pathophysiological mechanisms 
Standardized, problem-oriented neuropsychological assessment can be used to un-
derstand why survivors experience difficulties at school or in daily life activities. In its 
present form, neuropsychological assessment is therefore a diagnostic tool rather than 
a prediction tool. Furthermore, the use of neurobiological correlates as early predictors, 
such as smaller hippocampal volume, is promising but will only become feasible once 
normative hippocampal volumes become available. As we should strive to identify and 
treat patients at risk well before the neuropsychological deficits have hampered their 
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school performance, it is imperative that we understand why and how patients develop 
these deficits.
In chapter 3 of this thesis, we analyzed associations between clinical characteristics 
at the time of hospitalization and neuropsychological outcome at 8 years of age. We 
found a specific negative association between the maximum dose of vasoactive medica-
tion received during first admission (measured by the Vasoactive Inotropic Score; VIS) 
and long-term verbal and visuospatial memory following neonatal ECMO and/or CDH. 
In these analyses, we adjusted for diagnosis and various measures of severity of ill-
ness, suggesting that a specific association exists between the VIS and memory later 
in life (chapter 3). Although currently speculative, receiving high levels of vasoactive 
medication in the first period of life may be an indirect marker of temporarily (regional) 
inadequate brain perfusion. As the hippocampus is particularly vulnerable for hypoper-
fusion and/or hypoxia, the association between the VIS and memory may be the indirect 
result of this pathophysiological mechanism. In addition, previous findings from both 
preclinical and clinical studies have shown that the hippocampus shows pronounced 
vulnerability to hyperoxia.46-50 Hyperoxia, experienced by critically ill infants in need of 
oxygen supplementation51,52, may therefore also play a role in the hippocampal altera-
tions and memory deficits observed following neonatal critical illness. Importantly, the 
current lack of insight into how hypoxia/hyperoxia may affect hippocampal develop-
ment in these children has direct clinical implications as the optimum resuscitation 
strategy in critically ill infants remains a topic of debate.53,54 Future research that collects 
dense and detailed data on continuous oxygen saturation and supplemental oxygen 
supply will allow us to closely monitor oxygen fluctuations in critically ill neonates. 
Analyzing a combination of absolute values and the area under the curve55 will provide 
more detailed information on the exposure to different levels of oxygen throughout the 
infant’s hospital stay. Coupled with outcome parameters such as hippocampal volume 
and/or memory functioning, this data can provide insight into the extent to which hy-
poxia, hyperoxia or a combination of both, influences the hippocampus and memory in 
later life. To further understand the molecular, cellular and behavioral consequences of 
exposure to hypoxia/hyperoxia on the pathophysiology of the neonatal hippocampus, 
experimental studies using in vitro and in vivo animal models are of interest. In these 
types of experiments, the effect of hypoxia and/or hyperoxia on the hippocampus and 
memory at different stages of development can also be taken into account by includ-
ing both a preterm model and a full-term model.47,56,57 Such translational studies may 
eventually contribute to earlier identification of critically ill infants at risk of long-term 
deficits. Moreover, they may also lead to adjustments in the resuscitation strategy and 
thus the prevention or reduction of damage to the developing brain in critically ill 
neonates.
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Importantly, in addition to hypoxia-ischemia, critically ill infants are exposed to many 
other potentially deleterious factors (chapter 9). A complex interplay amongst differ-
ent factors associated with the underlying disease, (pharmacological) treatment and 
“iatrogenesis” are therefore likely to determine a child’s neurodevelopment, further 
complicated by the child’s genetic predisposition58 and social economic status59. Using 
comprehensive literature reviews, in chapters 9 and 10 of this thesis we explored how 
these factors may affect the developing brain, and in particular the hippocampus, in 
critically ill infants. Because of its highly excitable and plastic nature, the hippocampus 
shows pronounced sensitivity to both internal and external influences and may there-
fore be particularly vulnerable in critically ill infants.49 However, the exact pathophysi-
ological mechanisms underlying hippocampal alterations and subsequent memory 
impairments in these children remain largely unknown. A first step will be to collect 
dense data on factors associated with neonatal critical illness, such as oxygen fluc-
tuations, analgesic and sedative use, metabolic profiles60,61, and neuromonitoring data62 
throughout hospital stay. Since children following neonatal critical illness ‘grow into 
their deficits’, longitudinal assessment is imperative. The detailed clinical information 
collected during initial hospital stay should therefore be coupled with neuroimaging 
and problem-oriented, standardized neuropsychological assessment at later stages of 
development. Such detailed data collection in combination with longitudinal assess-
ment of neurodevelopment may allow us to identify which specific pathophysiological 
conditions lead to alterations in hippocampal volume and memory deficits later in life in 
these children. Furthermore, with a longitudinal design, windows of sensitivity (i.e. when 
infants are most at risk of impairment, the optimal timing of MRI or neuropsychological 
assessment) and opportunity (i.e. when it is best to implement therapy or interventions) 
can be identified. As differences in brain development and the timing of critical illness 
(e.g. preterm versus full-term brain) are likely to influence how and when the hippocam-
pus is affected, a longitudinal design that starts collecting data in the prenatal period, 
for instance with the use of prenatal ultrasounds63, is of interest as well. Favorably, the 
outcome parameters, such as the neuroimaging data and neuropsychological data, 
are compared to healthy control data to understand when hippocampal volumes and 
memory are different from the norm. The Generation R study, a pediatric population 
study in which over 3000 healthy children have undergone longitudinal neuroimaging, 
is a good example of such a healthy control cohort64, which may make the use of norma-
tive brain parameters feasible in the future. In our institution, a longitudinal follow-up 
program in children who have been critically ill in the neonatal period has recently been 
initiated (Systematic Hospital-based Assessment of Rotterdam’s (critically) Ill Infants’ 
Neurodevelopment and Growth: S.H.A.R.I.N.G.). It is important to keep in mind that when 
comparing neuroimaging data, the image acquisition and type of analyses65,66 as well as 
the scanner itself67 may influence the results and should thus be similar or controlled for 
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in the analyses. Therefore, large sample sizes are needed. In this respect, multicenter col-
laborations should be a goal for future studies assessing long-term neurodevelopment 
following neonatal critical illness as well.
TreaTmenT
neurorehabilitation
Given the complex interplay of factors that are likely to affect the developing brain 
in critically ill infants (chapters 9 & 10), rehabilitation strategies aimed at improving 
impaired neuropsychological functions are of great interest as well. Cogmed Working-
Memory Training (CWMT) is a widely evaluated cognitive training for both children and 
adults.68 In this thesis, we reported the results of a nationwide, single-blind randomized 
controlled trial on the immediate and long-term effectiveness of CWMT in school-age 
survivors of neonatal ECMO and/or CDH with (working)memory deficits. Neuropsycho-
logical outcome was assessed before, immediately and one year after CWMT, and white 
matter microstructure was assessed before and immediately after CWMT (chapters 7 & 8).
Immediately after CWMT, we found significant improvements in verbal and visuospatial 
working-memory in the CWMT group compared to the non-training group (chapter 7). 
These findings are in line with the effects demonstrated in other clinical and non-clinical 
groups after CWMT.69-72 Coupling our data with the neuroimaging findings immediately 
post-intervention, we found that the improvements in verbal working-memory were as-
sociated with an increase in FA in the left superior longitudinal fasciculus (chapter 8). The 
frontoparietal network has been consistently shown to be affected by working-memory 
training and is thus a common finding following CWMT.68,73,74 The specific association 
between the superior longitudinal fasciculus in the left hemisphere and verbal working-
memory may be due to the fact that working-memory is lateralized, i.e. verbal working-
memory corresponds with the left hemisphere while visuospatial working-memory 
corresponds with the right hemisphere.75,76 Furthermore, as the majority of children in 
our cohort were right handed (80%), which is generally associated with left hemispheric 
dominance for language77, this may also explain this association. Nonetheless, after one 
year, we found that the improvements in working-memory had disappeared (chapter 
7). This is in contrast with two previous studies that have assessed long-term outcome 
following CWMT in children. Gains in working-memory performance have been found in 
very low birthweight children seven months post-intervention69 and in healthy children 
with working-memory problems one year post-training.78 However, working-memory 
was found to be within the average range in our population at baseline (chapter 7). As 
the children studied in the other two long-term studies did have significant working-
memory deficits69,78, this may explain the incongruent findings. Although speculative, 
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the benefits of the training – such as an increased capacity to learn and manipulate 
information – may be more prone to subside after a while in our population because an 
increase in this particular function was not needed to begin with, i.e. the “use it or lose 
it” principle. Furthermore, rehabilitation treatment may be disease-dependent, e.g. have 
different effects in survivors of childhood cancer than in children treated with neonatal 
ECMO.79,80 
One year after CWMT, we did find significant and sustained improvements in long-
term visuospatial memory in the CWMT group compared to non-trained controls 
(Chapter 7). These improvements were not associated with microstructural changes im-
mediately after CWMT (chapter 8). At baseline, we found an association between long-
term visuospatial memory deficits and higher MD in the parahippocampal part of the 
cingulum (chapter 5). We therefore expected that improvements in this domain might 
have been accompanied by training-induced changes in this white matter tract. Since 
the improvements in long-term visuospatial memory found in our cohort increased 
from the assessment immediately post-intervention to one year later in the CWMT 
group compared to the control group, neurobiological changes may have only become 
detectable one year post-intervention. In line with this, a recent study has shown that a 
reverse relationship can exist between the brain and behavior, where behavior is actu-
ally shaping the brain, rather than the commonly assumed direction of the brain shap-
ing behavior.81 Such a downstream mechanism may explain why the improvements in 
long-term visuospatial memory in the CWMT group were not associated with changes in 
white matter microstructure immediately post-intervention. For instance, an increased 
ability following CWMT to memorize the location of information within a certain visual 
context may lead to increased use of this tactic to improve the ability to encode and 
recall information in various situations, thereby affecting the white matter connections 
underlying these abilities. However, this remains speculative as the MRI exam was un-
fortunately not repeated at this time. It is also important to note that neurobiological 
changes underlying these memory improvements may simply not have been detectable 
using DTI.82 Nonetheless, given the fact that over 50% of children following neonatal 
ECMO and/or CDH has long-term visuospatial and verbal memory deficits at school-age 
(chapter 3), improving memory in these children is of great importance. We found that 
larger improvements in long-term visuospatial memory were significantly associated 
with higher scores on self-rated school functioning and parent-rated attention one year 
after CWMT (chapter 7). Additionally, the majority of children trained with CWMT and 
their parents reported to be happy with the results and to see improvements in memory 
and attention (data not shown). These findings taken together may suggest that the 
improvements in long-term visuospatial memory in the CWMT group have general-
ized to daily life activities. If so, intervention before memory problems have interfered 
with school performance should be strived for. In children with very low birthweight, 
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memory improvements have been found six months after CWMT at preschool-age69, 
suggesting earlier intervention may lead to similar results. However, these results need 
to be replicated in preschool survivors of neonatal ECMO and/or CDH with long-term 
visuospatial memory deficits, as well as in other survivors of critical illness such as fol-
lowing complex cardiac anomalies, before any definitive conclusions can be drawn. In 
future trials, neuropsychological assessment and neuroimaging should be conducted 
both immediately and one year post-intervention.
Overall, our findings demonstrate that cognition and white matter microstructure are 
malleable with CWMT in survivors of neonatal ECMO and/or CDH. Working-memory was 
the primary outcome measure in our trial, which had been based on initial reports of 
neuropsychological outcome in our study population.1-3 However, ongoing research, as 
described in this thesis, led to new insights of primarily short- and long-term memory 
and sustained attention deficits following neonatal ECMO and/or CDH. Although CWMT 
may be beneficial for survivors of neonatal ECMO and/or CDH with visuospatial memory 
deficits, it is not the (complete) answer to the long-term neuropsychological deficits 
observed in these children. Importantly, our results demonstrated that it is essential 
to conduct an elaborate neuropsychological assessment before initiating CWMT in 
survivors of neonatal critical illness to determine its clinical utility. Furthermore, if mul-
tiple domains are affected in a child, treatment strategies should ideally affect multiple 
domains as well. A combination of different intervention programs may therefore be 
of interest. Findings from both experimental and clinical studies have suggested that 
multimodal training leads to better results compared to a single training program.83,84 
Exercise training in children has been found to affect memory and learning by targeting 
the hippocampus.85 Combining such a physical program with cognitive training aimed 
at improving attention or memory, may strengthen the results and be beneficial in 
survivors of neonatal critical illness.
However, these are future perspectives and of little use in today’s clinical practice. Cur-
rently, survivors of neonatal critical illness with long-term neuropsychological deficits 
may have to manage with practical tools to improve school performance and daily life 
activities. To improve long-term outcome in these children, we recommend that survi-
vors of neonatal critical illness receive information on the practical implications of the 
deficits they may experience (e.g. difficulty remembering homework that is due tomor-
row or appointments with friends), as well as learn about compensatory techniques or 
external (memory) aids that may be used to improve their activities of daily living (e.g. 
errorless learning, mental imagery to improve recall, writing important things down and 
using a schedule book80). Ideally, this information is personalized to the patient’s specific 
impairments and needs. Personalized information and practical tools can be realized by 
conducting neuropsychological assessment to evaluate the degree of neuropsychologi-
cal deficits, as well as by evaluating the degree to which these deficits affect activities of 
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daily living in the patient.80 The neuropsychologist as such can play an essential role in 
(the improvement of ) long-term outcome following neonatal critical illness (figure 1). A 
multidisciplinary approach to long-term follow-up after neonatal critical illness should 
therefore be strived for.
Prevention 
Ideally, the deleterious effects of neonatal critical illness on the neonatal brain should be 
prevented. This may be (partly) accomplished by fine-tuning therapy or treatment strat-
egies, but may also be achieved with the use of neuroprotective agents in the future. 
While it remains unknown which pathophysiological mechanisms are most detrimental 
to the developing brain, we do know that the hippocampus is highly vulnerable in 
critically ill infants (chapters 9 & 10). Besides hypothermia (chapter 9), the use of phar-
macological agents that may have neuroprotective effects may therefore be of great 
value in critically ill infants. For instance, the effect of maternal allopurinol, which may 
protect the fetus against hypoxic-ischemic brain injury, is currently being investigated.86 
Here, we mention two other agents that are commonly used in the NICU and may have 
neuroprotective effects.
Dexmedetomidine, used in particular for sedation in the pediatric ICU population, 
may have neuroprotective effects on the hippocampus, in particular against hypoxic-
ischemic damage.87 These effects have been suggested to result from an activation of 
α2-adrenergic receptors by dexmedetomidine, which inhibits inflammation following 
brain ischemia.88 As the hippocampus has been found to be vulnerable to both hypoxia-
ischemia as well as inflammation (chapter 9), this specific mechanism of action is of in-
terest. However, these findings are mostly based on animal models and studies in adult 
The role of the neuropsychologist  
Multidisciplinary follow-up after neonatal critical illness 
To identify neuropsychological deficits 
- Elaborate neuropsychological assessment 
- Assessment of effects on activities of daily living 
To offer personalized practical tools  
- Compensatory techniques 
- External (memory) aids 
To provide psychoeducation 
- Creating awareness and understanding 
- Practical implications for activities of daily living 
figure 1. The role of the neuropsychologist in multidisciplinary follow-up after neonatal critical illness
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populations.87,88 Future clinical trials that assess the efficacy and safety of dexmedetomi-
dine in critically ill neonates that also include neurobiological outcome parameters, such 
as hippocampal volume, are therefore needed. Another agent that may be of interest in 
this respect is erythropoietin. Erythropoietin is produced by various cell types in the 
developing brain as a growth factor and as an endogenous neuroprotective response to 
hypoxia.89 As previously mentioned, in addition to hypoxia, high oxygen concentrations 
as a result of supplementary oxygen may lead to neonatal brain damage as well.46-50 A 
recent study in 6-day-old rat pups showed that a single dose of erythropoietin at the 
onset of hyperoxia (24 hours 80% oxygen) improved memory impairment and reduced 
acute oligodendrocyte degeneration up to the adolescent and adult stage.90 Given the 
vulnerability of pre-oligodendrocytes in the periventricular white matter during the peri-
natal period29, which may potentially be (partly) underlying the attention and memory 
deficits observed later in life in survivors of neonatal critical illness (chapter 6), reducing 
microstructural abnormalities in these fibers would have direct clinical benefits. In ad-
dition, studies have found that erythropoietin may have neurotrophic effects as well by 
increasing synaptic plasticity in the hippocampus and improving memory formation.90,91 
The hippocampus shows a uniquely high degree of neuroplasticity, which means it has 
the ability to adapt and reorganize in response to internal or external stimuli.49 Although 
this unfortunately seems to result in more pronounced vulnerability than plasticity – the 
mechanisms underlying this (im)balance remain largely unknown – its ability to gener-
ate new neurons throughout life does make it a promising target in this respect.49 Trials 
on potentially neurotrophic agents such as erythropoietin are therefore of interest. In 
infants with extreme prematurity, hypoxic-ischemic encephalopathy, perinatal stroke, 
and complex cyanotic heart disease, trials have demonstrated safety, and the potential 
for efficacy of erytrhopoietin.92 However, the optimal dose and regimen for neuroprotec-
tion in neonates remains largely unknown.93 Future clinical intervention trials assessing 
the effects of neuroprotective agents before, during or after exposure to both hypoxia 
and hyperoxia are needed in critically ill neonates.
concluSion 
In this thesis, we have demonstrated that survivors of neonatal critical illness are at risk 
of sustained attention and verbal and visuospatial memory deficits, despite generally 
average intelligence. These neuropsychological deficits seem to be associated with spe-
cific brain alterations that are mainly located in the brain’s limbic system. In particular, 
we demonstrated that hippocampal alterations and associated memory deficits exist 
across survivors of neonatal critical illness, irrespective of underlying disease or gesta-
tional age. We suggest that this common neurodevelopmental pathway across survivors 
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of neonatal critical illness is due to factors associated with neonatal critical illness, such 
as hypoxia-ischemia, inflammation, stress, and analgosedatives, or a complex interplay 
amongst these factors. Our findings have further demonstrated that CWMT could be 
considered for school-age survivors of neonatal ECMO and/or CDH who have long-term 
visuospatial memory deficits. It is therefore important that, in today’s practice, neuro-
psychological assessment is conducted before a child starts an intervention program 
such as CWMT to establish its clinical utility. Although it is promising that we find neu-
rodevelopmental outcome to be malleable following neonatal critical illness, CWMT is 
not the optimum solution as multiple neuropsychological domains are affected in these 
children. To improve outcome following neonatal critical illness in current practice, pro-
viding psychoeducation, compensatory techniques and external (aids) should become 
a standard part of (long-term) care following neonatal critical illness.
The findings described in this thesis have underlined the necessity of broadening our 
focus from short-term to long-term outcome following neonatal critical illness. Given 
the increasing number of critically ill infants that survive today94,95, future research di-
rected at improving long-term outcome by protecting the vulnerable brain, particularly 
in the newborn period, is of utmost importance.
fuTure reSearch direcTionS
- Future research should aim to gain insight into the exact pathophysiological mecha-
nisms underlying long-term neuropsychological deficits following neonatal critical 
illness. This may lead to the identification of clinical, iatrogenic or therapeutic factors 
that are most detrimental to the developing hippocampus in critically ill infants, 
which will improve risk stratification and better targeted treatment.
- As critically ill infants ‘grow into their deficits’, longitudinal studies that combine 
dense data collection in the perinatal period with follow-up neuroimaging and 
neuropsychological assessments are imperative. This will allow us to find ‘windows 
of sensitivity’ (i.e. when infants are most at risk of impairment, the optimal timing 
of MRI or neuropsychological assessment) as well as ‘windows of opportunity’ (i.e. 
when it is best to implement therapy or interventions).
- To improve outcome, future studies on the efficacy and safety of pharmacological 
therapy in critically ill infants should include the assessment of its effects on the 
developing brain in addition to other outcome parameters.
- Future trials on cognitive interventions following neonatal critical illness should be 
problem-oriented, i.e. focused on those neuropsychological domains or brain areas 
most at risk in survivors of neonatal critical illness.
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Summary
introduction
Children growing up after neonatal critical illness are at risk of long-term neuropsy-
chological deficits and school problems. However, the specific neuropsychological 
profile and its underlying neurobiology have remained largely unknown. Furthermore, 
strategies to prevent or diminish impaired outcome have remained unstudied. These 
knowledge gaps are tackled in a clearly delimited group of survivors of neonatal critical 
illness: children treated with neonatal extracorporeal membrane oxygenation (ECMO) 
and children with congenital diaphragmatic hernia (CDH) treated without ECMO.
cognition and the brain after neonatal critical illness
In chapter 2, the developmental trajectory of IQ in survivors of neonatal ECMO is de-
scribed at the ages of 2, 5, and 8 years. We show that IQ is stable and average in these 
children. Despite average IQ, neonatal ECMO survivors are more often in need of extra 
help in school compared to the general population. Specific neuropsychological deficits 
may be underlying these school problems. Indeed, we show that increased need for help 
in school is associated with sustained attention deficits, irrespective of IQ. We further 
demonstrate that children with CDH who needed ECMO treatment are at highest risk of 
long-term neuropsychological deficits.
In chapter 3, we use elaborate neuropsychological assessment to assess the neuro-
psychological outcome profile following neonatal ECMO and/or CDH at 8 years of age. 
Despite a generally average IQ, we show significant deficits in sustained attention, and 
short- and long-term verbal and visuospatial memory in survivors of neonatal ECMO 
and/or CDH compared to the general population. We find that children with CDH who 
needed ECMO have lower IQ than those not treated with ECMO and those treated with 
ECMO following diagnoses other than CDH. However, the specific neuropsychological 
deficits are similar across these groups. We also explore potential risk factors of long-
term neuropsychological deficits. Our results show that a higher maximum vasoactive-
inotropic score (maximum dose of vasoactive medication required during hospital stay) 
is specifically associated with long-term verbal and visuospatial memory deficits at 8 
years of age. These findings may indicate a relationship between early cerebral hypoper-
fusion and memory in later life.
In chapter 4, we assess neuropsychological outcome in 17-year-old survivors of neo-
natal ECMO. We find similar deficits as those found at 8 years of age. Adolescents have 
significantly worse short- and long-term verbal and visuospatial memory compared 
to the norm. Sustained attention is not assessed at this age. These findings suggest 
memory deficits to persist until adolescence following neonatal ECMO.
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In chapter 5, Diffusion Tensor Imaging and structural MRI are used to compare white 
matter microstructure and hippocampal volume between neonatal ECMO survivors and 
healthy controls (8-15 years). We find that neonatal ECMO survivors have significantly 
lower global fractional anisotropy, a measure of coherence of white matter fibers, which 
may indicate long-term injury to neural tracts. In addition to these global differences, we 
find significantly lower fractional anisotropy in the cingulum bundle, and higher mean 
diffusivity – suggestive of decreased integrity in axonal membranes, packing, or myelin 
– in the parahippocampal part of the cingulum. Furthermore, we show smaller hippo-
campal volume in neonatal ECMO survivors compared to controls, which is associated 
with worse verbal memory in these children. These results help define the underlying 
neurobiology involved in the long-term neuropsychological deficits following ECMO.
In chapter 6, we assess whether the neuropsychological deficits observed following 
neonatal ECMO are specifically associated with the brain alterations described in chapter 
5. In a different cohort of survivors of neonatal ECMO and/or CDH (8-12 years), we show 
that lower global fractional anisotropy and lower fractional anisotropy in the cingulum 
bundle are associated with sustained attention deficits. Higher mean diffusivity in the 
parahippocampal part of the cingulum is associated with visuospatial memory deficits, 
whereas smaller hippocampal volume is associated with verbal memory deficits. Our 
findings indicate specific neurobiological correlates of attention and memory deficits in 
school-age survivors of neonatal ECMO and CDH. The structure-function relationships 
are observed irrespective of diagnosis or type of ECMO-cannulation. Interestingly, our 
results are in line with findings in survivors of other types of critical illness in early life, 
such as neonatal hypoxia and congenital heart disease.
can we train the damaged brain after neonatal critical illness? 
In chapter 7, we describe neuropsychological functioning immediately and one year 
after Cogmed Working-Memory Training (CWMT), assessed using a nationwide, single-
blind randomized controlled trial in school-age (8-12 years) survivors of neonatal ECMO 
and/or CDH. In children trained with CWMT, we find immediate improvements in verbal 
and visuospatial working-memory compared to non-trained controls. However, these 
improvements do not persist until one year post-intervention. Sustained improve-
ments in long-term visuospatial memory in the CWMT group are found one year post-
intervention compared to the non-training group. Given the high risk of visuospatial 
memory deficits in this population, CWMT may be beneficial for survivors of neonatal 
critical illness with these specific deficits.
In chapter 8, white matter microstructure assessed using Diffusion Tensor Imaging is 
compared between school-age (8-12 years) neonatal ECMO and/or CDH survivors im-
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mediately after CWMT and compared to non-trained survivors. We find training-induced 
changes in both global white matter microstructure as well as in the left superior longi-
tudinal fasciculus in the CWMT group compared to non-trained children. Increased frac-
tional anisotropy in the superior longitudinal fasciculus is significantly associated with 
improved verbal working-memory in the CWMT group. However, the global increase in 
fractional anisotropy is not associated with any cognitive improvements. Nonetheless, 
our findings demonstrate neuroplasticity following neonatal ECMO and/or CDH. Future 
studies that include neuroimaging and neuropsychological assessment both immedi-
ately and one year post-intervention are needed.
The vulnerable brain in critically ill infants
In chapter 9, we describe the results of a comprehensive literature review on memory 
and its neurobiological substrates, specifically the hippocampus, in children following 
preterm birth, congenital heart disease, neonatal ECMO treatment and/or CDH. We 
propose a common neurodevelopmental pathway following neonatal critical illness 
where early hippocampal alterations are associated with memory deficits later in life 
across survivors of neonatal critical illness, irrespective of underlying diagnosis or ges-
tational age. We suggest that this shared hippocampal vulnerability is probably related 
to common conditions associated with neonatal critical illness, including hypoxia, neu-
roinflammation, stress, exposure to anesthetics, or a complex interplay of these factors 
at different postconceptional ages. The clinical implications of these findings and future 
perspectives are discussed.
In chapter 10, we describe the results of a literature review on the effects of commonly 
used analgesics and sedatives (analgosedatives) on the brain and neuropsychological 
outcome in critically ill neonates. Infants admitted to neonatal or pediatric intensive 
care units receive very high amounts of these drugs, which may contribute to the 
neurodevelopmental impairments observed in these children. Although less obvious 
in human studies than animal studies, results indicate that exposure to analgosedatives 
in neonates and infants may have long-term effects on the brain and cognition. Specifi-
cally, the hippocampus and memory may be affected by sedatives such as midazolam 
and propofol. A balanced approach that includes the assessment and quantification 
of both wanted effects and unwanted effects of analgosedatives is needed. Therefore, 
long-term neuropsychological outcome should be assessed as well when evaluating 
drug efficacy and safety.
In chapter 11, we discuss our main findings, compare them with the current literature 
and make recommendations for future research to improve long-term outcome follow-
ing neonatal critical illness. Our findings emphasize the need for long-term neuropsycho-
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logical follow-up in these patients and the need for early identification of patients at risk 
for long-term neuropsychological deficits and school problems. As MRI is a non-invasive 
technique, using hippocampal volume in early infancy as a neurobiological marker of 
memory deficits in later life may in the future lead to earlier identification of patients at 
risk. Longitudinal studies in which neurodevelopment is assessed using both neuroim-
aging and neuropsychological assessment are therefore imperative following neonatal 
critical illness, favorably using a healthy control group. Furthermore, an important area 
of future research is to gain insight into the exact pathophysiological mechanisms. This 
insight may lead to diminished or even prevention of long-term adverse outcomes by 
adjustments in neonatal critical care and/or application of neuroprotective strategies. 
Intervention strategies that aim to improve impaired neuropsychological outcome at 
a later stage in survivors of neonatal critical illness remain of interest as well. Assessing 
the effectiveness of multimodal interventions, such as cognitive training combined with 
an exercise program, may be beneficial in survivors of neonatal critical illness. Finally, to 
improve outcome following neonatal critical illness in current practice, providing psy-
choeducation, compensatory techniques and external (aids) should become a standard 
part of (long-term) care following neonatal critical illness.
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Dutch summary
introductie
Kinderen die in de neonatale periode zeer ernstig ziek zijn geweest, hebben op latere 
leeftijd een verhoogd risico op neuropsychologische problemen en schoolproblemen. 
Het specifieke neuropsychologische profiel en de onderliggende neurobiologie is 
echter onbekend. Daarbij zijn behandelingsmethoden om de neuropsychologische 
uitkomsten van deze kinderen te verbeteren nog altijd niet bestudeerd. Dit is daarom 
onderzocht bij kinderen die zijn behandeld met neonatale extracorporale membraan 
oxygenatie (ECMO) en bij kinderen met een congenitale hernia diafragmatica (CDH; 
congenital diaphragmatic hernia) die niet zijn behandeld met ECMO.
cognitie en het brein 
In hoofdstuk 2 wordt de ontwikkeling van het IQ na behandeling met neonatale ECMO 
beschreven op de leeftijden van 2, 5 en 8 jaar. We laten zien dat het IQ van deze kinderen 
stabiel en gemiddeld is. Ondanks dit gemiddelde IQ hebben kinderen die zijn behandeld 
met ECMO in vergelijking met leeftijdsgenoten vaker extra hulp nodig op het regulier 
basisonderwijs. Specifieke neuropsychologische problemen liggen hier mogelijk aan 
ten grondslag. We laten zien dat kinderen die extra hulp nodig hebben op school vaker 
problemen hebben met de volgehouden aandacht. Deze problemen zijn niet gerela-
teerd aan het IQ. Ook zien we dat kinderen met CDH die zijn behandeld met ECMO het 
hoogste risico hebben op deze neuropsychologische langetermijnproblemen.
In hoofdstuk 3 gebruiken we uitgebreid neuropsychologisch onderzoek om het neu-
ropsychologisch profiel na behandeling met neonatale ECMO en/of CDH te onderzoe-
ken op 8-jarige leeftijd. Hoewel deze kinderen een gemiddeld IQ hebben, zien we in 
vergelijking met gezonde leeftijdsgenoten significante afwijkingen in de volgehouden 
aandacht, en in het verbaal- en visueel-ruimtelijke, korte- en langetermijngeheugen. We 
zien dat kinderen met CDH die zijn behandeld met ECMO over het algemeen een lager 
IQ hebben dan kinderen met CDH die niet zijn behandeld met ECMO en dan kinderen 
die zijn behandeld met ECMO na andere diagnoses. Onze resultaten laten zien dat een 
hogere maximale vasoactieve-inotropische score (maximum dosering vasoactieve 
medicatie tijdens de ziekenhuisopname) specifiek geassocieerd is met problemen in 
het verbaal- en visueel-ruimtelijk langetermijngeheugen op 8-jarige leeftijd. Deze 
bevindingen duiden mogelijk op een relatie tussen cerebrale hypoperfusie tijdens de 
eerste levensmaanden en het geheugen op latere leeftijd.
In hoofdstuk 4 beschrijven we neuropsychologische uitkomsten bij 17-jarige adoles-
centen die zijn behandeld met neonatale ECMO. We tonen aan dat de adolescenten 
problemen hebben die vergelijkbaar zijn met de geconstateerde problemen van de 
8-jarige kinderen. Adolescenten die zijn behandeld met neonatale ECMO hebben een 
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significant slechter verbaal- en visueel-ruimtelijk korte- en langetermijngeheugen dan 
gezonde leeftijdsgenoten. Volgehouden aandacht is niet onderzocht op deze leeftijd. 
Deze resultaten suggereren dat de geheugenproblemen na behandeling met neonatale 
ECMO ook in de pubertijd nog aanwezig zijn.
In hoofdstuk 5 gebruiken we Diffusion Tensor Imaging en structurele MRI om de micro-
structuur van de witte stof en het hippocampaal volume bij kinderen na behandeling 
met neonatale ECMO te vergelijken met gezonde leeftijdsgenoten (8-15 jaar). We laten 
zowel globale als specifieke afwijkingen zien in de microstructuur van witte stof bij 
kinderen die zijn behandeld met ECMO, in vergelijking met gezonde leeftijdsgenoten. 
Daarnaast zien we dat het hippocampusvolume kleiner is bij kinderen die zijn behandeld 
met ECMO dan bij gezonde kinderen. Een kleiner hippocampaal volume is eveneens 
geassocieerd met een verminderd verbaal geheugen bij kinderen die zijn behandeld 
met ECMO. Deze resultaten dragen bij aan het definiëren van de onderliggende neuro-
biologie van neuropsychologische problemen na behandeling met ECMO.
In hoofdstuk 6 onderzoeken we of de neuropsychologische problemen na neonatale 
ECMO geassocieerd zijn met de veranderingen in het brein die zijn beschreven in hoofd-
stuk 5. In een ander cohort van kinderen die zijn behandeld met neonatale ECMO en/
of CDH (8-12 jaar), vinden we dat globale afwijkingen in de microstructuur van witte 
stof geassocieerd zijn met problemen in de volgehouden aandacht. Specifieke afwij-
kingen in het parahippocampale deel van de cingulum zijn geassocieerd met slechter 
visueel-ruimtelijk langetermijngeheugen, terwijl een kleiner hippocampaal volume 
geassocieerd is met problemen in het verbaal langetermijngeheugen. De associaties 
tussen het brein en cognitie zijn onafhankelijk van de onderliggende diagnose of het 
type ECMO-canulatie dat gebruikt is. Opmerkelijk is dat onze bevindingen overeenko-
men met bevindingen bij kinderen die om andere redenen in de neonatale periode op 
de Intensive Care hebben gelegen, zoals kinderen met een aangeboren hartafwijking of 
met hypoxie in de neonatale periode.
kunnen we het beschadigde brein trainen? 
In hoofdstuk 7 beschrijven we het neuropsychologisch functioneren direct en één jaar 
na Cogmed werkgeheugentraining. Dit onderzoeken we met een gerandomiseerde, 
gecontroleerde trial onder 8- tot 12-jarige kinderen die zijn behandeld met neonatale 
ECMO en/of CDH. We vergelijken kinderen die zijn getraind met Cogmed met kinde-
ren die niet deze training hebben gehad, zowel direct als een jaar na de training. De 
Cogmed-kinderen laten verbeteringen zien in zowel verbaal- als visueel-ruimtelijk werk-
geheugen direct na de training in vergelijking met de niet-getrainde kinderen. Deze 
verbeteringen verdwijnen echter na een jaar. De Cogmed-groep laat wel blijvende ver-
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beteringen zien in het visueel-ruimtelijk langetermijngeheugen een jaar na de training, 
in vergelijking met niet-getrainde kinderen. Omdat deze populatie een verhoogd risico 
heeft op dit soort geheugenproblematiek, is Cogmed werkgeheugentraining mogelijk 
een waardevolle interventie voor kinderen met problemen in het visueel-ruimtelijk 
langetermijngeheugen.
In hoofdstuk 8 wordt het effect van de Cogmed werkgeheugentraining op de micro-
structuur van witte stof onderzocht door middel van Diffusion Tensor Imaging in 8- tot 
12-jarige kinderen die zijn behandeld met neonatale ECMO en/of CDH. In vergelijking 
met de ongetrainde groep zien we direct na Cogmed zowel globale als specifieke 
veranderingen in de microstructuur van de witte stof. De specifieke veranderingen zijn 
geassocieerd met verbeteringen in het verbaal werkgeheugen direct na Cogmed. De 
globale veranderingen zijn niet geassocieerd met cognitieve verbeteringen direct of 
een jaar na Cogmed. Onze resultaten laten desalniettemin zien dat er neuroplasticiteit 
bestaat bij kinderen die zijn behandeld met ECMO en/of CDH. Studies die zowel direct 
als een jaar na Cogmed het neuropsychologisch functioneren en het brein onderzoeken 
zijn nodig om beter te begrijpen hoe Cogmed precies werkt.
het kwetsbare brein 
In hoofdstuk 9 beschrijven we de resultaten van een literatuurstudie naar het geheu-
gen en de hippocampus van kinderen die prematuur geboren zijn, kinderen die een 
aangeboren hartafwijking hebben, kinderen die behandeld zijn met neonatale ECMO, 
en kinderen met CDH. Op basis van deze resultaten veronderstellen wij dat er mogelijk 
een ‘common neurodevelopmental pathway’ bestaat na een periode van zeer ernstig 
ziek zijn in de eerste levensmaanden: vroege afwijkingen in de hippocampus leiden tot 
geheugenproblemen, onafhankelijk van de onderliggende diagnose of zwangerschaps-
duur. Deze gedeelde hippocampale gevoeligheid is mogelijk gerelateerd aan algemene 
factoren die horen bij zeer ernstig ziek zijn, zoals hypoxie, neuroinflammatie, stress, 
blootstelling aan sedativa en analgetica, of een complexe interactie tussen die factoren. 
De klinische implicaties en perspectieven voor toekomstige studies gebaseerd op deze 
bevindingen worden besproken.
In hoofdstuk 10 worden de uitkomsten besproken van een literatuurstudie naar het 
effect van veelgebruikte analgetica en sedativa op het brein en de neuropsychologi-
sche ontwikkeling bij kinderen die zeer ernstig ziek zijn geweest. Kinderen die worden 
behandeld op de neonatale of kinder-intensive care unit krijgen zeer hoge doseringen 
van deze medicamenten, die mogelijk de neurocognitieve ontwikkeling negatief 
beïnvloeden. Hoewel de resultaten in studies met mensen minder duidelijk zijn dan in 
dierstudies, hebben analgetica en sedativa mogelijk een negatief effect op het brein 
Chapter 13
262
en op het cognitief functioneren van deze kinderen. Met name de hippocampus en het 
geheugen lijken gevoelig voor sedativa zoals propofol of midazolam. Een evenwichtige 
aanpak, waarin zowel de gewilde als de ongewilde effecten van deze middelen worden 
geanalyseerd, is nodig. Hierin dienen de effecten op de neurocognitieve ontwikkeling 
meegenomen te worden.
In hoofdstuk 11 worden de belangrijkste bevindingen besproken en in perspectief ge-
plaatst op basis van de bestaande literatuur. Ook worden er aanbevelingen gedaan voor 
toekomstige studies om zo de uitkomsten van kinderen die in de neonatale periode 
zeer ernstig ziek zijn geweest te verbeteren. Onze resultaten laten zien dat kinderen 
die zijn behandeld met ECMO en/of CDH een verhoogd risico hebben op geheugen- en 
aandachtsproblemen, terwijl ze een normaal IQ hebben. Omdat dit soort neuropsy-
chologische functies zich pas op latere leeftijd ontwikkelt, is het van groot belang dat 
deze kinderen herhaald gezien worden op de lange termijn. We laten zien dat specifieke 
afwijkingen in het brein, zoals een kleiner hippocampaal volume, geassocieerd zijn met 
neuropsychologische problemen die deze kinderen hebben. Het in kaart brengen van 
het hippocampaal volume in de eerste levensjaren via MRI, een non-invasieve techniek, 
zou mogelijk kunnen bijdragen aan vroegere identificatie van kinderen met een ver-
hoogd risico op geheugenproblemen. Longitudinale studies waarin de neurocognitieve 
ontwikkeling onderzocht wordt met zowel MRI als neuropsychologisch onderzoek, en 
waarbij een vergelijking wordt gemaakt met gezonde kinderen, is daarom essentieel. 
Een belangrijke volgende stap is het bestuderen van de exacte pathofysiologische 
mechanismen die aan de neurocognitieve problemen bij deze kinderen ten grondslag 
liggen. Deze kennis zal mogelijk leiden tot verbetering van de uitkomsten doordat be-
handelmethoden kunnen worden aangepast of specifieke neuroprotectieve middelen 
kunnen worden toegepast. Interventies gericht op het verbeteren van neuropsycholo-
gische problemen zijn echter ook van belang. Verder onderzoek naar de effectiviteit van 
multimodale interventies, zoals de combinatie van een cognitieve en lichamelijke trai-
ning, is nodig bij deze kinderen. In de huidige praktijk is het noodzakelijk dat kinderen 
en ouders psychoeducatie, compensatietechnieken en handvatten wordt aangeboden. 
Dit zou een standaard onderdeel moeten zijn van de zorg voor kinderen die in de neo-
natale periode zeer ernstig ziek zijn geweest.
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PhD portfolio
Phd PorTfolio
Name PhD student: Raisa Schiller 
Erasmus MC Department: IC Children/Pediatric Surgery and Child and Adolescent Psychiatry/psychology
PhD period: April 2014 – April 2018
Promotor(s): Prof. dr. Tibboel and prof. dr. Verhulst
Supervisor(s): Dr. Hanneke IJsselstijn and dr. Tonya White
Training program year Workload 
general academic skills
EndNote and Pubmed courses 2014 1.0 EC
Open Clinica course, Erasmus Medical Center 2014 0.2 EC
Research management for PhD students 2014 1.0 EC
BROK 2015 1.0 EC
How to present your poster 2015 0.1 EC
Workshop Presenting Skills for junior researchers 2016 1.0 EC
Scientific Integrity 2017 0.3 EC
research skills
MRI safety course and technical training 2014 0.6 EC
Biostatistics Part II: Classical Regression Models 2015 2.8 EC
Advanced topics in MR imaging of the brain, Donders Institute 2015 1.0 EC
Introduction in GraphPad Prism, MolMed 2015 0.3 EC
FSL course 2016 2.0 EC
Presentations
Research meeting neuroradiology (AMBER) 2014 0.3 EC
Research meeting Pediatric Surgery/IC 2014-2017 1.2 EC
Conference Verona, Italy on behalf of Ped. Surgery Dept. 2015 0.3 EC
Grand Round 2016 0.3 EC
KNICR Symposium 2016 0.3 EC
OHBM Conference Vancouver, Canada 2017 0.3 EC
Pediatric Psychology research meeting 2017 0.3 EC
Great Ormond Street Hospital, London 2018 0.3 EC
conferences 
Conference Verona, Italy 2015 1.0 EC
Neuroimaging conference, Amsterdam 2015 0.3 EC
Pump your Career, NWO, Amersfoort 2015 0.3 EC
young Researchers Day, Tulips, Maarssen 2015 0.3 EC
Child Health Symposium, Noordwijk 2016 1.0 EC
KNICR symposium, Erasmus MC – Sophia 2016 0.3 EC
OHBM Conference Vancouver, Canada 2017 1.0 EC
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Training program year Workload 
Seminars and workshops
PhD Day Erasmus MC, several workshops 2014+2015 0.5 EC
Research meetings pediatric surgery (monthly) 2014-2018 2.0 EC
Research meetings neuroradiology (monthly) 2014-2018 2.0 EC
Research meetings neuroimaging (biweekly) 2014-2018 4.0 EC
Research meetings CHIL (monthly) 2014-2018 2.0 EC
Teaching tasks
Tutor neuropsychological diagnostics, EUR 2014 1.3 EC
Tutor psychological diagnostics, EUR 2014 1.3 EC
Supervisor minor Neurobiology, Erasmus MC 2015 1.0 EC
other
Committee Sophia Research Day 2015 2014-2015 2.0 EC
Committee Sophia Research Day 2016 2015-2016 2.0 EC
Committee Sophia Research Day 2017 2016-2017 2.0 EC
TULIPS PhD curriculum 2016-2018 4.0 EC 
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The Netherlands. She grew up in Bilthoven, where she 
received her Gymnasium degree in 2006. That same 
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ogy and play Division-1 Field Hockey on a full schol-
arship at Wake Forest University in Winston-Salem, 
North Carolina. After graduating in 2010, she moved 
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and master Clinical Neuropsychology (cum laude).
From September 2013, Raisa started working as a neuropsychologist at the outpatient 
clinic of the Department of Child- and Adolescent Psychiatry/Psychology at the Erasmus 
MC-Sophia Children’s Hospital in Rotterdam for six months. She then commenced her 
PhD-project in April 2014 on neurodevelopmental outcome following neonatal critical 
illness at the departments of Intensive Care and Pediatric Surgery (Prof. dr. D. Tibboel 
(promotor), Dr. Hanneke IJsselstijn (copromotor)) and Child and Adolescent Psychiatry/
Psychology (Prof. dr. Frank Verhulst (promotor), Dr. Tonya White (copromotor)).
Raisa aims to combine research with clinical work. In January 2018, she started work-
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the Intensive Care and Pediatric Surgery department, which she will combine with her 
clinical work.
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Over the last decade, the 
number of children admitted 
to specialized intensive 
care units has increased 
significantly worldwide. 
The majority of critically ill 
infants nowadays survive. 
This development requires 
our focus to broaden from 
minimizing mortality rates 
to maximizing long-term 
quality of life following 
neonatal critical illness. 
The findings presented in 
this thesis demonstrate 
the importance of long-
term neurodevelopmental 
follow-up in survivors of 
neonatal critical illness and 
stress the need for early risk 
stratification and targeted 
intervention strategies for 
these children.
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